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CHAPTER 1
INTRODUCTION
1.1 Long-Term Goals
Analytical technologies for biological compounds have developed rapidly and
become essential and indispensable in life science, pharmaceutical chemistry, clinical,
and health care fields. For example, diseases are driven by molecular modifications in the
cell, such as some cancers that result from the phosphorylational modification on amino
acid residues of proteins. 1,2 Analyses on the cellular levels is therefore important for
disease diagnoses and treatment. In the real world, analysis of complex materials is
difficult, mainly due to issues of sensitivity, dynamic range, solubility, and complexity. 3
Brain tissue is an example of a complex material. It is composed of lipids, peptides,
proteins, and carbohydrates, as well as other substances4,5 that build up the brain structure
and maintain brain functions. There are also numerous exogenous species accumulating
in brain tissue, such as drugs from disease treatment or drug addiction.6 In addition to the
fact that the amount of lipids in cells is overwhelmingly higher than proteins,4,5 the
structure diversity of lipids is much more significant than other compounds.7,8 Therefore
the analysis of a compound of interest from a complex environment becomes more
difficult.
A number of analytical technologies have been developed to analyze complex
biological compounds in order to understand property/function relationships. To name a
few, separation methods such as gas chromatography, liquid chromatography (LC), and
thin layer chromatography were developed to separate components from complex
mixtures, with the separation usually taking minutes to hours.9,10 Spectroscopy methods
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such as ultraviolet-visible absorption spectroscopy is used to detect, identify and quantify
atoms and molecules, but often lacks sensitivity and specificity.9 Nuclear magnetic
resonance (NMR) spectroscopy elucidates structural information of organic compounds,
but usually requires milligrams or milliliters of samples.11 Immunoassays are commonly
used in clinical analyses for targeted proteins and have high specificity, but the
development of antibodies for this purpose is costly and time consuming.12
Mass spectrometry (MS) has a number of advantages for providing molecular
information relative to other spectroscopic methods, has matched sensitivity and less cost
for consumables than immunoassays while overcoming problems like cross-reactivity
with metabolites, and achieving higher speed than traditional separation methods
applicable for high-throughput analyses.9- 15 The disadvantages of MS include the
relatively costly instrumentation, lack of robustness, and requirement for trained
operators and expertise.12,16,17 Scheme 1.1 lists the challenges that need to be addressed
to promote MS to have further practical utility, taking clinical analyses as an example.18
Higher sensitivity and dynamic range are required to observe all components from
complex substrates.19 For example, signals from lipids often dominate the mass spectrum,
while peptides, proteins, and small molecules may not be observable. 20 , 21 Separation
technologies prior to MS, e.g. LC-MS, can help to reduce the complexity and improve the
dynamic range and specificity. Tandem MS with, for example, collision induced
dissociation (CID) can improve specificity by requiring specific fragmentation transitions.
This method can also provide structural information for e.g. peptides and drugs. 22,23
Reproducibility and spatial resolution are desired for quantification and exact location, to
differentiate e.g. the diseased tissue from the healthy area. 24 Data acquisition of MS for
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rapid response in, for example, emergency rooms or surgical facilities need to be fast.
The instrumentation and consumables should be financially affordable and simple to
use.12,17 Therefore, MS has particular value in biological material characterization.
Scheme 1.1 Technology development needed to expand the use of MS for
clinical applications [Adopted from Reference 18]. Points highlighted in red
will be covered in this thesis.
A.

B.
C.

Sensitivity and dynamic range: to observe all components (e.g.,
lipids and proteins, hydrophilic and hydrophobic, low and high
abundance) directly from native and complex environment (e.g., tissue,
plasma, serum, urine), improvements needed include:
1. Separation: to deal with complexity and isoforms (LC, mass
resolution, IMS)
2. Specificity: fragmentation (MS/MS: CID, ETD) for confirmation
and ID (bottom up, top down)
3. Reproducibility: for quantitation
4. Spatial resolution: for location (with and without a laser)
Speed: of data acquisition and interpretation
Robust, simple and cheap: automation, disposables

1.2 General Introduction on Mass Spectrometry and Tandem Mass Spectrometry
The essential components of a mass spectrometer are the ionization source, the mass
analyzer, and the detector (Scheme 1.2). Samples can be introduced into the ion source
by direct sample introduction. Alternatively, complex materials can be passed through
other separation methods prior to MS and then introduced via the interface, e.g. LC-MS
to be discussed in Section 1.3.2. Analyte molecules are converted to gas-phase ions in the
ion source; the ions are subsequently separated in the mass analyzer according to their
mass-to-charge ratio (m/z) and are detected by the detector. The result is displayed as a
mass spectrum of m/z versus relative ion intensity.
Scheme 1.2. Representation of the basic components of a mass spectrometer.
Direct
sample
introduction
Preseparation
techniques

Mass spectrometer
Ion
source

Mass
analyzer

Detector

Data
system
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Tandem MS is used for the ions of interest to undergo a second or more mass
spectrometric analysis. The ions at a certain m/z are selected (MS1) and fragmented
intentionally; the fragment ions are separated by the mass analyzer (MS2). This process
can be repeated several times for MSn analysis. The intentional fragmentation is typically
achieved by CID, electron-capture dissociation (ECD), or electron-transfer dissociation
(ETD).25 CID employs a collision gas (e.g. N2, He) to collide with the gas-phase analyte
ions and results in fragmentation. For example, when a peptide ion encounters the
collision gas, the peptide N-C bonds are cleaved so that smaller peptide fragments are
analyzed to provide structural information. This is a harsh process that fragile sites, e.g. a
phosphate group on a peptide, is easily cleaved off; on the contrary, ETD is a softer
dissociation process that normally retains the phosphate group on the structure. 26 The
radial anion of a small molecule, e.g. flouranthene, is generated and reacts with the
analyte ions. The electron transfers from flouranthene to the analyte ion, and the excess
energy obtained by the analyte ion leads to fragmentation. CID and ETD are frequently
used in structural analysis such as peptide sequencing and proteomics.26
This dissertation is focusing on ionization methods, and specifically coupling a novel
ionization process with different mass analyzers. Therefore, a more detailed description
of ionization methods and mass analyzers will be provided in the next sections.
1.3 Ionization for Mass Spectrometry
Any form of MS analysis can only occur when molecules are efficiently converted to
gas-phase ions. Various ionization methods have been developed over decades. Early
invented ionization methods include electron ionization (EI), 27 chemical ionization
(CI),28 fast atom bombardment (FAB),29 secondary ion mass spectrometry (SIMS),30 etc.
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Matrix-assisted laser desorption/ionization (MALDI) 31 , 32 and electrospray ionization
(ESI), 33 developed during the 1980’s, are currently the two most widely used “soft”
ionization methods in MS and are capable of ionizing non-volatile compounds from
biological materials. The inventors shared the Nobel Prize in Chemistry in 2002. This
section focuses on the principles of operation, sample preparation, fundamental, and
application aspects of MALDI, ESI, and a few ambient ionization methods.
1.3.1 Matrix-Assisted Laser Desorption/Ionization (MALDI)
MALDI was developed as a vacuum ionization method (Scheme 1.3.A) and has been
extended to atmospheric pressure (AP) (Scheme 1.3.B).
Scheme 1.3. Schematic representation of the MALDI process in vacuum (A) and at
atmospheric pressure (B).
Matrix

In Vacuum

Laser Beam
(Reflection
Geometry)

Metal Plate

A.

+

To
Mass
Analyzer

Analyte

B.

Metal Plate

Matrix

+

Laser Beam
(Reflection
Geometry)

Atmospheric
Pressure

To
Mass
Analyzer
MS Orifice

Analyte

-
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1) Vacuum MALDI
Traditional MALDI utilizes a ultraviolet (UV) laser in vacuum to ablate the surface
of matrix:analyte crystals on a target plate in reflection geometry. The ions produced are
accelerated by the voltage (~20 kV) applied on the target sample plate, and guided by
focusing lens to the mass analyzer (Scheme 1.3.A). Initially, an inexpensive and smaller
nitrogen laser was used in MALDI,30,31 but the laser repetition and life span is limited.34
The demands of higher repetition rate and longer lifetime lasers in MALDI applications
such as imaging and high-throughput are fulfilled by neodymium-doped yttrium
aluminum garnet (Nd:YAG) lasers (wavelength ~355 nm, repetition rate >1000 Hz).34
As can be seen in the scheme above, the particles do not leave the target surface at the
same time, resulting in time dispersion of ions. Delayed extraction reduces the velocity
distribution. 35 Before the extraction voltage is applied, the generated ions first pass
through a field-free region, and after a short delay (normally below a millisecond), the
extraction voltage is turned on for subsequent time-of-flight (TOF) analysis.
Solid organic compounds (shown in Scheme 1.4) are used as traditional UV-MALDI
matrices. α-Cyano-4-hydroxycinnamic acid (CHCA), 2,5-dihydroxybenzoic acid (2,5DHB), and sinapinic acid are commonly used for peptides and proteins, 3hydroxypicolinic acid is for oligonucleotides, dithronal for polymers, and 9nitroanthracene for fullerenes. The aromatic rings in these MALDI matrices absorb light
at UV wavelengths.
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Scheme 1.4. Examples of common MALDI matrices. (A) α-Cyano-4hydroxycinnamic acid (CHCA), (B) 2,5-dihydroxybenzoic acid (2,5-DHB), (C)
sinapinic acid, (D) 3-hydroxypicolinic acid , (E) dithranol, (F) 9-nitroanthracene.

A.

B.

O

O

O

C.

OH

H3CO

OH
CN

HO

HO

HO

D.

E.
OH
N

OH

OH

OH

OCH3
OH

OH

F.

NO2

COOH

Traditional solvent-based MALDI sample preparation uses dried-droplet or layer
method for sample preparation.31,32 Homogenous crystals are ideal for MALDI sample
preparation to avoid the “hotspot” issue. If the laser beam strikes at the hotspot, more
ions are generated, thus resulting in poor reproducibility from shot to shot. The analyte
and matrix should be soluble in respective solvents that are compatible with each other.
A solvent-free sample preparation method has been reported36 as an alternative to
overcome the difficulties with insolubility of analyte, e.g. with membrane proteins37 and
synthetic polymers.38 The matrix powder is mixed with dried analyte at higher molar ratio,
homogenized and transferred to sample holders by a mini ball mill device.36,37 This
approach overcomes the hurdles of the solubility restrictions for traditional MALDI, and
in some cases yields even better mass spectra than solvent-based methods,39,40 without
the hotspot issue, but generally with lower sensitivity.41
Photoionization 42 and cluster models 43 are the most commonly accepted ion
formation mechanisms in MALDI. 44 In the photoionization model, the laser energy is
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absorbed by the matrix, producing a plume about 10 µm above the sample surface, and
generating primary ions. Analyte molecules react with the primary ions in the hot plume
and become ionized by a charge transfer mechanism. In the cluster model, charged
matrix/analyte clusters are produced upon laser firing, and the clusters are desolvated to
produce analyte ions.
Dominant singly charged ions are formed from the solid state. For larger peptides and
proteins, multiply charged ions can be produced with the matrix CHCA.45 However, the
ions are metastable and dissociate during travel through the analyzer.46 The production of
singly charged ions simplifies data interpretation in a straight-forward fashion. MALDI is
commonly coupled with a TOF mass analyzer and will be discussed in more details in
Section 1.4.1. New developments have involved coupling MALDI to other mass
analyzers, e.g. quadrupole-TOF for tandem MS, 47 or FT-ICR for ultrahigh mass
accuracy.48 More details on mass analyzer will be introduced in Section 1.4.
MALDI is applicable to the ionization of a wide range of biological compounds such
as peptides and proteins, lipids, carbohydrates, oligonucleotides, bacteria, etc., directly
from solid surfaces. 49 - 54 This merit enables MALDI for mass spectrometric imaging
applications,55,56 which is a technique to visualize the spatial distribution of compounds
by their m/z values. MALDI imaging can provide spatial information of peptides and
proteins, lipids, metabolites, etc. directly from surfaces like tissue sections.55,57,58 Sample
preparation is critical in MALDI imaging, especially matrix application to the
surfaces.57, 59 Progress including applying small matrix droplets 60 and subliming dry
matrix onto the surfaces57 has been made to reduce sample delocalization. The spatial
resolution achieved by MALDI is typically ≥25 µm.55 Development of lasers is also
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reported to achieve improved spatial resolution. Ablation areas with diameters <10 µm
can be achieved by sophisticated laser focusing setup 61 and at the expense of long
acquisition time.62

MALDI imaging not only provides the location of the analyte of

interest, but also the relative amount by color-coded display. Quantification has been
reported by spotting internal standard on the tissue sections.63,64
2) AP MALDI
About one decade after the invention of vacuum MALDI, Burlingame and co-workers
introduced MALDI to be operated at AP (Scheme 1.3 B). 65 With this configuration,
common MALDI matrices (Scheme 1.4) and lasers can be used except that the target
plate and laser ablation take place at AP. 66 AP MALDI greatly simplifies the operation
procedure. 67 It is “softer” than vacuum MALDI because of the elimination of harsh
vacuum conditions and lower acceleration voltage (~5 kV).65 Galicia et al. have proposed
laser ablation using transmission geometry to improve laser beam focusing and ion
transmission.68 The ionization efficiency of this approach was reported to be poor. In
general, the ion efficiency and thus the sensitivity of AP MALDI is lower than vacuum
MALDI because of the reduced ion transmission from AP to vacuum. It has been
modeled that 99% of the ions formed are lost in AP MALDI.69
The disadvantages of MALDI mainly include high chemical background resulted
from the use of matrix in conjunction with a laser,70 the production of singly charged ions
limits the application of high-performance mass spectrometers, the high cost of
commercial MALDI sources, and not being able to couple to online separation.

10

1.3.2 Electrospray Ionization (ESI)
In contrast to MALDI as a surface ionization method, ESI ionizes analyte from
solution.33,71 Scheme 1.5 presents the ionization process of ESI operating in positive ion
mode. The analyte solution is sprayed through a metal capillary on which high voltage (a
few kV) is applied. A “Taylor cone” is formed at the capillary tip and ejects charged
droplets. The charged droplets undergo solvent evaporation and Coulombic explosion,
producing bare analyte ions.33,72 The mechanisms for ion production currently accepted
are the ion evaporation 73 and charge residue models. 74 The ion evaporation model
suggests that ions are ejected from evaporating charged droplets.73 The charge residue
model suggests that the solvent evaporates from the charged droplets producing smaller
charged droplets, leaving bare analyte ions after a few cycles.74 The ions are subsequently
extracted into the inlet of the mass spectrometer where a few volts of extraction voltage is
applied. Negative ion mode is applicable by switching the potential on the spray capillary
and extraction cone. Multiply charged ions are dominantly produced (from all but small
molecules) by ESI that are beneficial for extending the mass range of high-performance
mass spectrometers 75 and efficient intentional fragmentation for improved structural
characterization.76
Scheme 1.5. Schematic representation of ESI.
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Because ESI directly ionizes analyte in solutions, it can be interfaced with
separation techniques such as LC for online separation and analysis. The eluent eluting
from the LC column is pushed through the electrospray capillary and the resulting gasphase ions ions are introduced into the mass spectrometer. This coupling requires the
solvent of the eluent to be “sprayable”. Proteomics is one of the most important
applications to which LC-ESI can be applied.77 After enzymatic digestion, large proteins
are converted to peptides and smaller proteins. The peptide/protein mixture is separated
by LC and then subsequently ionized by ESI. Tandem MS (CID and ETD) are commonly
used to obtain sequence information.
Quantification of small molecules is another application typically achieved by LCESI-MS or tandem MS. The calibration curve is usually obtained by injecting a series of
standard solutions at different concentrations, and the peak area of the ion of interest is
plotted against concentration.
In some cases only very limited amounts of samples are available, e.g. a few µg
protein can be obtained for mammalian proteomics. 78 LC and ESI 79 at nanoliter per
minute flow rates are necessary for better separation and sensitivity when less material is
consumed.80 Ion efficiency is improved by nanoESI mainly due to the fact that smaller
charged droplets are produced at the needle tip from which the solvent evaporates more
rapidly in the time available. Therefore, the tip can be placed closer to the mass
spectrometer orifice, resulting in higher ion transmission efficiency.81 However, the low
flow rate will increase the time for analysis, and the fragile emitters for use in nanoESI
with smaller diameters are considerably more expensive. 82 The nanoESI capillary
requires more user expertise for proper alignment and is prone to clogging.
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1.3.3 Ambient Ionization
A variety of “ambient ionization” techniques have been developed that ionize
samples from their original states, with little or no sample preparation.83-89 To name a few,
direct analysis in real time (DART)83 and atmospheric solids analysis probe (ASAP)88
rapidly ionize materials by vaporizing them in the environment of heated gas (e.g. N2 or
He). Surface analysis methods based on desorption, e.g. desorption electrospray
ionization (DESI)85 and nanoDESI89, ionize a large variety of compounds by spraying
ESI solvent onto the surface while collecting the desorbed and ejected ions. Direct
surface liquid-extraction has also been used for sampling followed by ESI.86 Laser-based
approaches 90-93 have been introduced to combine the advantages of ESI and MALDI
using solvent to collect laser-ablated materials from surfaces, and producing multiply
charged ions. However, these AP ionization methods are subject to lower ion transfer
efficiency due to the rim and dispersion losses as in ESI and MALDI.69
1.4 Mass Analyzers for Mass Spectrometry
Once the molecules are converted to gas-phase ions, they are guided into the mass
analyzer and separated according to their m/z. Vacuum is critical in mass analyzers to
provide a longer mean free path. Better vacuum means less collision occurring between
ions before they reach the detector. Currently oil based rotary and turbo pumps are
commonly used to provide high vacuum in mass spectrometers (<10-7 mbar).
Common mass analyzers are sorted by their principle of operation as follows: 1) TOF
used to separate pulsed ion beams; 2) scanning mass analyzers such as magnetic sector
and quadrupole to separate continuous ion beams; 3) linear ion trap (LIT) and triple
quadrupole separate continuous ion beams and can also trap ions; 4) trapped-ion mass
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analyzers such as Orbitrap, and Fourier transform ion cyclotron resonance (FT-ICR).
These mass analyzers have different duty cycles, providing mass analysis with different
mass accuracy and resolution, sensitivity, analysis speed, and mass range. But there is no
“ideal” mass analyzer for all applications. The principle of operation, resolving power
(defined as the minimum mass difference between two peaks is calculated as m/Δm at the
half-maximum peak height), mass range, and applications of several different analyzers
that are used later in this dissertation, along with examples of hybrid mass spectrometers,
will be discussed in more details in the following sections.
1.4.1 Time-of-Flight (TOF)
TOF analyzers use an electric field to accelerate ions, and the ions fly through a fieldfree tube to the detector (Scheme 1.6). The ions are accelerated based on their m/z with
approximately the same kinetic energy. The time it takes for the ions to fly through the
field-free tube and reach the detector is measured and converted to m/z of the ions. The
heavier ions take longer time to reach the detector. It is necessary to let the ions start their
flight at the same time, therefore TOF is usually coupled with a pulsed ionization method
(e.g. MALDI). The continuous ion methods (e.g. ESI) employ orthogonal extraction to
interface to TOF. 94 The orthogonal extraction uses a “pusher” to accelerate ions
perpendicularly to their original direction and push them into the flight tube, so that a
pulsed beam is produced from the continuous ion production.
In principle, the mass range for TOF is unlimited as eventually all of the ions get to
fly through the flight tube. 95 TOF was introduced as a linear tube for ions to fly through
a certain distance before being detected. Shown in Scheme 1.6 is the TOF in both linear
and reflectron ion detection modes, with the reflectron mode to achieve better mass
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resolution of the smaller ions. The reflectron works as an ion mirror and is made of a set
of grids on which potential is applied to change the directions of the ions. The use of a
reflectron not only extends the distance for ions to fly, but also corrects the slightly
different positions and velocity of ions with the same m/z. As a result, the mass resolving
power of the TOF mass spectrometer is improved. It has been reported the mass resolving
power of 80,000 at m/z=2500 was achieved by spiral TOF instrument.96
Scheme 1.6. Schematic representation of TOF analyzer in both linear and reflectron
detection modes. The red circles represent “heavier” ions, and the blue ones are
“lighter” ions. Ions are introduced through either 1) pulsed ion source or 2) a
continuous ion source and are accelerated by orthogonal extraction.
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1.4.2 Quadrupole
A quadrupole analyzer consists of four rods on which DC and AC voltages are
applied (Scheme 1.7). Positive and negative potential is applied on the opposite pairs of
rods, respectively. When ions enter the quadrupole analyzer in the z direction, only the
ions with certain m/z that resonate with the RF voltage will oscillate and pass through the
rods (red line), while others are filtered out (blue line).
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Scheme 1.7. Schematic representation of a quadrupole analyzer. The red line
represents the path of ions that pass through the rods, and the blue line represents the
ions that do not pass through.
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The quadrupole is a scanning mass analyzers thus it is not well suited to pulsed
ionization method. The duty cycle for full scan is very low because only the ions at a
certain m/z can be projected at a given time.97
Three sets of quadrupole rods in a series (triple quadrupole mass spectrometer) can be
used in tandem mass spectrometers. The first and third quadrupole serve as mass filters,
and the center quadrupole works as the collision cell. The ions of interest are selected in
the first quadrupole, fragmented in the second quadrupole, and the fragments are mass
analyzed in the third quadrupole. Selected ion monitoring is achieved by fixing the RF
and can provide 100% duty cycle. Therefore these are more sensitive and suitable for
targeted analysis.98
1.4.3 Linear Quadrupole Ion Trap (LIT)
An LIT consists of three sets of hyperbolically shaped rod electrodes similar to the
quadrupole analyzer. The front and back ends are applied with higher potential that can
trap ions within the quadrupole region (Scheme 1.8).
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Scheme 1.8. Schematic representation of a linear quadrupole ion trap mass analyzer.
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The LTQ Velos (Thermo, Bremen, Germany) is a commercial linear ion trap mass
spectrometer used in most of the studies in this thesis. The scanning linear ion trap
instrument offers fast scanning speed (typically 33000 amu/s) and improved sensitivity, 99
at the expense of mass resolving power97 (e.g. 6000 at m/z 609100). The mass range is up
to m/z 4000 on the LTQ Velos.
The capability of trapping ions enables LIT to be used for tandem MS. Collision gas
for CID or radical anions for ETD can be introduced to the trap and react with analyte
ions during gas-phase collisions for MS2. Multiple stages of ion selection and
fragmentation can take place in the trap, therefore ion trap can achieve MSn for more
thorough structural analysis.
1.4.4 Fourier Transform Ion Cyclotron Resonance (FT-ICR)
When an ion enters a magnetic field perpendicular to its original velocity direction, it
will move in a circle by Lorentz force. The angular frequency is only dependent on the
ion’s mass, charge, and the magnetic field. The ions therefore will circulate in the
cyclotron cell. The FT-ICR detects the ions based on the image currents the ions produce
when they approach the electric plates. The time-domain current image is converted to
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frequency-domain spectrum by Fourier transform, and the frequencies are subsequently
converted to m/z values (Scheme 1.9).101
Scheme 1.9. Schematic representation of the principle of FT-ICR MS. Image current
signals are obtained when the ions approach the electrode plate, and the signals are
converted to a mass spectrum by Fourier transformation.
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The FT-ICR mass spectrometer has the highest resolving power by far. The mass
resolving power is over 400,000 at m/z 1000.101 However, the mass range is limited (e.g.
m/z 400-2000 for optimal response) and it takes longer (~ 1 s) than other instruments to
measure ions.101
1.4.5 Hybrid Mass Spectrometer
Quadrupole time-of-flight (Q-TOF) is an example of a hybrid mass spectrometer that
combines mass analyzers for better performance and tandem MS capability. Q-TOF
couples a quadrupole with a TOF analyzer. TOF has a higher duty cycle than the fullscan quadrupole, therefore Q-TOF is more sensitive than triple quadrupole except in the
selected ion monitoring mode, and the reflectron TOF increases the mass resolving power
at the same time.102
The SYNAPT G2 (Waters, Manchester, UK) is a commercial hybrid quadrupole/ion
mobility spectrometry (IMS)/orthogonal TOF mass spectrometer also used in the work
reported herein. The configuration is similar to Q-TOF, but adds an IMS device between
the quadrupole and TOF. Unlike MS, ions are separated according to their number of
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charges, size, and shape.103,104 IMS-MS has advantages for extended dynamic range and
the ability to separate isomeric compounds.105,106 The TriWave region also consists of a
trap before the IMS cell and a transfer after it. Fragmentation for tandem MS is
applicable in both trap and transfer regions.
1.6 Motivation
In all cases described in the previous section, ionization methods should be efficient
to produce ions and simple to interface with mass spectrometers to utilize these advanced
mass analyzer features. Advancement of MS towards the goal of more efficient ionization
and simpler operation may be achieved through the development of new ionization
methods. Ionization methods are discovered before and during my PhD period for which
I contributed in some cases during the initial discovery phase and helped mass
measurements, but will not be the main focus of this thesis. More details of the
development, summary of the schemes, and fundamental understandings of these
methods will be introduced in Chapter 3.
ESI-like ions can be produced by novel inlet and vacuum ionization methods. Inlet
ionization methods include laserspray ionization inlet (LSII),75 107 , 108 matrix assisted
ionization inlet (MAII), 109 , 110 and solvent assisted ionization inlet (SAII). 111 - 114
Ionization process occurs in the heated inlet tube linking AP and the first stage of vacuum
in a mass spectrometer. Solid matrix/analyte (LSII and MAII) or liquid analyte solution
(SAII) is introduced into the heated inlet tube of the mass spectrometer with (LSII) or
without (MAII and SAII) laser ablation. ESI-like multiply charged ions are produced by
either method with sufficient ion abundance for MS and tandem MS analysis, without the
use of voltage or nebulizing gas. Vacuum ionization, in analogy to LSII and MAII,
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includes laserspray ionization vacuum (LSIV) 115 , 116 and matrix assisted ionization
vacuum (MAIV).117-120 Heat is not required in vacuum ionization. With the assistance of
proper matrix and “softer” instrument settings (e.g. low or no laser power, sample plate
voltage removed), multiply charged ions can be produced from surfaces in vacuum.
By the time I started my PhD research, multiply charged ions from peptides/proteins
had already been observed by laser ablating a mixture of proper matrix and analyte from
the solid state without using any voltage, but the mechanism of LSII was not yet clear.
Predominantly solvent-based sample preparation was used, solvent-free preparation was
only attempted with a vortexer that did not provide efficient homogenization.108 Other
new ionization methods were developed along the way with some limitations at the initial
discovery stage. For example, the use of a silica tube to infuse analyte solution at the
hotspot in the capillary tube is not applicable for fast and simple operations. The inlet
ionization methods are beneficial to mass spectrometers equipped with heated inlet (e.g.
LTQ Velos), but many high performance mass spectrometers (e.g. Apex II FT-ICR) do
not have this feature. Fabrication of a heated capillary has been reported by attaching a
copper tube to the skimmer cone of a SYNAPT G2 but is less analytically useful.121 No
new ionization methods have been used for quantification. These limitations will be
overcome or at least reduced as reported in this thesis.
1.7 Scope of This Dissertation
This dissertation presents the instrumental development, fundamental insights, and
initial applications of the new ionization method developed by my colleagues and me,
towards the potential to employ the novel ionization process for their rapid, robust, and
simple-operated analyses during the course of the work described here.
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Chapter 2 describes the general experimental procedures including materials, sample
preparation, instrumentation, data acquisition, software, etc. used during this research.
More detailed experimental sections relevant to each chapter are included in individual
chapters.
Chapter 3 briefly states the history of novel ionization method development. Inlet
and vacuum ionization is introduced in more detail in this chapter, along with mechanistic
discussions. Our initial understanding of the unprecedented mechanisms of ion
production will be revealed in this chapter.
Chapter 4 presents a total solvent-free analysis approach using LSII-IMS-MS to
analyze both hydrophobic and hydrophilic compounds. The total solvent-free analysis
consists of solvent-free sample preparation and solvent-free gas-phase separation using
IMS coupled with MS. This chapter reports the first example of highly charged
peptide/protein ions to be produced in MS from solid state without using solvent during
either sample preparation or separation. TissueLyzer and grinding beads are utilized to
homogenize dry matrix compounds with dried analytes. Factors such as temperature, and
homogenization frequency during sample preparation, and thermal requirements for
different matrices, are investigated to discuss the multiple charging results.
Chapter 5 reports the construction of a simple and convenient instrumental setup to
couple LC at very low flow rates (as low as 400 nL min-1) with SAII. In contrast to ESI,
it was demonstrated that no voltage or extra connection is required to interface LC to MS.
Data dependent tandem MS is also shown in this chapter for rapid sequence analysis of
BSA digested peptides achieved by SAII-CID. Comparable sensitivity to ESI is achieved
by this SAII method with much less effort.
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Chapter 6 reports the development of instrumentation and methods that allow
multiplexing of a variety of molecules, including small drugs to larger protein. With the
assistance of heat applied to the inlet tube, 42 samples of 7 analyte solutions in 6 cycles
were analyzed within 5 min under the same inlet temperature. As a proof of principle, the
sample holder was carried by an x,y-stage for automation. For convenient observation
and fast analysis, the sample locations were mapped using the m/z of the ions by imaging
software so that the content of each solution and relative abundance can be visually
displayed. The map can provide the m/z for signal identity, tandem MS for specificity,
and signal intensity for relative amounts of certain compounds in different wells of the
96-well sample holder.
Chapter 7 presents the development of matrix assisted ionization vacuum to FT-ICR
mass spectrometer to establish the capability of ultrahigh performance mass
measurements. Over 400,000 mass resolving power was achieved for proteins at m/z 800.
Both the MALDI and ESI source on the commercial dual-source instrument were used.
Multiply charged ions of peptides and proteins are produced in the MALDI source
without firing the laser, and on the ESI source without voltage, sheath gas, or heat.
Chapter 8 describes the development of simple and rapid surface assessment
methods to quantify a schizophrenia drug from brain tissue sections of a drug-treated
mouse. The material can be extracted either by solvent and subsequently transferred to
the heated inlet (SAII), or by proper matrix when exposing the partially matrix-covered
tissue section to vacuum (MAIV). Compared to the traditional quantification method,
LC-ESI-MS/MS, similar results were obtained by SAII but at a much faster speed (a few
minutes for SAII and over an hour for LC-ESI-MS/MS). MAIV is slower but is
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independent of a heated inlet and more reproducible due to the continuous ion production.
Both sampling methods demonstrate that only the material from the surface was extracted,
independent of the tissue thickness.
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CHAPTER 2
MATERIALS AND INSTRUMENTATIONS
2.1 Materials and Sample Preparation
The analytes and matrices were purchased from Sigma Aldrich (St. Louis, MO)
unless otherwise noted. Angiotensin I and non-β-amyloid component of Alzheimer’s
disease (NAC) were obtained from American Peptide Co. (Sunnyvale, CA), trypsindigested BSA MS standard (CAM-modified) was purchased from New England BioLabs
Inc. (Ipswich, MA, USA), sphingomyelin was from Avanti Polar Lipids, Inc. (Alabaster,
AL), clozapine and clozapine-d8 were from Santa Cruz Biotechnology (Santa Cruz, CA).
Leucine enkephalin was provided by Waters Co. (Milford, MA). N-acetylated myelin
basic protein fragment from Anaspec (Fremont, CA), and phosphopeptide standard I was
from Protea Biosciences (Morgantown, WV). 3-NBN was from Tokyo Chemical Industry
Co., Ltd. (Portland, OR). Solvents were obtained from Fisher Scientific Inc. (Bremen,
Germany) unless otherwise stated. HPLC grade water was purchased from EMD
Chemicals (Gibbstown, NJ). Microscopy glass slides were obtained from Gold Seal
Products (Portsmouth, NH).
Stock solutions of peptides and proteins were prepared by dissolving them in water as
1 mg mL-1 concentrations. The stock solution of bovine insulin was in a 49.5:49.5:1
MeOH:water:acetic acid solution. Lipids were in methanol, and clozapine was in ethanol.
Peptides and proteins were diluted to desired concentration by water or 50:50 ACN:water,
with or without 0.1% formic acid. Lipids were diluted by MeOH with 1% acetic acid.
Clozapine was diluted by water. The matrices were prepared by dissolving 5 mg of each
matrix in 100 µL 50:50 ACN:water unless otherwise stated.
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For solvent-based analysis, the samples were prepared by either the droplet method or
layer method. In the droplet method, the analyte and matrix solutions were mixed in 1:1
volume ratio, and 1 µL was spotted on the sample holder (glass slide or MALDI plate)
and allowed air dry. In the layer method, 1 µL analyte solution was spotted on the sample
holder first, followed by 1 µL matrix solution and mixed with the pipet tip. For solventfree analysis, 10 µL analyte solution was dried overnight in a PCR tube placed in the
Biodryer, containing 3 stainless steel beads; a spatula tip-full (amount not critical) 2,5DHAP powder was added to the dry analyte. Then the dry mixture was homogenized and
transferred onto the glass slide by TissueLyzer using frequencies 5-25 Hz for 2-10 min.
More details about solvent-free sample preparation can be found in Chapter 4.
Mouse Brain Tissue – Mouse brain tissue sections were provided by Prof. Ken
Mackie and Dr. James Wager-Miller from Indiana University. They were cut with a
cryostat and mounted on microscopy glass slides. Briefly, mice were injected
intraperitoneally with 50 mg kg-1 clozapine and sacrificed 60 minutes post-dosing with
isoflurane overdose followed by perfusion of 20 mL of ice cold phosphate buffered saline.
Brains were rapidly removed and frozen. Tissue sections were sliced on a Cryostat
(Leica) to 10 or 20 µm thicknesses and sections were stored at -80 °C prior to analysis.
All animal procedures were approved by the Indiana University Bloomington
Institutional Animal Use and Care Committee.
2.2 Instrumentation
2.2.1 Mass Spectrometers
LTQ Velos. On the mass spectrometers that are commercially equipped with an inlet
tube, e.g. LTQ Velos (Thermo Scientific Inc., Bremen, Germany), the temperature of the
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inlet was directly heated from 50 ºC to 450 ºC. The ESI source housing was removed and
the interlock was overridden so that free access to the inlet orifice was available. Helium
gas was used for collision induced dissociation (CID), and a mixture of ultrapure helium
and nitrogen (25% helium and 75% nitrogen; purity ~99.995%) was used as the reaction
gas for electron transfer dissociation (ETD). Fluoranthene was used as electron reagent
for ETD. Both positive and negative ion mode were used with the following settings: the
Auto Gain Control was on, maximum injection time was 20 ms, and each mass spectrum
was obtained by summing up 5 microscans. The sheath gas, aux gas, sweep gas, and
capillary voltage were all set at 0. S-lense was 65%. Mass range was set to ‘normal’, scan
rate was ‘normal’, and scan time was ‘full’. Xcalibur 2.1.0 was used for data analysis.
For ESI, the commercial housing was used. The capillary voltage was set at 2.5-4 kV,
depending on the solvent system. Sheath gas around 10. CID was performed for ESIMS/MS experiments.
SYNAPT G2. On those mass spectrometers that are not equipped with an inlet tube
that can be heated, e.g. SYNAPT G2 (Waters, Manchester, UK), the skimmer cone can
only be heated up to 150 ºC and is not efficient for inlet ionization methods. Therefore, a
capillary was attached to the skimmer cone to help desolvation. The source temperature
was held at 150 ºC, and the nichrome wire which wrapped the copper tube around was
connected to a Variac for additional heat. More details about fabricating the inlet
capillary can be found in Chapter 4.
The SYNAPT G2 was operated in positive and resolution modes. The sample cone
was set at 40 V and the extraction cone was 4 V. The scan time was set at 1 sec. Nitrogen
gas was used for drift time separation at a flow of 22 mL min-1. The IMS wave velocity
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was 650 m s-1 and wave height of 40 V. The pressure of the drift cell was 3.2 mbar.
MassLynx 4.1 and DriftScope ver. 2.1 (Waters Corp., Manchester, UK) were used for
data analysis.
FT-ICR. An Apex II FT-ICR mass spectrometer (Bruker, Bremen, Germany) was
used for MAIV and LSIV as the application of novel ionization methods on highperformance instruments to take advantage of its ultra-high mass resolving power. The
dual MALDI/ESI source was used. For MAIV measurements, the laser fluence was set to
0, and the laser beam was blocked with paper. Voltage on the sample plate (240 V-300 V)
was applied to assist lifting up ions. For LSIV measurements on the FT-ICR mass
spectrometer, ubiquitin was combined with 2-NPG. The arbitrary laser fluence was 50%,
and the plate voltage was 400 V.
MAIV from AP was performed on the dual MALDI/ESI source. The ESI source, the
cover, and the cap over the ESI capillary were removed for direct access to the orifice of
the ESI capillary. The capillary voltage, spray shield, nebulizing gas flow, and dry gas
flow were all set to 0, and no override was necessary for operation. No added heat was
applied to the ESI capillary.
2.2.2 Ultrahigh Performance Liquid Chromatography (UPLC)
A Waters Corporation NanoAcquity UPLC was used. Columns used include a Waters
100 μm x 100 mm BEH130 C18 column with 1.7 μm particles, and a Waters 1 mm x 100
mm BEH 130 C18 column with 1.7 μm particles.
Water and ACN were used as mobile phase, the gradient can be found in more details
in Chapters 5 and 8.
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2.2.3 Other Equipments
Microscopy. Optical microscopy (Nikon Eclipse LV100) was performed to observe
droplet production upon LSII, and to determine the analyzed area in surface SAII for
clozapine quantification. The microscope was operated at 5x magnification.
Automated x,y-stage. A computer-controlled automated x,y-stage (Newmark Systems,
Mission Viejo, CA) was used to carry and move sample holders in front of the mass
spectrometer.
2.2.4 Other Software
BioMap 3.7.5.6 imaging software (Novartis Institution for Biomedical Research,
Basel, Switzerland), typically used for imaging applications, was incorporated to map in
which solution analyte was present as determined by the m/z ratio values obtained by MS
or MS/MS. Besides mapping the location of analyte, the software allows relative
concentrations to be displayed by color code. Thermo XCalibur .RAW files were
converted to .IMG files using customized imaging software.
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CHAPTER 3
FUNDAMENTAL UNDERSTANDING
Ionization methods are discovered before and during my PhD period. In some cases I
have contributed during the initial discovery phase. This chapter focuses on a brief
history of new ionization methods development and our current understanding of the
mechanistic aspects of the novel ionization process. The experiments I participated in
which led to the discovery and understanding so the relevant mechanism are included in
this chapter. Figures and schemes are adopted from my co-authored publications from my
contribution as follows:
Inutan, E.D.; Wang, B.; Trimpin, S. Commercial Intermediate Pressure MALDI Ion Mobility
Spectrometry Mass Spectrometer Capable of Producing Highly Charged Laserspray Ionization
Ions. Anal. Chem. 2010, 83, 678-684.
Trimpin, S.; Wang, B.; Inutan, E.D.; Li, J.; Lietz, C.B.; Harron, A.; Pagnotti, V.S.; Sardelis, D.;
McEwen, C.N. A Mechanism for Ionization of Nonvolatile Compounds in Mass Spectrometry:
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Newly discovered ionization methods at their initial developed phase are summarized
in Scheme 3.1. The left column represents inlet ionization and right column for vacuum
ionization. These methods will be introduced respectively in the following sections.
Scheme 3.1. Schematic representation of: (A) Inlet ionization methods that produce
ions with the assistance of heat and vacuum drop, ionization occurs in the inlet tube
of the mass spectrometer (B) Vacuum ionization methods the utilize proper matrix
occurring by exposing to vacuum. (1) Laserspray ionization that employs laser
ablation to remove matrix/analyte mixtures from sample holder such as a glass slide;
(2) matrix assisted ionization of which samples are introduced by mechanical force or
matrix sublimation; (3) solvent assisted ionization that utilizes solvent instead of
organic compounds as matrix. [Modified from 18]

Laser
Laserbeam
beam
Transmission
(TG)
Geometry

2. MAII

Glass Plate

180

angled

To
vacuum

1. LSIV*2

++++++
++
+++++
+++
++++
+++++

Heated
transfer
capillary

Matrix/analyte clusters

Matrix/ Flow entrapment
analyte Mass spectrometer
crystals orifice

Pressure drop

+

+

+ +
+
+ ++
+ +
+
+
+ + ++ +
++ +

Matrix/analyte
Matrix/analyte clusters
crystals

e.g. tapping
To

vacuum

+
++
+++ ++ +
+++
Heated
transfer
capillary

3. SAII*1

B. Vacuum
Glass/Metal plate

1. LSII*

Laserbeam
Geometry

Laser beam
Reflection
(RG)
~1-3 mm

Fused
silica
tube

Matrix/
Pressure
analyte
drop
crystals
To
vacuum

++
++
++++
++++++
+
++
+++
+++
+++
Heated
transfer
capillary
Pressure drop
Analyte in
solution

2. MAIV*1

Glass/Metal plate

A. Inlet

LSII 1

+
+ +
+
+ ++
+ +
+
+ ++
+ + +
++ +
+

Matrix/analyte
Matrix/analyte clusters
crystals

*1 I developed these ionization
methods as described in this thesis.
*2 I contributed in the initial discovery
phase with mass measurements.

30

3.1 Inlet Ionization
LSII was developed to use a UV laser to dislodge the solid analyte/matrix mixture
from the sample plate and transfer it into the heated inlet.75,107,108 The matrices were first
thought to have similar features in MALDI that they require an aromatic benzene ring to
absorb UV laser energy. However, if the same matrix/analyte mixture (e.g. 2,5DHAP/ubiquitin mixture) is ablated by UV, visible, and infrared laser respectively
(Figure 3.1), similar mass spectra are produced indicating that LSII operates with a
different mechanism than MALDI.122
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Figure 3.1. LSII-MS spectrum of ubiquitin (MW 8570) using 2,5-DHAP matrix. The
matrix/analyte mixture was ablated by (A) ultraviolet (B) visible and (C) infrared
laser at different wavelengths and produced similar ions. The numbers on the right
top corner denote ion abundances. [Adopted from 122]
Based on this observation, mechanical force, instead of laser ablation, can be
employed to introduce analyte/matrix mixture to the heated inlet.109,110 SAII is a liquid
sample introduction method that does not require organic compound as matrix and
directly infuses analyte solution into the heated inlet.111 In all cases, the super heating of
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the inlet tube is required as well as the pressure drop from AP to the first stage of vacuum
of the mass spectrometer.122 Depending on the matrix (solid or solvent), up to 450 ºC may
be required for good analyte ionization.110,122 In contrary to traditional ionization methods
such as MALDI and ESI as described in Chapter 1, no voltage is used in inlet ionization.
The ionization source of inlet ionization is the heated inlet tube in the mass
spectrometer.18 Gas-phase ions are produced when compounds, preferably in a matrix or
solvent, pass through a heated tube linking the first vacuum stage of a mass analyzer with
AP.122
A unified mechanism was proposed for all three inlet ionization methods shown in
Scheme 3.2.122 When matrix/analyte (organic matrix/analyte droplets or particles for LSII
and MAII, solvent/analyte solution for SAII) enter the heated inlet tube, heat and the
pressure drop result in charge separation that may be caused by superheating and
bubbling carrying away surface charge into small droplets.123 Millions of charges can be
generated from charge separation. In this mechanism, the progency droplets will have
opposite charge from the remaining parent droplet. The charged droplets undergo solvent
evaporation and coulombic fission. They also collide with the inner walls of the inlet tube
and with each other, and finally matrix/solvent evaporation producing bare gas-phase
analyte ions.122 It was proposed by Vestal in 1983, before the invention of MALDI or ESI,
that ions are produced from charged clusters.124 This solvent removing process is similar
to ESI after the analyte solution is sprayed from the ESI capillary, but in inlet ionization
ions are produced without applying any voltage or nebulizing gas.
Therefore, similar ions can be produced as long as the mixture of matrix (solid or
liquid) and analyte are transferred into the heated inlet tube, and it does not matter if a
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laser or organic matrix is used.125 Figure 3.2 shows the mass spectra of the myelin basic
protein fragment peptide introduced to the instrument by LSII, MAII, and SAII,
respectively. Identical mass spectra were produced. ETD was performed to the quadruply
charged ions, and similar sequence coverage was obtained with all three methods (Figure
3.2.B).
Scheme 3.2. Schematic representation of the fundamental understanding of inlet
ionization. SAII is displayed in the scheme by pipetting analyte solution right in front
of the heated inlet tube linking AP and vacuum of the mass spectrometer.
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Figure 3.2. MS and MS/MS spectra of myelin basic protein fragment (MW 1832) by
(A) LSII and (B) MAII using 2,5-DHAP as matrix, and (C) SAII using water with 0.1%
formic acid as solvent. In all cases, the inlet temperature was held at 250 ºC.
[Adopted from 125]
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Charge separation also occurs from freezing water droplet (Figure 3.3).126 Charged
particles are produced and ejected from frozen droplet surfaces by surface splintering.
The sublimation of dry ice helps surface splintering and can produce highly charged
protein ions directly from a frozen droplet of analyte aqueous solution. An extended inlet
was used and wrapped by ice bags to assist cold ionization. Up to +10 charge state was
observed from ubiquitin in aqueous solution.
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Figure 3.3. Analysis of ubiquitin aqueous solution by cold ionization. (A) Picture of a
10 µL ubiquitin aqueous solution spotted on dry ice and introduced into the cold
extended inlet assisted by dry ice sublimation. (B) Mass spectrum of
ubiquitin.[Adopted from 126]
Instruments such as the LTQ Velos have a heated inlet that benefits inlet ionization,
but many high-performance mass spectrometers are not equipped with commercial heated
inlet. If the proposed mechanism is correct – that ions are produced from charged
analyte/matrix clusters, more volatile matrix compounds will efficiently evaporate or
sublime from charged analyte/matrix droplets or particles in the presence of vacuum and
without added heat. With such a matrix, it would be necessary to have a means of
producing the charged particles.

34

3. 2 Vacuum Ionization
With the proper matrix with a low thermal requirement to produce LSII ions, e.g. 2,5DHAP, and “soft” instrument parameters (low laser power and no plate voltage), ESI-like
ions were first produced from a mixture of lipids, peptides, and proteins employing laser
ablation on a commercial intermediate pressure (10-2 mbar) MALDI-IMS-MS
instrument.115 Although there is no heated inlet or external thermal energy, a pressure
drop is present inside the mass spectrometer, and absorption of the laser beam provides
heat. In analogy to laserspray ionization inlet, the ionization occurring in the vacuum
source is termed laserspray ionization vacuum (LSIV). More volatile matrices, e.g. 2nitrophloroglucinol (2-NPG), can be used in high vacuum MALDI-TOF-TOF mass
spectrometers of which the source is at even lower pressure (10-6 mbar).116
Among the volatile matrices, 3-nitrobenzonitrile (3-NBN) sublimes in vacuum. When
the analyte is exposed to the matrix and vacuum, multiply charged ions from peptides and
proteins are produced without employing the laser or applying extraction voltage.117-120
This method is termed matrix assisted ionization vacuum (MAIV) and produces ESI-like
ions from a wide range of compounds such as drugs, peptides, lipids, and proteins. A
number of novel matrices with different functionalities have been discovered to produce
ions.127 Interestingly, the crystal morphologies vary a lot according to the microscopy
images. Their sublimation capabilities are quite different, too. Shown in Table 3.1 are
representative microscopy images of 3-NBN, coumarin, and 2-bromo-2-nitro-1,3propanediol (bronopol) that sublime differently over 24 hour period. 3-NBN sublimed at
room temperature and pressure in 3 h; coumarin was partially sublimed after a 24 h, but
no observable sublimation occurred for bronopol. This method has been extended to
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operate on slightly or non-modified ESI source to simplify the operation and improve
throughput.119
Table 3.1. Microscopic images of 3-NBN, coumarin and bronopol showing the
sublimation of these matrices at room temperature and atmospheric pressure. Images
were taken right after spotting, 3 h, 6 h, and 24 h. [Adopted from 127]
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CHAPTER 4
PRODUCING HIGHLY CHARGED IONS WITHOUT SOLVENT USING
LASERSPRAY IONIZATION: A TOTAL SOLVENT-FREE ANALYSIS
APPROACH AT ATMOSPHERIC PRESSURE
First examples of highly charged ions in mass spectrometry (MS) produced from the
solid state without using solvent during either sample preparation or mass measurement
are reported. Matrix material, matrix/analyte homogenization time and frequency,
atmospheric pressure (AP) to vacuum inlet temperature, and mass analyzer ion trap
conditions are factors that inﬂuence the abundance of the highly charged ions created by
laserspray ionization (LSI). LSI, like matrix-assisted laser desorption/ionization
(MALDI), uses laser ablation of a matrix/analyte mixture from a surface to produce ions.
Preparing the matrix/analyte sample without the use of solvent provides the ability to
perform total solvent-free analysis (TSA) consisting of solvent-free ionization and
solvent-free gas-phase separation using ion mobility spectrometry (IMS) MS. Peptides
and small proteins such as non-β-amyloid components of Alzheimer’s disease and bovine
insulin are examples in which LSI and TSA were combined to produce multiply charged
ions, similar to electrospray ionization, but without the use of solvent. Advantages using
solvent-free LSI and IMS-MS include simplicity, rapid data acquisition, reduction of
sample complexity, and the potential for an enhanced eﬀective dynamic range. This is
achieved by more inclusive ionization and improved separation of mixture components as
a result of multiple charging.
B. Wang, C. B. Lietz, E. D. Inutan, S. M. Leach, S. Trimpin, Anal. Chem., 2011, 83,
4076-4084. Reprinted with permission from Copyright (2011) American Chemical
Society.
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4.1 Introduction
Mass spectrometry (MS) at atmospheric pressure (AP) is of analytical interest for
reasons ranging from rapid data acquisition to sample analysis of biological materials
under more physiologically relevant conditions.39,84,128 Unfortunately, the observation of
high-mass singly charged ions is limited by the mass-to-charge (m/z) range of most highperformance mass spectrometers, a major drawback of AP matrix-assisted laser
desorption/ionization (MALDI).65 Laserspray ionization (LSI) MS is a newly introduced
method capable of soft ionization of small and large molecules such as lipids, peptides,
proteins, and other high-mass compounds by laser ablation at AP.75,107,108,121, 129 - 135
Advantages include small ablation areas/volumes, AP conditions, speed of analysis, and
the production of multiply charged ions to extend the mass range of high-performance
mass spectrometers. The ability to obtain multiply charged ions also provides enhanced
fragmentation important for structural characterization. For example, sequence analysis
by electron transfer dissociation (ETD) was obtained on a Thermo LTQ-ETD mass
spectrometer providing nearly complete sequence coverage of ubiquitin and identiﬁed an
endogenous peptide directly from mouse brain tissue.107,134
LSI ions have been generated on commercial atmospheric pressure ionization (API)
sources directly,75,107,129,130,131,133-135 after retroﬁtting with a home-built LSI desolvation
tube,121,130,132 and by introducing LSI conditions on a commercial AP-MALDI source.108
Initial solvent-free gas-phase separation results enabled by the ion mobility spectrometry
(IMS) dimension showed the utility and beneﬁts for the analysis of protein mixtures,
even when isomeric, directly from surfaces.121,132 Recently, LSI has been extended to
intermediate pressure (IP) MS applications, producing highly charged and high abundant
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peptide and protein ions.115 These ions, especially in mixtures as complex as mouse brain
tissue, are notably well-separated by IMS-MS using a solvent-based LSI approach.
Solvent-free sample preparation/ionization operates independent

of analyte

solubility,38 a key advantage over any solvent-based MS method. Combined with solventfree gas-phase separation using IMS-MS, this provides total solvent-free analysis (TSA)
by MS.39,136 Potential advantages using solvent-free LSI and IMS-MS in a TSA approach
include simplicity, rapid data acquisition, reduction of sample complexity, and enhanced
effective dynamic range. Justiﬁcations for exploring solvent-free approaches relate to a
number of factors that can be broadly deﬁned as (i) the need to perform chemical analysis
on molecules that are difficult or impossible to solubilize, known collectively as the
“insolubelome”; 137 (ii) the need to avoid chemical reactions that can spontaneously
change the structures of certain types of molecules when they are in solution; (iii) the
need to address problems associated with extreme loss of certain analytes in solution
during sample preparation; and (iv) the need to address diffusion of analytes within a
complex matrix such as tissue sections for mass spectrometric imaging, where spatial
distribution of analytes is a major variable in the analysis. The poorly soluble constituents
of living organisms, such as membrane proteins, as well as hydrophobic compounds,
such as lipids, metabolites, synthetic polymers, crude oil, and biofuels, need new
analytical methods for their analysis.
Solvent-based LSI, similar to ESI, forms singly charged ions of lipids and low
molecular weight peptides but for higher molecular weight biological and synthetic
macromolecules produces highly charged ions.75,107,108,115,121,129-135 Using a laboratory
vortexer 138 and 2,5-dihydroxybenzoic acid (2,5-DHB) as matrix, LSI was reported to

39

exclusively produce singly charged ions with solvent-free sample preparation and
employing 350 °C on the heated inlet capillary of a Thermo Scientiﬁc Orbitrap Exactive
mass spectrometer.75 We show here the ﬁrst examples that matrix/analyte materials
combined in the solid state can produce abundant highly charged peptide and protein ions
and, when in mixtures, are well-separated in the solvent-free gas-phase dimension
provided by IMS because of the successful introduction of multiple charging. Further,
pictorial “snapshots” of this TSA experiment using the dimensions of drift time and m/z
suggest usefulness for rapid observation of changes in relative sample composition even
in complex samples such as crude oil without the need of extensive optimization of
sample preparation and separation.
4.2 Materials and Methods
Materials. Besides the general chemicals stated in Chapter 2, oils were obtained
from a local store. Stainless steel beads (1.2 mm) were obtained from BioSpec Products,
Inc., Bartlesville, OK, USA.
LSI Sample Preparation. Stock solutions were prepared as described in Chapter 2.
For the peptide/lipid mixture, angiotensin I and sphingomyelin were premixed to a 1:1
volume ratio using the stock solutions.
Solvent-Free Sample Preparation. The matrix/analyte samples were simultaneously
homogenized and transferred to the glass microscopy slide using the TissueLyser II
(Qiagen Inc., 27220 Turnberry Lane, Valencia, CA, USA), similar to published
procedures.139,140 Solutions of 10 μL of 772 pmol μL-1 angiotensin I in water, 10 μL of
peptide/lipid mixture in MeOH/H2O, 3.26 μL of 307 pmol μLÀ1 NAC in water, and 5.73
μL of 174 pmol μL-1 bovine insulin in MeOH/H2O with 1% acetic acid were used.
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Identical to previous solvent-free preparation,37,41 the respective analyte samples were
transferred to individual 0.2 mL PCR tubes containing three stainless steel beads and then
evaporated in the Biodryer (BioSpec Products Inc., PO Box 788, Bartlesville, OK, USA)
for 3 h to ensure complete dryness of the samples. The oil samples were prepared without
solvent by pipetting 1 or 2 μL of the liquid directly to the vial to be used for
homogenization; waxy and oily materials were previously studied by solvent-free sample
preparation protocols.36,138 After the samples were completely dry, except for the crude
oil, a spatula tip amount (this is not a critical parameter) of 2,5-DHAP matrix was added
into each tube, identical to the previously published procedures.139,140 The top opening of
the tube was then covered by the microscopy glass slide and was firmly and securely
placed in the TissueLyser II sample holder. Each set of sample was homogenized with
the desired frequency and time. The matrix/analyte mixtures of angiotensin I, NAC, and
peptide/lipid mixture were homogenized for 10 min at 25 Hz, while bovine insulin and
oils were ground at 30 Hz.
Specific Study of Frequency and Time. Angiotensin I was homogenized with the 2,5DHAP matrix for time periods of 2, 5, 10, and 20 min at grinding frequencies of 15, 20,
and 25 Hz. To ensure the most identical matrix/analyte ratio composition, the mixture
was ground for 2 min so that a reasonably homogeneous powder was obtained before
removing the glass slide cover with matrix/analyte powder attached. The powdered
matrix/analyte sample on the glass surface was then analyzed by LSI-IMS-MS. The
remaining matrix/analyte sample in the tube was covered with a new glass slide and
rehomogenized for another 3 min to prepare the sample with the second time point (5
min), and so on.
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Specific Study of Temperature. Angiotensin I was homogenized with the 2,5-DHB
matrix for 2 and 10 min and with 2,5-DHAP matrix for 10 min with a grinding frequency
of 25 Hz. The homogenized matrix/analyte sample was initially analyzed by LSI-IMSMS (SYNAPT G2) at 150 °C on the skimmer cone with and without additional heat
applied on the home-built desolvation device described previously.121 To gain more
accurate temperature values, we also analyzed the homogenized matrix/analyte sample on
the Thermo LTQ Velos instrument equipped with the commercial desolvation device
with accurate temperature readings. Temperatures of 40, 150, 275, and 400 °C were
applied.
Solvent-Based Sample Preparation. The solvent-based sample preparation was
carried out for comparison. To ensure the most direct comparison, homogenized
matrix/analyte powder mixture that remained in each tube from the respective TSA
experiment was used by adding 5 μL of 50:50 ACN/H2O. The powder and solvent were
stirred by a micropipet tip. Only some of the analyte/matrix mixture was dissolved, and
approximately 4 μL of the saturated solution was transferred to the glass slides. After
complete evaporation of the solvent, LSI-IMS-MS analysis was performed identical to
the solvent-free prepared samples. Solvent-based crude oil sample was prepared by
dissolving crude oil in 2:1 toluene/methanol mixture141 and then was premixed with 2,5DHAP solution with a 1:4 volume ratio. Two times 2 μL of the crude oil/matrix mixture
was spotted without drying between on the microscopy glass slide and then blow-dried at
low heat. NAC and bovine insulin were prepared by solvent-based layer method similar
to previous studies.132
Laserspray Ionization. The nitrogen laser (Spectra Physics VSL-337ND-S, Mountain
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View, CA, USA) was focused and aligned to the ion entrance of the SYNAPT G2 and
LTQ Velos mass spectrometers as previously described.121,135 The fabrication of the
desolvation device for the SYNAPT G2 was also described previously.121 Briefly, the exit
end of a 3.175 mm o.d., 1.5875 mm i.d., 19.05 mm copper tube, which was wrapped with
24 gauge nichrome wire (Science Kit and Boreal Laboratories, Division of Science Kit,
Inc., Tonawanda, NY, USA) and coated with Saureisen P1 cement (Inso-lute Adhesive
Cement Powder no. P1) was securely attached to the ion entrance skimmer cone of the
Waters Z-spray source by Saureisen cement. The source temperature was held at 150 °C,
indirectly heating the copper desolvation device. To supply additional heat to the
desolvation device, the nichrome wire was connected to a Variac (Powerstat, the Superior
Electric Co., Bristol, CT, USA). With analyte/matrix samples facing the mass
spectrometer, the glass slide was placed in front of the ion entrance of the desolvation
device using the x,y,z stage of the nanolockspray source (SYNAPT G2) or manually
(LTQ Velos) and was slowly moved through the focused laser beam aligned with the
orifice in transmission geometry (180°with the ion entrance capillary) and focused ~2
mm from the orifice. For allstudies using the laser, gloves and laser safe goggles were
worn.
IMS-MS Instrumentation. The SYNAPT G2 HDMS (Waters Corporation,
Manchester, UK) with a quadrupole having a high mass limit of m/z 8000 was used to
perform LSI-IMS-MS analysis. The first generation of this instrument has been
previously described. 142 The instrument was operated in resolution mode at a cone
voltage of 0 to 40 V and extraction cone of 4 V. The total acquisition time was set at 1
min, acquiring 1 mass spectrum per second. The flow rate of nitrogen, which was used
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for drift time separation, was 22 mL min-1. The IMS cell pressure was 3.13 mBar and in
the Triwave region, wave velocity ranged from 450 to 650 ms-1, and wave height from 30
to 40 V. DriftScope version 2.1 (Waters Corp., Manchester, UK) was used to plot and
process the two-dimensional (2-D) data of drift time versus m/z using emerald forest and
hot metal color backgrounds. For acquisitions without IMS, only the source and trap
gases were on. Other parameter settings used were the same excluding the IMS settings.
LTQ-MS Instrumentation. The LTQ Velos (Thermo Fisher Scientific Inc., Fitchburg,
WI, USA) was used to perform LSI-MS for the ion entrance capillary temperaturedependent studies. The API source housing of the instrument was removed.133-135 For the
temperature-dependent studies, the total acquisition time was 1 min, summing three
microscans using a maximum injection time of 50 ms for each acquired mass spectrum.
The matrix/analyte produced by ablation directly enters the heated capillary of the mass
spectrometer. The capillary temperature was set to 40, 150, 275, and 400 °C for the
respective studies.
Microscopy. An optical microscope (Nikon, ECLIPSE, LV 100) was used to study
the formation of liquid droplets in the LSI plume during the ablation of 2,5-DHAP and
2,5-DHB. Samples were prepared with the TissueLyser II as previously described in
solvent-free sample preparation,139,140 but with the omission of analyte. The matrix was
ground using 1.2 mm stainless steel beads and transferred to a glass slide using the
TissueLyser II at a grinding frequency of 25 Hz. One batch of samples was ground for 30
s, and a second batch was ground for 10 min. The ablated plume from a single pulse of
the 337 nm UV laser was collected on a separate glass slide for microscopy analysis.
Additionally, a third batch of sample was created by a vortexer (Vortex-Genie 1 Touch
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Mixer, Scientific Industries, Inc., Bohemia, NY, USA). Each matrix was ground in a PCR
tube with three stainless steel beads for 30 s on the vortexer similar to published
procedures.138 The matrix was pressed onto a glass slide using a metal spatula to provide
a thin coverage similar to previous protocols used with MALDI.36-38,41,138
4.3 Results and Disscussion
Method Development for the Production of Multiply Charged Ions of Peptides and
Proteins by a Total Solvent-Free Analysis (TSA) Approach. Shown in Figure 4.1 is the
analysis of angiotensin I using a TSA approach consisting of solvent-free sample
preparation/ionization coupled to solvent-free gas-phase separation by IMS. In the
extracted mass spectrum (Figure 4.1A), abundant signal intensities for both the doubly
and triply charged ions are observed. There are no notable differences in the relative
intensities of the charge state distribution of the multiply charged ions as compared to the
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Figure 4.1. LSI-IMS-MS of angiotensin I (Ang. I) with 2,5-DHAP matrix using
solvent-free sample preparation, a TSA approach: left panel (A) mass spectrum and
right panel (B) 2-D plot of drift time versus m/z with insets displaying extracted drift
time distributions for charge state +2 and +3. Reference data for solvent-based ESIIMS-MS are included in Figure S4.1 in Appendix A.
solvent-based LSI analysis (Figure S4.1A in Appendix A) of the identical 2,5-
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DHAP/angiotensin I mixture. Singly charged ions were not produced by either solventfree or solvent-based LSI-MS. However, the total abundance of the angiotensin I ions
produced using solvent-free preparation is lower than when solvent was used. Similar
observations of relative intensities of soluble, more hydrophilic peptides using solventfree sample preparation/ionization for analysis of peptides and proteins with a MALDI
time-of-flight (TOF) mass spectrometer have been reported.37,41
Figure 4.1B displays the dataset in a 2-D plot of drift time versus m/z with false color
plot for the ion intensity showing that the multiply charged ions of angiotensin I obtained
by solvent-free sample preparation/ionization undergo solvent-free gas-phase separation
according to the number of charges and cross section (size and shape). This is best seen
when viewing the extracted drift time distributions of +2 and +3 displayed in the
respective insets of Figure 4.1B. The TSA results are essentially identical to those
obtained by the solvent-based LSI-IMS-MS method, as shown by the respective 2-D plot
and extracted drift time distributions (Figure S4.1B in Appendix A).
With increasing molecular weight (MW) of the analytes, ions with increasing number
of charges are produced by TSA. Again, singly charged ions are not observed. Examples
are shown in Figure 4.2 for the non-β-amyloids component of Alzheimer’s disease
(NAC) and bovine insulin. The extracted mass spectraare displayed in the left panel, and
2-D plots are shown in the right panel. NAC (MW 3260) produces multiply charged ions
ranging from +2 to +5 (Figure 4.2A.1) and bovine insulin (MW 5731) from +3 to +7
(Figure 4.2.B.1). Unexpectedly, with increasing charge state, an increasing degree of
metal adduction of sodium cations (e.g., BI charge state +6 has 0-2 Na+ ions replacing H+
ions) is observed. Previous LSI studies using solvent-based sample preparation primarily
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showed protonation of peptides and proteins.75,107,108,115,121,130-134 Solvent-free sample
preparation in conjunction with MALDI-TOF analysis also produces a higher degree of
metal cation adduction to the analyte, a key beneﬁt for hydrophobic ionization retarded
molecules.39,41,143 Furthermore, oxidation has been described for ESI and solvent-based
MALDI approaches and was diminished using solvent-free sample preparation
employing a mini-ball-mill approach with short homogenization times of about 1 min
using CHCA matrix.41 Here, however, in order to have precise control of sample transfer
to the vial, solvent was used, followed by evaporation of the solvent, allowing oxidation
processes to take place. We, therefore, tentatively assign one of the adduct species to
[NACoxidized + 2H + Na]3+ instead of [NAC + 2H + K]3+.
The TSA results were also compared with conventional solvent-based analysis
approaches. Solvent-based LSI-IMS-MS analysis was obtained by adding 4 μL of 2,5DHAP matrix solution on top of 1 μL of sample spotted on a glass slide, mixed, and
blow-dried similar to previous procedures.132 This procedure was applied to NAC (in
50:50 ACN/H2O with 0.1% TFA) and bovine insulin sample (in 50:50 MeOH/H2O with
1% acetic acid). The solvent-based LSI and the ESI-IMS-MS results for NAC also show
protonation, metal ion adduction, and the proposed oxidation (Figure S4.2 in Appendix
A). In contrast, the solvent-based LSI and ESI-IMS for bovine insulin only show
protonation (Figure S4.3 in Appendix A). Most likely, for NAC, the sample is already
partially oxidized as purchased.
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Figure 4.2. LSI-IMS-MS of (A) non-β-amyloid component of Alzheimer’s disease
(NAC) and (B) bovine insulin (BI) with 2,5-DHAP matrix using solvent-free sample
preparation, a TSA approach: left panel (1) mass spectrum and right panel (2) 2-D
plot of drift time versus m/z with insets displaying extracted drift time distributions of
diﬀerent ionizations for charge states +3 (NAC) and +6 (BI). Reference data for
solvent-based ESI- and LSI-IMS-MS are included in Figures S4.2 and S4.3 in
Appendix A.
The relatively high degree of sodiation and oxidation are observed starting at +3, as
seen by [M + 3H]3+, [M + 2H + Na]3+, and [Moxid + 2H + Na]3+, suggesting a speciﬁc
structural change in the peptide to enhance metal cation adduction. It is therefore
interesting to examine the drift time distributions (insets in Figure 4.2.A.2) for the
different adducts at charge state +3 to provide some insight into the structures of NAC
ions formed by protonation and sodiation. The charge state +3 ions of [NAC + 2H +
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Na]3+ and [NACoxidized + 2H + Na]3+ are signiﬁcantly separated in the drift time
dimension. The sodiated ion shows drift times very similar to the protonated ion
[NACoxidized + 3H]3+, while the oxidized ion shows a signiﬁcantly slower drift time
indicating a more elongated structure. The extent of the IMS gas-phase separation of
~7.0 (non-oxidized) and ~8.9 ms (oxidized) indicates a large difference in shape.
Similarly, the bovine insulin ions with higher charge states show metal adducted ions
(Figure 4.2.B.2) without a signiﬁcant change in drift time (insets in Figure 4.2.B.2). This
is in good agreement with previous investigations using an ESI-IMS-MS instrument with
high drift time resolution106 that demonstrated that the drift time distributions of lipid ions
with different metal adduction frequently fall into families with nearly identical drift
times (isodrifts), indicating that the cation attached to the molecule has little structural
inﬂuence.
A motivation for producing multiply charged LSI ions from solid-state solvent-free
preparation of the matrix/analyte is its potential application to tissue imaging. The results
of Figures 4.1 and 4.2 show the relative abundance and ease with which the formation of
the highly charged LSI ions can be achieved using a solvent-free approach. Compared to
the production of exclusively singly charged LSI ions using 2,5-DHB without the use of
solvents as described before,75 the important conditions for forming and increasing the
abundance of multiply charged LSI ions without the use of solvents are described below.
First, the homogenization conditions of the matrix/analyte were examined in terms of the
duration and frequency of the grinding process (Figure S4.3A and Figure S4.4 in
Appendix A). The abundances of the multiply charged ions of angiotensin I are low after
homogenization for 2 min with 15 Hz frequency using 2,5-DHAP and increase
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signiﬁcantly with 20 min, 25 Hz homogenization (Figure 4.3.A1 versus A2). The
abundance of multiply charged ions of angiotensin with 2,5-DHB shows the same trend,
comparing intensity after homogenization for 10 and 2 min (Figure S4.5A versus B in
Appendix A). Thus, the abundances of highly charged ions are enhanced when more
vigorous conditions for the matrix/analyte homogenization are applied. These
homogenization conditions are well beyond those that can be achieved with a simple
vortex device.75
A. Increasing Grinding Time and Frequency: DHAP

B. Increasing Temperature in Desolvation Device: for DHB and DHAP matrixes

Figure 4.3. Solvent-free mass spectra of angiotensin I obtained from (A) SYNAPT
G2, a TSA approach, using a home-built desolvation device and 150 °C source
temperature after using diﬀerent grinding times and frequencies during
homogenization of 2,5-DHAP matrix/angiotensin I: (1) 2 min at 15 Hz and (2) 20 min
at 25 Hz; (B) LSI-LTQ-Velos at 275 °C desolvation temperature homogenized at 25
Hz and 10 min using (1) 2,5-DHB and (2) 2,5-DHAP matrixes. More details are
included in Figures S4.4 and S4.5 in Appendix A.
It is of interest to obtain more detailed information by investigating the LSI plume of
different matrixes and grinding conditions by collecting the ablated matrix on a nearby
glass slide. Optical microscopy of the ablated material collected from the solvent-free
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prepared 2,5-DHB and 2,5-DHAP matrixes on a second microscope slide held at ~2 mm
distance from the matrix is shown in Figure 4.4 and Figure S4.6 in Appendix A. After
grinding for 30 s using the TissueLyser II, both matrixes produce liquid droplets upon
ablation (Figure 4.4). Larger droplets (~5 to 7 μm diameter) are observed for 2,5-DHB
compared to 2,5-DHAP (~1 μm diameter). The differences in volume of these molten
droplets correlate with the observed lower temperature required to produce the highly
charged LSI ions from 2,5-DHAP versus 2,5-DHB matrixes.
Increasing the grinding time to 10 min, 2,5-DHAP’s liquid droplets maintained the
same relative size, but 2,5-DHB’s droplets became smaller (Figure S4.6 in in Appendix
A). The third set of matrix samples were ground in a vortexer for 30 s, similar to the
method introduced by Hanton and Parees138 and used previously for solvent-free LSI.75
The liquid droplets collected for both matrixes are notably less abundant than the droplets
seen in the TissueLyser II sample (Figure S4.7 in Appendix A). While multiply charged
ions of angiotensin I were observed in all samples using 2,5-DHAP, samples using 2,5DHB and 30 s vortexer grinding times produced predominantly singly charged ions on
the LTQ Velos, similar to previous observations.75
For the study of the thermal requirements within the atmospheric pressure to the
vacuum transfer region on the formation of highly charged LSI ions of solvent-free
prepared matrix/analyte samples, a LTQ Velos is used that has a commercial heated inlet
capillary providing the ability to accurately control the desolvation temperatures (Figure
4.3.B). We ﬁnd for angiotensin I that the production of multiply charged LSI ions can be
enhanced with 2,5-DHB, as is shown for a temperature range from 40 to 400 °C (Figure
S4.5A,B in Appendix A). Only low abundance signal of singly charged ions can be
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observed at 40 °C using 2,5-DHB (Figure S4.5B in Appendix A), and high abundance of
both doubly and singly charged ions was produced when the capillary temperature was
increased to 275 °C (Figure 4.3B.1). In contrast, 2,5-DHAP provides abundant highly
charged angiotensin I ions at temperatures as low as 40 °C (Figure S4.5C in Appendix
A). Increasing the capillary temperature up to 400 °C did not have a signiﬁcant effect on
the charge state distribution but did on the abundance (ion count increased from 5.10 x
103 to 1.95 x 105) using 2,5-DHAP (Figure 4.3B.2 and Figure S4.5C in Appendix A).
The 2,5-DHAP matrix shows signiﬁcantly lower thermal requirements than the 2,5-DHB
using a solvent-free approach.

Figure 4.4. Microscopy images of liquid droplets produced by laser (N2) ablation
of (A) 2,5-DHAP and (B) 2,5-DHB matrixes after the material was ground
for 30 s in the TissueLyser II. Reference data for optical microscopy of ablated 2,5DHB and 2,5-DHAP after being ground for 10 min in the TissueLyser II (Figure S4.6
in Appendix A) and 30 s in the vortexer (Figure S4.7 in Appendix A) are included.
Interestingly, with all of the studies performed with angiotensin I using 2,5-DHAP,
the SYNAPT G2 provides highly charged ions, increasing in abundance with increasing
time and frequency of matrix/sample homogenization. Singly charged ions are not
observed, as can be seen in Figures 4.1 and 4.3A. The LTQ Velos, however, frequently
provides some degree of low abundant singly charged ions along with abundant multiply
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charged ions as observed in Figure 4.3B. Because enhancement in multiply charged ion
formation is observed with longer grinding times, higher grinding frequency, and higher
temperature, the LTQ Velos (Thermo) results displaying both multiply and singly
charged ions (Figure 4.3B) compare well, considering the conditions used, with the
previously obtained Orbitrap Exactive results showing singly charged ion formation.75
The SYNAPT G2 was used with and without the IMS dimension by controlling the
helium gas (Figure S8 ion count increased from). Only low abundant singly charged ions
are observed without the use of the IMS dimension (no helium), and abundant highly
charged ions are observed with the use of the IMS dimension (helium on). This
unexpected result may be related to the unique and delayed ionization phenomena
occurring inside the ion transfer region109 or in the Triwave of the SYNAPT G2 with the
IMS “on”.115 This could also involve an ion transmission issue.
Applications of TSA to Mixtures of Peptides/Lipids and Crude Oil. Similar to ESI,
under LSI conditions, lipids produce singly charged ions, thus, mixing a lipid with a
peptide should produce both singly and multiply charged ions. The analysis of a mixture
of angiotensin I and sphingomyelin using a TSA approach is shown in Figure 4.5. In the
extracted mass spectrum (Figure 4.5.A), the doubly and triply charged ions of
angiotensin I are observed in abundances similar to the pure sample along with abundant
singly charged ions of sphingomyelin. In comparison, when the solvent ACN/H2O
(50:50) was added to the same homogenized matrix/analyte powder, lipid ions were no
longer detected and the signal intensity for the peptide increased (Figure S4.9A in
Appendix A). Without the TSA analysis, this would incorrectly suggest that the lipid
component is not present in the mixture. This result has implications for the analysis of
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biological materials, such as tissue imaging, in which lipids and peptides (proteins) are
present and may be analyzed simultaneously. It also demonstrates that, with the IMS
“on”, singly charged LSI ions are transferred to the MS detector.
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Figure 4.5. LSI-IMS-MS of a mixture of angiotensin I and sphingomyelin with 2,5DHAP matrix using the solvent-free sample preparation method, a TSA approach: left
panel (A) mass spectrum and right panel (B) 2-D plot of drift time versus m/z.
In the 2-D plot of drift time versus m/z (Figure 4.5.B), well-separated singly charged
lipid (8.3 ms) and multiply charged peptide ions (4.2 ms for +2, 2.9 ms for +3) are
observed. Previous IMS-MS studies using MALDI showed that lipid and peptide ions fall
into respective charge state families (trend lines) with some separation.144 Further, the
solvent-based LSI-IMS-MS study (Figure S4.9B in Appendix A) shows in the 2-D plot
abundant doubly charged angiotensin I ions and a low abundant feature in the area where
sphingomyelin singly charged ion and doubly charged ion of metal adducted dimer are
expected based on the results observed in Figure 4.5.B. Without a prior knowledge of the
sample composition, these ions would not be noticed in the mass spectrum (Figure
S4.9A in Appendix A). More detailed DriftScope analysis of the solvent-based results
veriﬁes the identity of the singly charged sphingomyelin ions, demonstrating the
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enhanced effective dynamic range achieved by incorporating the drift time separation in
an IMS-MS experiment. The comparison of results of solvent-free and solvent-based
LSI-IMS-MS analyses of this model mixture demonstrates the more inclusive ionization
without the use of solvents during sample preparation/ionization.
Additional samples known to ionize exclusively by singly charged ion formation in
LSI were used to compare the relative ability of the SYNAPT G2 using the IMS
dimension versus the LTQ or Orbitrap mass spectrometers to determine if ion
transmission discrimination by charge state exists. Here, the applicability of TSA by LSI
for oil samples is examined. These samples are notoriously sticky and of extreme
complexity and therefore prone to sample loss.145 Furthermore, the ionization of crude oil
samples is frequently limited to ESI, atmospheric solids analysis probe (ASAP), or
atmospheric pressure photoionization (APPI).146-148 MALDI performs poorly because of
the chemical background introduced with the matrix in the mass range of the oil sample
and, most notably, the tendency of gas-phase aggregation and coalescence due to use of
higher laser ﬂuence, as shown with these and similar systems.146,149 - 154 Additionally,
solvent-based separation approaches for the reduction of sample complexity are difficult,
so the analyses are predominantly obtained using ultrahigh mass resolution Fourier
transform ion cyclotron resonance (FT-ICR) instrumentation145,146,148,153 and more
recently by IMS-MS.146,147
The analyses of liquid oils from various origins were prepared and analyzed by the
TSA approach using LSI with 2,5-DHAP as matrix. Typical examples are shown in
Figure 4.6 and Figure S4.10 in Appendix A. The 2-D plot of drift time versus m/z shows
abundant signals in the expected mass range of m/z 200 and 800 and demonstrates that
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laser-induced aggregates are not observed, even though the laser ﬂuence is higher using
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Figure 4.6. LSI-IMS-MS of crude petroleum oil with 2,5-DHAP matrix using
solvent-free sample preparation, a TSA approach: left panel (A) mass spectrum and
right panel (B) 2-D plot of drift time versus m/z with insets displaying extracted drift
time distributions of m/z 205.18 and 205.24. Reference data for other oily and sticky
materials are included in Figure S4.10 in Appendix A.
been reported for laser-based analyses such as MALDI and LDI of crude oil and similar
materials.146,149-152 The LSI-TSA approach does not show aggregation or clustering. The
chemical background introduced by the matrix is also insigniﬁcant using the LSI-TSA
approach. The lower chemical background has been described for solvent-free ionization
approaches for a number of low molecular weight systems including efficient ionization
of fatty acids, pigments, and polycyclic aromatic hydrocarbon compounds.36,143,154 A
comparison with solvent-based LSI-IMS-MS shows some chemical background related
to the use of solvent (Figure S4.11 in Appendix A). Again, the observation of singly
charged ions under LSI conditions with the IMS “on” suggests that transmission
discrimination is not a detrimental issue. The solvent-free gas-phase separation of small
structures of isobaric composition is delineated by the extracted drift time distributions of
m/z 205.18 and 205.24 in the inset of Figure 4.6.B. An initial study on TSA using a
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MALDI approach delineated isobaric tissue composition at m/z 863.3 to 863.7.136 When
comparing the different oil samples relative to each other, the differences are evident
(Figure 4.6 and Figure S4.10 in Appendix A). Both the pure vegetable oil and the motor
oil exhibit the presence of more low mass species, while crude oil shows a more complex
nature with more abundant high mass species. This indicates the useful nature of the 2-D
plots when using the snapshot approach as previously indicated for the analysis of
synthetic polymers. 155
4.4 Discussion
The preparation of supersaturated 2,5-DHAP solution is crucial for the success of
LSI, though the solubility of 2,5-DHAP is low in most solvents.132 As shown here, the
solvent-free sample preparation is more streamlined, and the solubility of 2,5-DHAP or
deposition procedure to the sample holder is no longer a setback for obtaining similar and
in some cases improved mass spectra as compared to solvent-based sample preparation.
The ability and simplicity of preparation and ionization of even sticky oil samples
relates well with previous studies of sticky and liquid polymeric samples using a solventfree MALDI approach.36,138,154 The disadvantage of the solvent-free sample preparation
used here as well as other solvent-free sample preparation methods developed for surface
analysis136 is the larger sample requirement relative to solvent-based LSI sample
preparation, which showed sensitivities in the low femtomole range for insulin and midattomole range for peptides. 75 The ability to produce highly charged ions without the use
of a voltage75,107,108,121,129-135 is of analytical utility but is also of fundamental importance.
Previous work showed that the ion production occurs inside the capillary in the AP
vacuum pressure drop region and that desolvation processes of the matrix occur, leaving

57

behind the multiply charged ions similar to ESI-like processes at AP.107,131 Multiply
charged ions were previously obtainable only by using ionization methods that involve a
solution state such as in ESI
75,107,108,115,121,130-134
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or solvent-based sample preparation for LSI.

Interestingly, adding a drop of solvent to a sample prepared solvent-

free using a vortexer for homogenization of matrix/analyte converts the singly charge
ionization observed using that procedure to the sole production of multiply charged ions,
suggesting that analyte incorporation in MALDI might be important in forming multiply
charged LSI ions.75 Here, we show that solvent is also not a necessity to produce multiply
charged ions of peptides and proteins. The solid matrix/analyte mixture prepared and
homogenized without employing solvent when ablated from a surface forms molten
droplets upon the absorption of the laser energy similar to solvent-based LSI
observations.131 Garrison et al. modeled matrix droplets in vacuum laser ablation of solid
matrix. 157,158
Initial solvent-free results show that multiply charged ions from solvent-free sample
preparations are easily obtained on the SYNAPT G2 (Figures 4.1 and 4.2), but that the
reproducibility between instruments and relative to published work75 on the Orbitrap is
low. Exploring different preparation (e.g., grinding time and frequency) and instrument
parameters (e.g., oriﬁce temperature, IMS gas) on two different mass spectrometers (LTQ
Velos, SYNAPT G2) elucidated a number of important mechanistic aspects to solventfree and multiply charged ion formation (Figure 4.3). 2,5-DHAP solvent-free sample
preparations are readily obtained and reproducible on the LTQ Velos and SYNAPT G2,
but the DHB results notably vary between instruments. To elucidate the differences, an
approach similar to that of published work131 on solvent-based LSI-MS was used that
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showed that signiﬁcant amounts of matrix/analyte materials are transformed by the
impact of the laser on the solid matrix/analyte to liquid droplets collected on a glass slide
2 mm distant from the matrix holding glass slide and visualized by microscopy. Here
(Figure 4.4, Figure S4.6 and S4.7 in Appendix A), ablating solid matrix material from
the surface shows that both the DHAP and the DHB matrixes produce droplets, though
not to as large of an extent as with solvent-based sample preparation, and that the droplet
sizes are signiﬁcantly different for both matrixes prepared solvent-free. DHAP produces
small droplets under all tested preparation methods that do not signiﬁcantly change in
size using various grinding conditions. However, the size of DHB’s droplets are large
relative to the droplets formed from DHAP and are inversely proportional to grinding
time in the ball-mill device. The smaller droplets likely require less energy for efficient
desolvation in the ion transfer region and consequently enhance the ease and thus the
abundance for forming multiply charged ions. The always small sized DHAP droplets
(Figure 4.4A) also offer a sound argument for the reproducibility of the solvent-free
experiment using DHAP. Microscopic results are in agreement with our mass
spectrometric observations. We cannot assert a causal relationship between smaller
matrix/analyte droplets and the formation of more abundant multiply charged ions, but
there is a correlative connection. A correlation appears to exist between the production of
multiply charged LSI ions and the abundance of small liquid droplets formed from
ablated matrixes. In the case of the DHB matrix, this is achieved with longer grinding
times (10 min) on the Velos at a temperature of 275 °C for which the doubly charged ion
is now the base signal relative to the singly charged ion (Figure 4.3).
Relating the microscopy data to the mass spectrometric results of DHB and DHAP
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matrixes seems to suggest that the production of highly charged ions is more effcient
from materials that form smaller droplets. A droplet of ~2 μm (DHAP) versus ~8 μm
(DHB) diameter has 64 times more matrix material. The difficulty of desolvation of the
larger droplets may explain the higher temperature requirements in the transfer capillary
of the mass spectrometer for DHB. It is possible that the thermal energy requirement for
producing the multiply charged ions is only suffcient for the smaller droplets. Small
droplets can be achieved from appropriate matrix material by laser ablation at AP from
samples that were not “incorporated” into the matrix in a conventional way but by the
grinding forces. Extended grinding times (SYNAPT G2; Velos) and high desolvation
temperatures (Velos) allow highly charged LSI ions to be formed in the source region as
well as downstream of the mass spectrometer (SYNAPT G2).
LSI is a subset of MAII109 in which a laser is used to transfer the matrix/analyte
material to the ion transfer capillary for ionization. Other means of MAII are the use of,
for example, a center punch or simply a spatula giving identical results as compared to
LSI. Clearly not all MAII methods start with small molten droplets but produce multiply
charged ions. Important to success is effcient heating (Figure 4.3.B1 and Figure S4.5A,B
in Appendix A), low thermal requirements (Figure 4.3.B2 and Figure S4.5C in Appendix
A), and homogeneity (Figure 4.3A and Figure S4.4 in Appendix A). The singly charged
ions previously produced using a solvent-free LSI approach are a result of nonincorporating vortexing conditions.75
Previous MALDI studies discussed ionization, incorporation of analyte into the
matrix,

morphology

changes

in

solvent-free

and

solvent-based

sample

preparation/ionization for analysis,36,39,159-166 with some indication that the solvent-free

60

method enhances the effciency of MALDI ion production of compounds diffcult to
protonate because the analyte and metal cations get close in the solid state through the
grinding process.39,41,143,154,157 Solvent-based LSI-MS and LSI-IMS-MS provides little
evidence for producing Na+ adduction to peptides or proteins similar to MALDI or ESIMS, probably because of segregation that occurs upon crystallization on removal of
solvent. It seems possible that the more aggressive homogenization in solvent-free
MALDI produces smaller and better mixed matrix/analyte(/metal cation) particles which
produce the desired “incorporation” and molten state, thus accounting for the observation
of multiply charged ions formed by proton and metal cation attachment. In contrast to
MALDI and LDI, the chemical background in TSA by LSI is relatively low and analyte
aggregation146,149-152 is not observed, similar to ESI-IMS-MS, but provides the ability for
fast, solvent-free, and surface analyses independent of analyte or matrix solubility.
The structural changes observed in the IMS dimension for protonation versus
sodiation are small based on the drift time separation, whereas the structural changes of
oxidized and non-oxidized NAC are signiﬁcant, demonstrating the potential of structural
diﬀ erentiation of ions directly from the solid state. Because ESI-IMS-MS gives the same
results, the oxidation or structural changes are not related to one ionization method.
Morphology changes during sample preparation to produce small molten droplets and the
absence of sodiation in ESI and LSI-IMS-MS measurements lead us to conclude that the
attachment of metal cation(s) is a direct result of the homogenization process of the
matrix/analyte.
4.5 Conclusion
We report the ﬁrst observation of multiply charged ions produced from the solid state
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using solvent-free matrix/analyte sample preparation. Combined with IMS-MS, this TSA
approach provides greatly improved IMS separation of compound classes that diﬀer by
charge states (e.g., lipids and peptides). Other advantages of a TSA approach include
one-step sample preparation and deposition on the target plate, rapid data acquisition for
simplifying sample complexity relative to ESI and LC-MS, reduction of sample artifacts
caused by the use of solvents, and enhancement of the eﬀective dynamic range by the
IMS dimension. The ability to observe multiply charged ions using LSI from solvent-free
sample preparation will have immense beneﬁts if it can be translated to solvent-free
matrix deposition for tissue imaging where the use of solvent is detrimental to retaining
spatial integrity of the more soluble compounds.
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CHAPTER 5
A NEW APPROACH TO HIGH SENSITIVITY LIQUID
CHROMATOGRAPHY-MASS SPECTROMETRY OF PEPTIDES USING
NANOFLOW SOLVENT ASSISTED INLET IONIZATION
Liquid chromatography (LC) solvent assisted inlet ionization (SAII) mass
spectrometry (MS) was previously reported to give good chromatographic resolution and
MS detection injecting 66 ng of a BSA tryptic digest. In analogy to nano-electrospray
ionization (nESI), we extend SAII LC/MS to nano-SAII (nSAII) operating at nL min–1
flow rates and demonstrate good quality ion chromatograms and mass spectra from
injection of as little as 0.7 ng of BSA digest onto a capillary LC column. Data dependent
fragmentation is demonstrated for injection of 7 ng of a BSA digest. This method has
advantages over nESI in ease of use and low cost as it requires no voltage and is
operational without the necessity of connectors or fragile nESI emitters, although similar
constricted tips can be helpful in nSAII to stabilize the signal at low nanoliter flow. At a
flow rate of 0.8 μL min–1, the only requirement for nSAII is that the exit-end of
the capillary LC column be adjusted near the aperture of the heated inlet of the mass
spectrometer.

B. Wang, E. D. Inutan, S. Trimpin, J. Am. Soc. Mass Spectrom. 2012, 23, 442-445.
Reprinted with permission from Springer Science and Business Media.
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5.1 Introduction
Modern liquid chromatography/mass spectrometry (LC/MS) almost exclusively uses
electrospray ionization (ESI) except for low polarity compounds which use atmospheric
pressure chemical ionization (APCI). 167 , 168 , 169 For analyses where sample amount is
limited, ESI LC/MS is performed at nanoliter (nL) min–1 mobile phase flow
rates.78,170,171,172 This approach, called nano-ESI (nESI), 173 is especially important for
peptide and protein analyses. Because ESI is a concentration sensitive method, lower
flow rates produce similar signal to higher flow but with consumption of less material.80
However, the low flow condition also enhances ionization, presumably by producing
smaller solvent droplets with increased charge, thus reducing ion suppression and
ionizing a wider range of compounds. Because of the importance of nESI, ion sources are
commercially available. Recently, Smith and coworkers 174 , 175 reported on nESI at
subambient pressure using ion funnel technology. However, nESI has a number of
shortcomings. The low solvent flow greatly increases the time for a complete LC run
relative to higher flow rates, and achieving a stable ion current is notoriously difficult.
Special spray emitters are available to help address this issue,82 but the emitter tips are
fragile and add considerable cost to nESI. The sharp tips also reduce the voltage range
over which a stable ESI spray is observed: too high voltage produces a corona discharge.
Technical issues generally limit the use of nESI to problems that need its additional
capabilities.
Recently, inlet ionization methods have been introduced that have the potential to
compete with both matrix assisted laser desorption/ionization (MALDI) and ESI.
Methods that utilize a solid phase matrix similar to those used in MALDI are laserspray
ionization inlet (LSII)75,107,121,129,132,135 and matrix assisted inlet ionization (MAII).109
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Solvent assisted inlet ionization (SAII) is the equivalent of ESI in that similar mass
spectra are produced from solvent/analyte solutions introduced into the mass
spectrometer inlet and ionized.111 Just as in ESI, SAII can be used for ionization in
LC/MS.112 It was shown that introducing the LC mobile from a 1 mm i.d. LC column
directly into a heated inlet transfer tube of the mass spectrometer produced a high quality
ion chromatogram and corresponding mass spectra with injection of ca. 70 ng of bovine
serum albumin (BSA) tryptic digest. Here, we extend the applicability of inlet ionization
to nanoliter flow rates by positioning the LC effluent just outside of the mass
spectrometer inlet aperture and demonstrate similar results from injection of just 0.7 ng of
BSA digest.
5.2 Materials and Methods
Materials. Chemicals were stated in Chapter 2.
Methods.
SAII-MS. One end of a 40 cm length of 25 μm i.d. fused silica tubing (Polymicro
Technologies, Phoenix, AZ, USA) was connected to a syringe and the exit end taped on
an x,y,z-stage to control the alignment and distance of the exit end relative to the inlet
aperture of the heated atmospheric pressure (AP) to vacuum inlet tube of the mass
spectrometer. A study of the optimum distance of the fused silica exit from the inlet
orifice was performed by pumping a 1:1 ACN:water 0.1 % FA 1 pmol μL–1 angiotensin
I solution through the fused silica tube at a flow rate of 1.2 μL min–1. The x,y,zstage was used to adjust the exit end of the fused silica from 0.4 mm on the AP side to
0.2 mm on the vacuum side of the mass spectrometer inlet aperture.
NanoSAII and nanoESI LC-MS and MS/MS. A Waters Corporation NanoAcquity
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UPLC was used with a Waters 100 μm×100 mm BEH130 C18 column with 1.7 μm
particles. Water and ACN both containing 0.1% FA was used as the mobile phases in all
studies. A 35 min gradient of 1 to 85% ACN was used at mobile phase flow rates varying
from 0.4 to 0.8 μL min–1, and a 12 min gradient at a flow rate of 1.2 μL min–1. For
0.4 μL min–1 flow rate, a 6.35 cm long 360 μm o.d. × 20 μm i.d. (with 10 μm i.d. at
the tip) pre-cut PicoTip emitter (Waters) was employed as an extension to the end of LC
capillary column and mounted on the x,y,z-stage to be positioned about 0.1–0.2 mm
outside of the mass spectrometer inlet for optimum results. At flow rates of 0.8 μL min–1
and higher, the exit-end of the LC capillary column (100 μm i.d. × 360 μm o.d.) was
used without need of a special emitter or any tubing connections. A Thermo LTQ-Velos
mass spectrometer with the inlet tube heated to 300 °C was used for LC-nSAII-MS and
MS/MS. Data dependent MS/MS was obtained using collision induced dissociation
(CID) with 35 V collision energy. A three point boxcar smoothing was used for the LC
chromatogram display. A Waters SYNAPT G2 mass spectrometer109,112,121,132 was used
for LC-nESI-MS for relative comparison. The skimmer cone was heated to 150 °C. The
voltage applied on the nESI capillary is 3.06 kV. BSA tryptic digest solution, 1 μL of a
100 fmol μL–1, was analyzed using the same LC gradient at a mobile phase flow of
0.8 μL min–1 and 0.4 μL min–1.
5.3 Results and Discussion
SAII was recently interfaced with LC/MS at a mobile phase flow rate of 55 μL min–1
with chromatographic resolution comparable to ESI LC/MS and produces good
signal-to-noise with injection of 1 pmol of a BSA digest.112 This work was accomplished
on a LTQ-Velos, which has a heated inlet tube linking AP with the first vacuum region of
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the mass spectrometer. The higher flow rates used in the previous study requires that the
exit-end of the fused silica capillary be stripped of its polyimide coating and inserted into
the heated inlet tube of the mass spectrometer to a ‘sweet spot’ for ion production. Here,
we demonstrate, in analogy to nESI, that nanoliter mobile phase flow rates are also
compatible with SAII. The initial ‘tuning’ for the low flow rate was achieved by
delivering an angiotensin I solution using an infusion pump to the exit end of the fused
silica tube (25 μm i.d.) so that it could be adjusted (Figure S5.1 in Appendix B) for the
best stability and abundance of the signal from the triply charged angiotensin I ion (m/z
433). For flow rates of a few microliters and lower, the best position of the fused silica
capillary exit-end was found to just at the inlet entrance aperture, and no longer requiring
the removal of the coating. A stable signal with good sensitivity was achieved with the
mass spectrometer inlet tube temperature set to 300 °C. The flow of air into the vacuum
region of the heated mass spectrometer entrance inlet is sufficient to nebulize the solution
at the tip of the fused silica, sweeping the ensuing mist of solvent droplets into the inlet
where ions are generated with the assistance of heat and vacuum.
Laserspray ionization (LSII), potentially useful for imaging at high spatial
resolution,75,107,121,129,134,135 is a subset of matrix assisted inlet ionization (MAII)109 in
which a laser is used to transfer the matrix/analyte mixture to the mass spectrometer inlet
where ions are produced in the heated pressure drop region having similar charge states
to ESI. We hypothesize that ion formation is vacuum and thermal assisted.107,110,121,122,131
SAII111,112 is similar to the other inlet ionization methods of LSII

75,107,121,129,134,135

and

MAII109 in which any means of introducing matrix/analyte into the heated inlet produces
ions similar to ESI. In the case of SAII111 where the matrix is a solvent, it can be shown
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(Figure S5.2 in Appendix B) that ions are not produced by a sonic spray mechanism as is
evident by the requirement that the inlet be heated to produce ions:

heat is not a

requirement for sonic spray. 176,177 There are also significant differences between inlet
ionization with a solvent and thermospray ionization124 in addition to the high charge
states, low flow rates and the high sensitivity achievable with SAII, as was recently
pointed out.112
Without the need to place the fused silica inside the heated mass spectrometer inlet, it
is possible to use the exit of the capillary LC column and eliminate all connections,
unlike in our previous LC-SAII study.112 By attaching the exit of the LC column to an
x,y,z-stage with tape, the end of the LC column capillary tubing is visually adjusted near
the entrance of the mass spectrometer inlet for optimum ion current stability (Figure 5.1A
and Figure S5.3 in Appendix B). This procedure can be accomplished in a couple of
minutes. This arrangement provides stable ion current at flow rates from 0.8 μL min–1
(Figure S5.4A in Appendix B) to at least 1.2 μL min–1 (Figure S5.4B in Appendix B).
However, the signal is not sufficiently stable with this arrangement at 0.4 μL min–1 for
good quality LC/MS. Observationally, it appears that the instability is the result of larger
droplets exiting the fused silica tubing rather than a fine spray. A stable signal is achieved
by attaching the LC column to a Waters PicoTip emitter (Figure 5.1B), as is done in
nESI. Because SAII operates without the requirement for a voltage and at high nanoliter
flow rates without the necessity of a fragile emitter, it is exceptionally easy to implement.
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A.

B.

Figure 5.1. Pictures showing the setup for LC-nSAII. Side view of MS inlet in which
the tip of the fused silica capillary tube of the LC column is placed about 0.1 mm out
of the orifice inlet entrance of the mass spectrometer (A) directly or (B) by use of a
“PicoTip” attached to the end of the fused silica capillary tube. Front view of the LC
and mass spectrometer setup is displayed in Figure S5.3 in Appendix B.
Using the simple set-up (Figure 5.1A and Figure S5.3 in Appendix B) requiring no
emitter connected to the LC column and a mobile phase flow rate of 0.8 μL min–1,
injection of 100 fmol (7 ng) of BSA digest produces roughly equivalent results to those
reported112 for ca. 70 ng injected at 55 μl min–1. The base peak chromatogram for the 100
fmol injection is shown in Figure S5.5A in Appendix B. The mass spectrum from the
peak eluting at 17.8 min shows doubly and singly charged analyte ions (Figure S5.5B in
Appendix B). In order to have a relative comparison, nESI LC/MS was acquired using
the commercial nESI source on the SYNAPT G2 mass spectrometer at a mobile phase
flow rate of 0.8 and 0.4 μL min–1 using the same gradient and injecting 100 fmol of the
same BSA digest used in the SAII study (Figures S5.4 and S5.6 in Appendix B).
Additionally, data dependent fragmentation for the 100 fmol SAII injection on LTQ
Velos also produces excellent LC/MS/MS fragmentation as is demonstrated by the high
sequence coverage using MASCOT for the BSA peptide fragment at m/z 740 having the
sequence LGEYGFQNALIVR (Figure 5.2). MASCOT identified the protein as BSA
from this single MS/MS spectrum with a score of 103. The first nSAII LC/MS and
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MS/MS results, without the necessity of special connections, tips, or voltage, produce
roughly equivalent results to nESI and in much less set-up time for the experiment.
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Figure 5.2. LC-nSAII-MS/MS mass spectrum of 100 fmol μL–1 BSA tryptic digest
with 1 μL injection at a flow rate of 800 nL min –1 using the setup shown in
Figure 5.1(A). The sequence shows the Mascot coverage providing a MASCOT score
of 103.
Injection of just 10 fmol (0.7 ng) of BSA digest using SAII at 0.8 μL min–1 produces
the base peak chromatogram in which only the most abundant ions are observed.
However, connecting the exit of the LC column to a 20 μm i.d. PicoTip with 10 μm i.d.
on the tip allows a stable signal to be obtained at a flow rate of 0.4 μL min–1. Under these
conditions, injection of 0.7 ng of BSA digest produced the base peak chromatogram
shown in Figure 5.3. The signal-to-noise was calculated by the data system for the peak
eluting at m/z 582 is 277.
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Figure 5.3. nSAII-LC/MS base beak chromatograms of 10 fmol μL–1 BSA tryptic
digest with 1 μL injection at a flow rate of 400 nL min-1 using the “PicoTip”
extension shown in Figure 5.1(B).
5.4 Conclusion
Inlet ionization is a new method for producing mass spectra equivalent in charge state
to those produced by ESI but from solid (LSI or MAII) or solution (SAII) states without
the need for a laser or voltage for ionization. The sensitivity of inlet ionization is
demonstrated by the production of good quality base peak chromatograms and clean mass
spectra with high signal-to-noise with injection of as little as 0.7 ng of a BSA digest using
nSAII LC/MS. Data-dependent fragmentation was shown for injection of just 7 ng of
BSA digest using a mobile phase flow rate of 800 nL min–1. These results suggest the
potential of SAII for proteomics and most likely other areas where sample amounts are
limited. Detailed mechanistic discussion relative to inlet ionization is addressed in a
forthcoming paper.122
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CHAPTER 6
HIGH THROUGHPUT SOLVENT ASSISTED IONIZATION
INLET (SAII) FOR USE IN MASS SPECTROMETRY
In this work we developed a multiplexed analysis platform providing a simple highthroughput means to characterize solutions. Automated analyses, requiring less than 5 s
per sample without carryover and 1 s per sample, accepting minor cross contamination,
was achieved using multiplexed solvent assisted ionization inlet (SAII) mass
spectrometry (MS). The method involves sequentially moving rows of pipet tips
containing sample solutions in close proximity to the inlet aperture of a heated mass
spectrometer inlet tube. The solution is pulled from the container into the mass
spectrometer inlet by the pressure differential at the mass spectrometer inlet aperture.
This sample introduction method for direct injection of solutions is fast, easily
implemented, and widely applicable, as is shown by applications ranging from small
molecules to proteins as large as carbonic anhydrase (molecular weight ca. 29 000).
MS/MS fragmentation is applicable for sample characterization. An x,y-stage and
common imaging software are incorporated to map the location of components in the
sample wells of a microtiter plate. Location within an x,y-array of different sample
solutions and the relative concentration of the sample are displayed using ion intensity
maps.
B. Wang, S. Trimpin, Anal. Chem. 2014, 86, 1000-1006.1 Reprinted with permission
from Copyright (2014) American Chemical Society.
1

This publication has been converted to a provisional patent and later to a patent application,
pending. “Multiplexing system used to allow high throughput analysis of samples using solvent
assisted ionization inlet comprises ionizing system for solvent assisted ionization inlet, x,y-stage
or x,y,z-stage, and software program at maps samples” US2014166875-A1, Trimpin, S.
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6.1 Introduction
High-throughput screening is an important need of the pharmaceutical industry
including drug design and clinical applications.178-180 Commonly used technologies are
fluorescence, 181 electrophoresis, 182 and mass spectrometry (MS). 183 While electrospray
ionization (ESI) has a number of advantages, matrix-assisted laser desorption/ionization
(MALDI) is the faster ionization method by simply increasing the frequency of the laser
used for desorbing/ionizing the matrix/analyte (e.g., 20 kHz).184 Work on increasing the
speed of ESI technology is based on using multiple inlets,185,186 an automated chip-based
work flow (e.g., Nanomate), 187-191 or segmented flow. 192,193 Recent years have seen a
renaissance for ionization approaches used in MS. One result has been many clever ways
to analyze materials under ambient conditions,84 thus providing a convenient and direct
means of sample analysis.89, 194 The novel methods that are capable of ionizing
nonvolatile compounds are frequently based on ESI.33,156
A series of inlet ionization methods107,109,111 have been discovered recently that
produce ESI-like mass spectra from the solution or solid state. Ionization occurs in a
heated pressure drop region linking atmospheric pressure (AP) with the first vacuum
stage of a mass spectrometer. The simplicity of inlet ionization methods is that neither a
high voltage nor a laser is required, and the natural gas flow through the inlet replaces the
necessity of a nebulizing gas. Multiply charged ions produced by these methods extend
the mass range of highper formance mass spectrometers,107 enhance separations by
charge states in ion mobility spectrometry (IMS),132 and allow advanced fragmentation
using electron-transfer dissociation (ETD).134 Several modes of analyzing surfaces and
solutions are available with inlet ionization, some providing high spatial resolution or

73

high-speed imaging.195 These ionization methods, even in their early development, are
highly sensitive as has been shown for bovine insulin and steroids.111,196
Solvent assisted ionization inlet (SAII) is the liquid introduction variant of the family
of inlet ionization operating without a laser or a voltage and capable of coupling with a
liquid chromatography (LC)112,196 and nano-LC/MS/MS197 with high sensitivity (7 ng of
bovine serum albumin (BSA) tryptic digest injected on column,197 and low femtograms
for steroids196). Because in SAII, the exit end of a fused-silica capillary is placed inside
the inlet, a pressure differential drives the flow of solvent into the mass spectrometer
without the need of a pump.111 The best sensitivity was achieved in the initial approach
by aligning the fused-silica tube to a “hot spot” within the inlet tube.111 Subsequent SAII
work showed that for nanoliter flow, good sensitivity (e.g., 10 fmol of a BSA digest by
LC/MS), is achieved simply by placing the LC outlet in front of the inlet aperture of the
mass spectrometer.197 Solution is swept into the inlet in the flow of air, and analyte is
ionized in the inlet.
Here, we present a flexible SAII approach based on direct injection and use of
disposable pipet tips for the analyses of compounds independent of molecular weight and
volatility. This method can be used to conveniently map solution content, location, and
relative quantities in a high-throughput manner.
6.2 Materials and Methods
Materials and Sample Preparation.
Clarithromycin tablet (500 mg) was obtained from local pharmacy and ground to fine
powder by mortar and pestle. Other general chemicals were stated in Chapter 2. For the
experiments using directly pipetting, the phosphorylated peptide mixture was prepared in
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50:50 acetonitrile:water with 0.1% formic acid for positive mode acquisition at 150 °C,
and in 0.5% ammonia for negative mode acquisition at 400 °C. Myoglobin and carbonic
anhydrase were diluted in water with 0.1% formic acid and analyzed at inlet temperature
of 250 ºC. In the pH study, bovine insulin and lysozyme solutions at pH of about 3, 4.5,
6, and 9 were tested.

Bovine insulin stock solutions were prepared in 50:50

methanol:water with 1% acetic acid and 50:50 methanol:water with 1% ammonia. Then
the acidic solution was diluted with methonal:water with acetic acid or water, and the
basic solution was diluted with methanol:water with ammonia or water. Lysozyme was
prepared by dissolving lysozyme in 1% formic acid, 50:50 acetonitrile:water with 0.1%
formic acid, 50:50 acetonitrile:water with 0.05% formic acid, water, and 0.1% ammonia,
respectively. Carbonic anhydrase was diluted in water with 0.1% formic acid.
For the experiments using the 8-channel pipette, leucine enkephalin and galanin were
prepared in water with 0.1% formic acid, and ubiquitin was in 50:50 acetonitril:water
with 0.1% formic acid. Clozapine was diluted by methanol to desired concentrations. For
the analysis of tablets, 8 wells in the first row of the 384-well microtiter plate (Greiner
Bio-One Inc., Monroe, NC) were filled with 100 µL methanol. A pipette tip was used to
dip into the tablet powder, transferred random amount of the powder and swirled them
into the second, fifth, and eighth well (Scheme S6.2 in Appendix C). The tablet solutions
were then diluted 100 fold by methanol in the second row of the microtiter well plate, and
the diluted tablet solutions were diluted again 100 fold in the third row (Scheme S6.2.A
in Appendix C).
For experiments using the 96-well plate, analytes were diluted from their stock
solutions using the following solvent systems: clozapine was in methanol, sphingomyelin
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was in methanol with 1% acetic acid, bovine insulin in 50:50 methanol:water with 1%
acetic acid, and all the others were in 50:50 acetonitrile:water with 0.1% formic acid.
Methods.
The SAII-MS and SAII-MS/MS experiments were carried out on an LTQ Velos mass
spectrometer (Thermo Fisher Scientific, Bremen, Germany), from which the ESI source
was removed and interlocks overridden as described previously.135 The inlet of the mass
spectrometer was heated between 150 to 450 °C depending on solvent and its pH. To
avoid cross contamination, pipet tips filled with only solvent, used for dissolving the
analyte in the previous pipet tip, were added to alternate pipet tips. Mass spectra were
displayed as a single acquisition, generally by acquiring 1 microscan and with the
maximum injection time of 100 ms for pipetting, 1 microscan and 300 ms maximum
injection time for multiplexing, unless otherwise stated. Collision induced dissociation
(CID) and electron transfer dissociation (ETD) were employed for characterization of
certain analytes by selecting the parent ion using a mass tolerance of 1 m/z unit. Similar
to a previous study, 198 the CID MS/MS spectra were obtained using a normalized
collision energy setting between 20 to 30 depending on the analyte, and ETD using an
activation time of 100 ms.
For these experiments, pipet tips (10 μL micropipet tips, Fisher Scientific, Pittsburgh,
PA) are aligned with the MS inlet by having them held in an 8-channel pipet holder or the
96-pipet tip holder in which new pipets are shipped. Solutions containing sample, or
blank, were loaded by simultaneously dipping the pipet tips into a 96 multivial or well
plate containing the various analyte solutions; ~3 μL of each solution is drawn into the
pipet tip by capillary action (based on acetonitrile/water solution). The holder was affixed
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on the x,y-stage with the first pipet tip (typically empty) placed in close proximity (~0.1
mm at low inlet temperatures and ~0.5 mm at high inlet temperature) to the inlet aperture.
Using the control of the x,y-stage, rows of pipet tips were moved automatically in front
of the inlet aperture so that the solution containing the analyte exits the pipet tip under the
influence of the pressure differential when the tip is in close proximity with the inlet
aperture of the mass spectrometer. The x,y-stage movement was continuous, and rate of
movement was controlled from 1.5 to 18 mm s−1. Data were acquired in the mass-tocharge (m/z) range of 150−2000, unless otherwise stated. Mass spectra were displayed as
a single acquisition, generally by acquiring 1 microscan and with a maximum injection
time of 100 ms for pipetting, 1 microscan and 300 ms maximum injection time for
multiplexing, and 1 microscan and 500 ms maximum injection time for quantitative
studies. Biomap imaging software (Novartis Institution for Biomedical Research, Basel,
Switzerland), typically used for imaging applications,135,195,199 was incorporated to map in
which solution analyte was present as determined by the m/z ratio values obtained by MS
or MS/MS. Besides mapping the location of analyte, the software allows relative
concentrations to be displayed by color code.
6.3 Results and Discussion
Initial results were obtained using a single pipet and purchased standards. Sample
solution was introduced for mass analysis from a pipet tip held close to the inlet aperture
of the mass spectrometer. For ease of operation, the source housing was removed and
interlocks overridden. Analyte ions were observed as soon as the pipet tip was close, but
not touching, the heated (150 °C) inlet tube entrance of the LTQ Velos and solution was
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drawn into the inlet (Scheme 6.1A). Standards, and standard mixtures, of varying
concentrations were run to acquire initial benchmark results for ongoing improvements.
Scheme 6.1. Pictures of the SAII source setup using (A) a single pipet, (B) an 8channel pipet, (C) a 96-pipet array; loading of the samples through use of the 96
sample plate is displayed in Scheme S6.1 in Appendix C. (B) and (C) are automated
by mounting the pipet holder on a xy-stage and mapping of the location is achieved
through inclusion of the Biomap program.

A.

pipet tip

B.

inlet
inlet

tips

C.

tips

x,y-stage

inlet
96-well plate

With phosphorylated peptides, both positive (Figure 6.1A) and negative (Figure
6.1B) ions were produced using this method without the loss of phosphorylation.
Fragmentation using collision-induced dissociation (CID) provides good sequence
coverage of each phosphorylated peptide dispensing 1 μL of a 2.5 pmol μL−1 solution
(Figure S6.1 in Appendix C). Proteins as large as myoglobin and carbonic anhydrase are
efficiently ionized and detected using this approach (Figure S6.2 in Appendix C). The
angle of the pipet relative to the inlet had little effect so long as solution was drawn into
the inlet. Results from this study demonstrated that SAII is operationally simple and
tolerant of a wide range of solvents, such as 100% water (Figure S6.3A in Appendix C),
chloroform (Figure S6.3B in Appendix C), or 90% acetonitrile (Figure S6.3C in
Appendix C).
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Figure 6.1. A mixture of phosphorylated peptides (angiotensin II, molecular weight
(MW) 1125; cholecystokinin (10-20), MW 1330; and calcitonin (15-29), MW 1800)
was pipetted into the inlet (Scheme 6.1A). 1 µL of 2.5 pmol µL-1 solution was used
for each acquisition. Mass spectra of the mixture were obtained in (A) positive
acquisition mode at 150 °C and (B) negative acquisition mode at 400 °C. The
MS/MS spectra (CID) of each peptide are shown in Figure S6.1 in Appendix C.
Data were acquired in the m/z range of 50-2000 for positive mode and 155-2000 for
negative mode.
A pH study using bovine insulin and lysozyme was carried out at an inlet temperature
of 250 °C showing higher charge state ions were obtained in acidic solutions and that the
highest intensity for the most abundant charge state was obtained at pH ∼4.5 for
lysozyme (Figure S6.4 in Appendix C). Basic pH decreased the charge states of bovine
insulin. A temperature study using bovine insulin and lysozyme solutions is shown in
Figure S6.5 in Appendix C. Similar charge states but increasing ion abundance are
observed at higher temperatures (100 °C increments from 150 to 450 °C) as expected
from previous SAII studies on an Orbitrap with the solution introduced inside the inlet
tube.111 Over a wide range of temperatures, the method shows analytical utility. Higher
temperature is required to produce abundant ions when less volatile solvent, e.g., water, is
used (Figure S6.6 in Appendix C). However, “signal tailing” is observed using pure
water and at high temperature indicating the undesired adduction of sodium cations to the
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protein. Metal adduction is prevented through the addition of acids (Figure S6.5II in
Appendix C), as noted in previous SAII studies.111,114 The accumulation of results show
that, although the optimum inlet temperature is somewhat different for certain analytes
and sample preparation methods, sufficient ion abundance for analytical utility is
obtained over a wide range of conditions. As is the case with the traditional methods of
ESI and MALDI, smaller molecules are more easily detected than the larger nonvolatile
molecules. The optimal inlet temperature of the LTQ Velos is lower than those reported
for an Orbitrap Exactive in which solution was introduced inside the mass spectrometer
inlet.111
An advantage of the approach used here is that the volume of solution introduced to
the inlet can be better controlled using pipet tips relative to using fused-silica tubing, and
because the tips are disposable, cross contamination caused by sample adhering to the
walls of the fused silica is eliminated. The initial automation experiment with pipet tips
used an 8-channel pipet. The setup, designed to operate with the capillary inlet source of
the LTQ Velos, is shown in Scheme 6.1B. Three microliters of solutions containing
leucine enkephalin (2.5 pmol μL−1), galanin (1 pmol μL−1), and ubiquitin (1 pmol μL−1)
were simultaneously drawn from multisample well plates into alternate pipet tips with
pure solvent between each solution. The dispenser was fastened to an x,y-stage, and each
tip was sequentially moved in front of the inlet of the mass spectrometer. The setup was
previously aligned so that all plotting the total ion chronogram (TIC) (Figure 6.2A),
from which mass spectra of leucine enkephalin, galanin, and ubiquitin were extracted.
Good ion abundance was observed for each sample without cross contamination (Figure
6.2B.1−D.1). The Biomap software displays the location of any selected m/z in the
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sampled multisample well plate, as is commonly performed with imaging of tissue
sections.135,195,199 This is exemplified in Figure 6.2B.2−D.2 for leucine enkephalin (+1,
m/z 556), galanin (+3, m/z 1053), and ubiquitin (+7, m/z 1224) using 150 °C inlet
temperature. The mass spectra from the same set of analytes tested at different inlet
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temperatures (250, 350, and 450 °C) are similar (Figure S6.7 in Appendix C).
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Figure 6.2. Multiplexing SAII-MS using the 8-channel pipet (Scheme 6.1B) at an
inlet temperature of 150 °C. The analysis of 5 tips filled (3 uL) with 3 different
samples with solvent (S) between each two samples. (A) Total ion chronogram (TIC):
(1) Mass spectra and (2) mapping of the location of individual analytes: (B) 2.5 pmol
µL-1 leucine enkephalin (LE, m/z 556), (C) 1 pmol µL-1galanin (Gal, m/z 1053), and
(D) 1 pmol µL-1 ubiquitin (Ubi, m/z 1224). Data were acquired in the m/z range of
300-2000.
However, split peaks are observed in the TIC at 350 and 450 °C because the pipet tips
needed to be further from the inlet to prevent pipet melting which caused the solutions to
be drawn inconsistently and slowly so that, instead of a liquid stream, droplets are drawn
into the inlet. The pipet tip size is not critical, but with the present setup, the smaller tips
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are more difficult to align properly with the inlet. It is interesting to note that the speed of
the x,y-stage has little impact for any given size of pipet tips tested. As soon as the
solution is exposed to the vacuum, it is drawn into the mass spectrometer and analyte
rapidly ionized. However, even smaller size tips than explored here are expected to slow
the speed of solution exiting the pipet, as has been demonstrated for the picotips using
nano-ESI.197
The rate of analyses can be paced by adjusting the movement of the x,y-stage and can
be as short as one sample/s, accepting some cross contamination between samples. In
principle, one could also actively stop the x,y-stage movement at the expense of time
requirements. Figure S6.8 in Appendix C displays the analysis of three analytes
(angiotensin I, bovine insulin, and ubiquitin) in only 2 s with some acceptable carryover
between samples. For high-throughput screening this performance may already be
sufficient. Using this construction, three solutions of an antipsychotic drug clozapine at
25, 250, and 500 fmol μL−1 were mapped for relative amounts (Figure 6.3I). Two
solvents were used between each two analyte solutions. Different clozapine solutions or
pure methanol solvent were filled in the tips as indicated in Figure 6.3IA. MS/MS was
used to enhance the specificity of the experiment. The protonated ion (m/z 327) was
selected and fragmented by CID. The mass spectral data of the transition, 327 →
270,23,200 is visualized by a mapping display using Biomap (Figure 6.3IB). The color
trace correctly displays the location of the analytes with little or no carryover in the
methanol acquisitions. The color code also reflects the relative analyte concentration,
with blue at lower concentrations and red at higher concentrations. Figure 6.3II shows
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the TIC (Figure 6.3IIA) and mass spectra with ion abundances (Figure 6.3IIB) for each
of the samples.
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Figure 6.3. Mapping using the 8-channel pipette (Scheme 6.1B). (I): (A) Schematic
representation of content in each pipette tip. Red boxes indicate tips filled with 2 µL
clozapine solutions at 25 fmol µL-1, 250 fmol µL-1, and 500 fmol µL-1, respectively;
grey boxes represent pure solvent methanol; (B) The mapping of m/z 270 peak. (II):
(A) TIC and (B) Mass spectra extracted from (1) 0.02 min, (2) 0.17 min, and (3) 0.34
min of the TIC. Data were acquired in the m/z range of 200-500.
Using the same approach and concentrations, the more concentrated analyte may have
an effect on the less concentrated samples as is seen in the mapping display of the
methanol solutions (Figure S6.9 in Appendix C). If necessary, more tips containing
methanol blank solutions can be employed to reduce cross contamination between
samples for quantitative analyses. Using this approach, a 1 μL solution of 1 fmol μL−1
clozapine was readily detected (Figure S6.10 in Appendix C). This automated method is
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therefore sensitive, rapid, simple, and robust and can characterize small and large
molecules.
The comparison of introducing the same amount of ubiquitin (3 μL) by either
manually injecting or vacuum drawing (Figure 6.4) shows that both methods produce
nearly identical results. A tip-to-inlet distance of ca. 0.5 mm allows solution transfer
without concern for the tip melting at higher inlet temperature, but increasing distance
beyond this makes drawing the entire content of each pipet problematic. The ability for
the sample to be dispensed for ionization only when the tip of the pipet is close to the
entrance aperture, to make use of the mass spectrometer vacuum for sample introduction,
suggests a simple means for high-throughput sampling.
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Figure 6.4. SAII mass spectra of ubiquitin at inlet temperature of 250 °C. Solutions
of 3 µL of 1 pmol µL-1 were introduced by (A) manually pipetting and (B) vacuum
drawing (Scheme 6.1A). Data were acquired in the m/z range of 150-2000.
The number of samples which can be analyzed in a single automated analysis was
therefore extended using a commercial 96-pipet holder (Scheme 6.1C) to affix the pipet
tips for sampling 96-well plates. Because of the physical limitations of our x,y-stage
relative to the mass spectrometer inlet, only 84 samples of the possible 96 positions were
in the range of the x,y-stage motion. Sample loading is straightforward because the pipet
tips only need to be placed into the well of a multisample plate containing the various
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solutions and capillary action loads the pipet tips with approximately the same volume of
each solution/solvent (Scheme S6.1 in Appendix C) providing the solvents used are of
approximately the same composition, especially in water content. On the basis of a 1:1
acetonitrile:water solution, and the pipet tips used in the experiment, ca. 3 μL are drawn
into each of the pipet tips. Different pipet tips are expected to load different volumes, and
higher viscosity solvents, such as water, are more problematic using this approach so that
organic solvents such as acetonitrile or methanol were added to lower viscosity. Again, to
avoid the possibility of carryover, solvent was placed between any two samples.
A typical TIC is shown in Figure 6.5I in which 42 tips out of 84 were analyzed with
seven different analyte solutions providing six analyses of each solution. This
corresponds to 1 sample per 5 s for the analyses of liquid samples using this approach.
Individual mass spectra of clozapine, leucine enkephalin, sphingomyelin, galanin, bovine
insulin, ubiquitin, and lysozyme (Figure 6.5II) are observed with little or no cross
contamination. Because of multiply charging, proteins can also be analyzed on a limited
m/z mass spectrometer. The minimal chemical background allows small and large
molecules to be characterized at subpicomole concentration using an inlet temperature of
250 °C. All six mass spectra for bovine insulin extracted from each cycle are displayed in
Figure S6.11 in Appendix C showing poor reproducibility as indicated by the ion
intensity. We attribute this to the difficulty with our home-built approach to properly
align all 84 pipet tips in the same position relative to the inlet aperture.
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Figure 6.5. SAII-MS using 84 tips mounted on a 96-well pipet tip holder (Scheme
6.1C) with the inlet temperature at 250 °C acquired in ~5 min. (I) Total ion current.
(II) Mass spectra of (A) 1 pmol µL-1 clozapine (in methanol), (B) 2.5 pmol µL-1
leucine enkephalin (in acetonitrile:water with formic acid), (C) 1 pmol µL-1
sphingomyelin (in methanol with acetic acid), (D) 1 pmol µL-1 galanin (in
acetonitrile:water with formic acid), (E) 5 pmol µL-1 bovine insulin (in
methanol:water with acetic acid), (F) 1 pmol µL-1 ubiquitin (in acetonitrile:water with
formic acid), and (G) 10 pmol µL-1 lysozyme (in acetonitrile:water with formic acid).
Data were acquired in the m/z range of 150-2000.
Figure S6.12 in Appendix C provides the TIC and mass spectra of the same set of
samples at lower speed. All 84 pipet tips (42 samples) were analyzed in ∼10 min by
reducing the x,y-stage movement to 1.5 mm s−1. No cross contamination was observed,
but at the expense of longer analysis time. This approach is also less reproducible for
larger molecules. However, in these experiments we used compounds ranging in
molecular weight from 326 to ∼14300. In practice, better reproducibility and higher
sensitivity is obtained if one only needs to look at a specific mass range for certain
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compound types such as drugs or peptides. For example, analyzing for the drug clozapine
in four different substantially lower concentrations (0.5−30 fmol μL−1) using MS/MS and
mapping m/z 270, the location and the relative amount present are correctly displayed for
each vial (Figure S6.13 in Appendix C).
Higher capacity microtiter plates are widely used in pharmaceutical industry. A 384well plate was used to analyze the drug clarithromycin in form of a tablet obtained from a
local pharmacy. Random amounts of tablet powder were dissolved and diluted in the
microtiter plate wells (Scheme S6.2 in Appendix C) and analyzed using CID with
solution introduction using the 8-channel pipet approach (Figure 6.6I). The major
fragment ion at m/z 590 201 was mapped using Biomap software. The map correctly
displays the locations where drug was present (Figure 6.6II). The first well with the first
sample contains the highest amount of tablet and the fourth well with the second sample
contains the least based on the color code of the map.
For the pipet tips used in this study, the speed of sample introduction is greatly
influenced by the exposure to the vacuum, and thus on the distance of the pipet exit to the
inlet aperture of the mass spectrometer, the scanning nature of the mass spectrometer, and
little if at all on the speed of movement of the x,y-stage. With increasing numbers of
samples, reproducibility becomes more challenging to achieve because of alignment
issues with the current method. Another possible issue is the pulsed nature of the
ionization, which may be improved using the appropriate analyzer with ion trapping
synchronized with the ionization event similar to the challenges previously observed with
MALDI.202,203 It is expected that this can be optimized using shorter ion trapping and
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multiple microscans. Narrower scan windows will increase reproducibility as is the case
for any targeted ESI analyses approach.204,205
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Figure 6.6. Mapping of clarithromycin from tablet in a 384-microtiter plate using the
8-channel pipette (Scheme 6.1B). (I) Picture of loading tablet solution and pure
solvent from microtiter plate to pipette. (II)(A) Schematic representation of content in
each pipette tip. Red boxes indicate tips filled with solutions containing
clarithromycin tablet (CLA); grey boxes represent pure solvent methanol (S); (B) The
mapping of a major fragment at m/z 590.3. Data were acquired in the m/z range of
205-1000.
At the current stage of development, automation of the SAII method provides a
simple high-throughput analysis approach for compounds regardless of mass, volatility,
or “sprayability”. With this approach potentially 4000 samples that can be analyzed per
day per instrument using profile mode without significant cross contamination. Such an
achievement will require more reproducible control of sample position relative to the
mass spectrometer inlet. Higher throughput is envisioned with larger well plate numbers.
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6.4 Conclusion
Mapping of select compounds in microtiter plate wells is an obvious application of
this new technology, but any area in which fast analyses are valued such as proteomics,
metabolomics, and lipidomics could be impacted. It is our expectation, based on current
performance, that some of these new ionization technologies in conjunction with
IMSMS, 206-208 ETD,209,210 and LC, 211-214 will have considerable advantages relative to
current analytical methods. The potential of these methods for direct analyses of complex
mixtures will be achieved using high mass resolution available with Fourier transform
instruments.215

89

CHAPTER 7
MATRIX ASSISTED IONIZATION VACUUM FOR HIGH
RESOLUTION FOURIER TRANSFORM ION CYCLOTRON
RESONANCE MASS SPECTROMETERS
Matrix-assisted ionization vacuum (MAIV) produces charge states similar to
electrospray ionization (ESI) from the solid state without requiring high voltage or added
heat. MAIV differs from matrix-assisted laser desorption/ionization (MALDI) in that no
laser is needed and abundant multiply charged ions are produced from molecules having
multiple basic sites such as proteins. Here we introduce simple modifications to the
commercial vacuum MALDI and ESI sources of a 9.4 T Fourier transform-ion cyclotron
resonance (FTICR) mass spectrometer to perform MAIV from both intermediate and
atmospheric pressure. The multiply charged ions are shown for the proteins bovine
insulin, ubiquitin, and lysozyme using 3-nitrobenzonitrile as matrix. These are the first
examples of MAIV operating at pressures as low as 10 −6 mbar in an FT-ICR mass
spectrometer source, and the expected mass resolving power of 100000 to 400000 is
achieved. Identical protein charge states are observed with and without laser ablation
indicating minimal, if any, role of photochemical ionization for the compounds studied.

B. Wang, E. Tisdale, C. L. Wilkins, S. Trimpin, Anal. Chem. 2014, 86, 6792-6796.
Reprinted with permission from Copyright (2014) American Chemical Society.
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7.1 Introduction
High-field Fourier transform ion cyclotron resonance (FT-ICR) mass spectrometry
(MS) is an important tool used in the analyses of biological materials because of the high
mass resolving power. 216 Frequently FT-ICR mass spectrometers are coupled with
electrospray ionization (ESI)91 to take advantage of multiply charged analyte ions which
bring the mass-to-charge (m/z) within instrumental limits. ESI requires analyte to be
desolved in a “sprayable” solvent and hundreds of volts applied to achieve analyte
ionization.33 Vacuum matrix-assisted laser desorption/ionization (MALDI) produces gasphase ions from the solid state using a vacuum stable matrix that has absorption at the
laser wavelength.31,35,217-219 An advantage of ionization at vacuum is that ion transmission
losses65,220 common with atmospheric pressure ionization (API) methods is mitigated.
Inlet ionization is an alternative method producing ESI-like multiply charged gasphase ions from the solid state with the assistance of a matrix (e.g., 2,5-dihydroxybenzoic
acid, 2,5-DHB), vacuum, and heat.18,107,109 Ionization is initiated in the heated inlet tube
without use of voltage or laser ablation.121 The first examples of coupling laserspray
ionization inlet (LSII) and matrix-assisted ionization inlet (MAII) to high field FT-ICR
MS were achieved on a home-built LTQ 14.5 T FT-ICR mass spectrometer by heating a
∼10 cm long inlet capillary to 350 °C.215 Myoglobin (17 kDa) was detected by MAII.
The need for applicability on mass spectrometers that do not use a heated inlet tube,
initiated a quest for more volatile matrix compounds that might operate at lower inlet
temperature.110
The discoveries of more volatile matrices led to vacuum ionization, which unlike inlet
ionization, is dependent on matrices that do not require a heated inlet tube to produce ions
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having ESI-like charge states. The ability to produce highly charged ions by laser
ablation of the matrix 2,5-dihydroxyacetophenone (2,5-DHAP) was first developed on a
commercial intermediate pressure (0.21 mbar) MALDI ion source of an ion mobility
spectrometry-mass spectrometer (SYNAPT G2).115 The more volatile matrix, 2nitrophloroglucinol (2-NPG), was later shown to produce multiply charged ions from
proteins upon laser ablation on a high vacuum (10−6 mbar) MALDI-TOF mass
spectrometer.116 Charge states observed at high vacuum are lower than at intermediate
and atmospheric pressure. A similar vacuum (10−6 mbar) is used on MALDI sources
coupled to FT-ICR mass spectrometers.221
One of the more volatile matrix compounds discovered, 3-nitrobenzonitrile (3-NBN),
produces ions having ESI-like charge states when used as a matrix and introduced with
incorporated analyte into the intermediate pressure vacuum MALDI source of a
SYNAPT G2 mass spectrometer without laser ablation.117 This method, which eliminates
the need of a laser, is termed matrix-assisted ionization vacuum (MAIV). MAIV ionizes
a wide range of compounds, including bovine serum albumin (66 kDaA). 3-NBN is
amenable to sample introduction from atmospheric pressure with tube or skimmer inlets
and produces ions at atmospheric pressure simply using mild heat.119,222 Working from
atmospheric pressure, proteinssuch as lysozyme (14.3 kDa) and carbonic anhydrase (28
kDa) are ionized, and the methods tolerance of salts enables direct analysis of urine and
blood.117,120
MAIV matrices are hypothesized117,118 to require sublimation as well as charge
separation through the fracturing process that produces triboluminescence; 3-NBN fulfills
both of these proposed requirements. 223 - 225 Here, we describe the implementation of
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MAIV using both the vacuum MALDI and atmospheric pressure ESI sources of a 9.4 T
FT-ICR mass spectrometer and discuss the role of vacuum in the ionization process.
7.2 Materials and Methods
Materials and Sample Preparation. Chemicals were obtained and stock solution
prepared as stated in Chapter 2. The peptide mixture was prepared by mixing leucine
enkephalin, angiotensin I, bombesin, allatostatin, and bovine insulin with the volume
ratio of 3:3:1:1:1. The angiotensin mixture contains 1 mg mL−1 of angiotensin I,
angiotensin II, and angiotensin (1−9) fragment in water solution. The MAIV matrix 3nitrobenzonitrile (3-NBN) was prepared by dissolving 5 mg in 50 μL (concentrated)
identical to the previous study,117 or 500 μL (diluted) acetonitrile with 0.1% formic acid.
The LSIV matrix 2-nitrophloroglucinol (2-NPG) was prepared by dissolving 5 mg in 100
μL 50:50 acetonitrile:water identical to previous work.116 For MAIV experiments on the
MALDI source, angiotensin I and bovine insulin were prepared by spotting 1 μL of
analyte on a AnchorChip plate (Bruker, Bremen, Germany) followed by adding 1 μL
concentrated matrix solution; 3 μL ubiquitin was spotted on 384 ground steel plate
(Bruker, Bremen, Germany), and 1 μL diluted matrix solution was added. Samples were
allowed to air-dry before loading the plate to the vacuum source. For LSIV experiments,
all analytes were premixed with the matrix 2-NPG in a 1:1 volume ratio on AnchorChip
target plates. For MAIV experiments from atmospheric pressure using the ESI source
inlet aperture, angiotensin, bovine insulin, ubiquitin, and lysozyme were premixed with
the concentrated 3-NBN matrix solution in a 1:1 volume ratio and stir-mixed using a
pipet tip. The matrix:analyte mixture, 2 μL, was drawn into a pipet tip and allowed to airdry at its tip.
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Vacuum Ionization on FT ICR Mass Spectrometer. The commercial high vacuum
MALDI and ESI sources on a 9.4 T Apex FT-ICR mass spectrometer (Bruker, Bremen,
Germany) were used for MAIV and LSIV studies. The source pressure of the high
vacuum MALDI source was 2.0E−6 mbar. Bruker DataAnalysis was used to determine
resolving power.
MAIV from High Vacuum. The sample plate was loaded after the samples were air-dried.
The laser fluence was set to 0, and the laser beam was blocked with paper. The plate
voltage was optimized at 240 V for angiotensin I, and 300 V for bovine insulin and
ubiquitin. Acquisition was started once the matrix:analyte mixture spotted on the target
plate was loaded. The acquisition size was 2 million points, and the mass spectra are 100
acquisitions summed for angiotensin I and bovine insulin. For ubiquitin, acquisition was
stopped when thebackground started to increase; in this case, about 20 acquisitions were
averaged.
LSIV from High Vacuum. Ubiquitin solution was mixed with 2-NPG matrix solution and
spotted on a target plate. The sample plate was loaded after the samples were air-dried.
For LSIV of ubiquitin, the arbitrary laser fluence was 50%, and the plate voltage was 400
V. The acquisition size was 512 K points for higher signal abundance. Twenty
acquisitions were averaged to obtain a mass spectrum.
MAIV from Atmospheric Pressure. The commercial ESI source housing was removed, as
well as the cover and the cap on the ESI capillary so that direct access to the capillary
orifice was obtained. The capillary voltage, spray shield, nebulizing gas flow, and dry gas
flow were all set to 0. On this dual ESI/MALDI source, the voltage on the MALDI plate
was set at 300 V and the MALDI source was disabled. The capillary temperature was
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kept at room temperature without additional heat. The dried matrix:analyte crystals on the
pipet tip were introduced into the vacuum of the mass spectrometer by gently contacting
the capillary opening. Acquisition lasted for about 2 min until the crystals were consumed
from the pipet tip.
7.3 Results and Discussion
Inlet ionization methods were previously demonstrated on a high field FT-ICR mass
spectrometer having a home-built heated inlet tube.215 Meanwhile, matrix compounds
were discovered that produce multiply charged gas-phase ions spontaneously without a
laser or heat, other than the ambient heat available in the matrix and target plate, when
exposed to low pressure conditions. Furthermore, the matrix, 3-NBN, produces abundant
analyte ions when introduced from atmospheric pressure to the subambient pressure inlet
aperture of a mass spectrometer without the necessity of a heated inlet tube.119 Previous
studies have suggested that pressure may be an important variable in MAIV. The Bruker
Apex 9.4 T FT-ICR mass spectrometer MALDI source operates at 2E−6 mbar, well below
the source pressure of previous MAIV studies118 and provides the opportunity to
determine if MAIV is compatible with high vacuum and ultrahigh mass resolving power.
The mass spectrum of ubiquitin (Figure 7.1A), with 3-NBN as matrix, produces a
measured resolving power of 403000 at +9 (m/z 952.5206) using the vacuum MALDI
FT-ICR source. The +4 charge state (m/z 1434.1586) of bovine insulin had a mass
resolving power of 254000, and the +2 charge state of the peptide angiotensin I (m/z
648.8432) had a resolving power of 185000. The MAIV mass spectra acquired using the
MALDI source produce the high resolving power characteristic of this FT-ICR mass
spectrometer.226
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Figure 7.1. Mass spectra of ubiquitin using 3-NBN as matrix obtained on the high
vacuum MALDI source of the Apex FT-ICR mass spectrometer (A) without (MAIV)
and (B) with the use of a laser (LSIV) for matrix:analyte ablation.
In similar experiments using the intermediate pressure (0.21 mbar) MALDI source of
a SYNAPT G2 mass spectrometer, the 3-NBN matrix produced analyte ions for ca. 2 min
after the sample was loaded (3 min, including loading time).117 The time over which
ionization is observed relates to the rate of sublimation of the matrix. In the lower
pressure MALDI source (2E−6 mbar) coupled to the Apex FT-ICR mass spectrometer,
sublimation of the matrix occurred over a 30 min period. Ions could be observed during
this time but in lower abundance.
In contrast to the SYNAPT G2 vacuum MALDI source in which the protein bovine
serum albumin (66 kDaA) was analyzed using MAIV,117 ubiquitin was the largest
molecule analyzed on the FT-ICR vacuum MALDI source. The most abundant and
highest charge state ions for ubiquitin were lower on the FT-ICR than SYNAPT G2 for
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the same compound. The most abundant ion shifts from +10 to +8, and the highest charge
state shifts from +12 to +10.
The differences observed with the MAIV analysis using the MALDI source of a
SYNAPT G2 and Apex FT-ICR logically relates to the pressure difference the sample
experiences in the two instruments. Under vacuum conditions, sublimation cools the
surface and at lower pressure heat transfer from the ambient environment is inefficient.
Thus, an ionization process dependent on sublimation will be inhibited under cooling
conditions. The higher pressure of the SYNAPT G2 MALDI source counters the cooling
effect of sublimation through heat transfer to the matrix surface from the residual gas. A
means of adding thermal energy is therefore expected to reduce the time over which
ionization occurs, increase the ion abundance, and expand the compounds that act as
matrices without need of a laser. This concept is supported by three independent studies.
In the first study, the target plate of the SYNAPT intermediate pressure source was
cooled, simultaneously inhibiting sublimation and ionization,118 but second, warming the
inlet used with atmospheric pressure sample introduction reduces the time of
ionization.127 In a third study, a warmed gas flow (75 °C) was used to dislodge the
matrix/analyte from the substrate holder to initiate analyte ionization.222 Under the
current conditions of the high vacuum source of the FT-ICR, proteins larger than
ubiquitin may not be observed because they cannot be removed from the surface under
the cooler conditions, or once removed they are not able to shed the matrix that
accompanies them into the gas phase.122
Although the 3-NBN matrix absorbs 355 nm photons poorly, a Nd:YAG laser was
used to ablate the matrix crystals over several minutes. Even though the rate of removal
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of the matrix was increased, no change in charge states and only a small increase in ion
abundance was observed for ubiquitin (Figure 7.1B). The minimal influence of the laser
fluence on ionization strongly suggests that the nitrogen discharge related to
triboluminescence of this matrix224,225 is not directly involved with ionization. In other
words, it is the charge separation that causes triboluminescence that is important and not
the dinitrogen discharge.
The 2-NPG matrix was previously shown to produce ESI-like charge states of analyte
by UV laser ablation using the SYNAPT G2 MALDI source.116 This matrix, however,
performs poorly relative to the more volatile 3-NBN matrix on the FT-ICR MALDI
source. Both the charge state and ion abundance are lower with the less volatile 2-NPG
than with the most volatile 3-NBN matrix. For example, FT-ICR of ubiquitin in 2-NPG
using laser ablation produced up to the +4 charges with +2 as the most abundant (Figure
S7.2 in Appendix D), while MAIV of the same analyte solution and mass spectrometer
using 3-NBN as matrix with or without the laser provided up to +10 charges (Figure 7.1)
and with higher ion abundance and signal-to-noise ratio. The vacuum Apex FT-ICR
results are similar to high vacuum laser ablation on a MALDI TOF mass spectrometer of
ubiquitin using the 2-NPG matrix where the most abundant charge state is +3.116 The
experimental observation of dependence of matrix and volatility has been proposed to be
related to the inability to evaporate matrix from the charged matrix:analyte clusters in the
time available before mass separation.110,122 These results relate well with the
observations that chemical structure of the matrix is not critical127 so long as volatility of
the matrix is sufficient to remove the matrix from the charged matrix/analyte
clusters.110,122 As observed with inlet ionization, 227 less energy is needed to remove
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matrix from smaller compounds which agrees with the ability to readily analyze peptides
using MAIV on the FT-ICR as shown for a mixture in Figure S7.1 in Appendix D.
However, for the FT-ICR, the time available for desolvation is much longer than with
MALDITOF and suggests that pressure may be a more important parameter in producing
bare ions.
In the present experiments, different plate voltages (240 and 300 V) and data
acquisition sizes (2 million and 512 thousand) were examined for MAIV. Nearly
identical charge state distributions and ion intensities were obtained for bovine insulin
(Figure S7.2 in Appendix D). Angiotensin I showed some plate voltage dependence
(Figure S7.3 in Appendix D), with 240 V being optimal forming +2 charge state ions
with +3 being observed in low abundance (Figure S7.3.II.C in Appendix D). With 200
(Figure S7.3.I.C in Appendix D) and 500 V (Figure S7.3.I.E in Appendix D) no ions
were observed for this peptide. Interestingly, at 400 V (Figure S7.3.I.D in Appendix D),
an abundant singly charged ion is observed. The voltage dependence is in agreement with
intermediate and atmospheric pressure LSI studies in which the charge states can be
altered by instrument parameters; lower charge states correspond to increased energy
input.108,122
Although the continuous ion formation of over 30 min using MAIV with the FT-ICR
mass spectrometer may benefit some applications (e.g., fragmentation methods for
characterization),227 the inefficiency in ionization at the low source pressure as well as the
∼1 min sample plate loading time are not favorable for many analytical applications.
Directly introducing the MAIV matrix from atmospheric pressure into the inlet aperture
of a mass spectrometer has been shown to be an effective means for rapidly analyzing
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samples using MAIV matrices.119,222 Therefore, introducing the matrix:analyte sample
from atmospheric pressure on the FT-ICR mass spectrometer provides an intermediate
pressure region to produce ions and a direct comparison with MAIV on the high vacuum
MALDI source of the same instrument. Figure 7.2 illustrates the approach.

ESI capillary

Pipet tip

Matrix/analyte
mixture

Figure 7.2. Picture of MAIV operating on the ESI source of the Apex FT-ICR mass
spectrometer.
Shown in Figure 7.3 are representative isotopic distributions of ubiquitin (Figure
7.3A) and lysozyme (Figure 7.3B) obtained when the individual 3-NBN:analyte crystals
were introduced to thesource by gently touching the capillary orifice so the vacuum of
the mass spectrometer can draw the matrix:analyte into the glass inlet tube held at room
temperature. Each mass spectrum was obtained in less than 2 min until the crystals were
consumed from the pipet tip. Similar to MAII on an LTQ FTICR instrument using the
matrix 2,5-DHAP,215 the most abundant charge state for ubiquitin using 3-NBN is +8. In
MAIV, the matrix:analyte introduced into the inlet experiences decreasing pressure as
well as the natural airflow from atmospheric pressure to the first vacuum region. Under
these conditions, the charge states and ion abundance of peptides and small proteins are
ESI-like. This increase in charge state makes larger proteins applicable (e.g., lysozyme,
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14303 Da, Figure 7.3B as compared to ubiquitin, 8560 Da Figure 7.1A on the high
vacuum MALDI source) using the same solutions. Further, MAIV from atmospheric
pressure provides equivalent mass resolving power for insulin (255000, +5 at m/z
1147.5279) and ubiquitin (376000, +9 at m/z 952.6316) to vacuum conditions, and
206900 for the +10 charge state of lysozyme (m/z at 1431.4889). Because of multiply
charging in MAIV, the mass range of the mass spectrometer is extended or compounds
analyzed from the solid state, as is the case with ESI from solution.
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Figure 7.3. MAIV mass spectra of (A) +9 charge state of ubiquitin and (B) +10
charge state of lysozyme using 3-NBN as matrix obtained on the ESI source of the
Apex FT-ICR mass spectrometer.
7.4 Conclusion
This study indicates the potential utility of MAIV and its applicability to highperformance FT-ICR mass spectrometers. The results presented here indicate that this
simple and easy to use ionization method can be widely adapted with a minimum effort.
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The importance of pressure conditions using MAIV is demonstrated. Because of the
multiply charging, electron capture dissociation (ECD) 228 , 229 and electron transfer
dissociation (ETD)107,117,134, 230 of ions sublimed directly from a surface should be
possible with FT-ICR. Because of the high resolving power, these methods are
potentially useful in the analysis of complex materials such as tissue and blood.117,120
While the experiments reported here used the standard ESI inlet and MALDI vacuum
sources, adaptation specifically for MAIV is expected to greatly improve sensitivity.
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CHAPTER 8
DRUG DETECTION AND QUANTIFICATION DIRECTLY FROM
TISSUE USING NOVEL IONIZATION METHODS FOR MASS
SPECTROMETRY
Solvent assisted ionization inlet (SAII) and matrix assisted ionization vacuum
(MAIV) were used to rapidly quantify an antipsychotic drug, clozapine, directly from
surfaces with minimal sample preparation. This simple surface analysis method based on
SAII- and MAIV-mass spectrometry (MS) was developed to allow detection of
endogenous lipids, metabolites, and clozapine directly from mouse brain tissue sections.
Rapid surface assessment was achieved by SAII with the assistance of heat on the mass
spectrometer inlet, and MAIV showed capability on heat-limited instruments with better
reproducibility. In addition, isotope dilution and standard addition were used without
sample clean-up, and the results correlate well to liquid chromatography (LC)-tandem
MS with sample work-up. Using the simple surface methods, standard solutions
containing clozapine and deuterated internal standard (clozapine-d8) at different
concentration ratios were used to extract and quantify clozapine from brain tissue
sections of a drug-treated mouse at different thicknesses. The amount of clozapine
extracted by these surface methods was independent of tissue thickness.

B. Wang, C. L. Dearring, J. Wager-Miller, K. Mackie, and S. Trimpin, submitted.
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8.1 Introduction
An ideal analytical method should be fast, simple, able to quantify material with
minimal effort, and provide spatial resolution. However, those ideals are difficult to
achieve in combination. Characterization methods based on mass spectrometry (MS)
have gained popularity in pharmaceutical industry for speed of analysis, sensitivity,
selectivity, and the ability to be coupled with separation methods such as liquid
chromatography (LC).231,232 In addition to identification, rapid quantification of drugs is
important in drug discovery. Quantifying drugs and their metabolites in biological tissue
is an even more arduous task. MS alone is a semi-quantitative method, since ion intensity
values can vary significantly during acquisition. 233 However, the signal ratio with an
isotopically labeled internal standard is reasonably reproducible.233 Isotope dilution is
commonly used in MS-based quantification methods234,235 (e.g. LC tandem MS236,237).
The traditional LC-MS method requires sample work-up,238,239 which can be time and
labor-intensive, and removes the analyte from its native environment, such as a surface.
MS has been used to provide chemical information directly from surfaces.55, 240
Information on relative amount of analytes from surfaces is achieved by MS
imaging241,242 using the mass to charge ratio (m/z) and a heat map of the ion abundances
detected. In addition, MS imaging provides location of compounds within a surface.
Quantification has been reported by spotting internal standard on the tissue section.63,64
Matrix-assisted laser desorption/ionization (MALDI) is widely used in molecular
imaging, providing relative amount and spatial information for peptides, proteins,56,243
lipids,57 and metabolites,58 etc. from surfaces such as tissue sections. Critical to the
success in MALDI-MS is the matrix sample preparation which may result in sample
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adulteration 244 and potential chemical delocalization if the surface wets during matrix
application. 245 Ambient surface analysis methods, such as desorption electrospray
ionization (DESI)85 and nanospray desorption electrospray ionization (nanoDESI)89
operate without the use of matrix compounds, allowing surface samples to be analyzed at
atmospheric pressure with no or minor sample preparation and less chemical
background.246-248 For example, the antipsychotic drug clozapine from mouse brain tissue
has been imaged using DESI23,233 with a typical spatial resolution of ~200 µm.249 Notable
exceptions are those that make use of a laser providing improved spatial resolution
measurements and some with ease in instrumental setup.24,61,135,195, 250 , Hours and
sometimes days are required for MS imaging especially at high spatial resolution using
sophisticated laser focusing setups.62,251
Spatial resolution can be useful, but is often not required. If the exact location of
surface analytes is not required, a liquid microjunction surface sampling probe can be
used to extract analytes employing a liquid junction formed between a probe and the
surface in a more rapid manner.189 A solid-phase tissue sampling method achieved by
thermal evaporation provided rapid volatile analyte identification capabilities.252 Some of
the ionization methods involve critical connections and precise alignments of the
ionization apparatuses, requiring considerable user expertise to obtain reliable
performance.16
The recently developed solvent assisted ionization inlet (SAII)111 and matrix assisted
ionization vacuum (MAIV)117 produce mass spectra similar to electrospray ionization
(ESI) without the use of any external voltage or a laser. SAII has sensitivity comparable
to ESI when the position of the capillary, which introduces samples to the mass
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spectrometer inlet, is at the “hot spot” inside of the heated inlet.111,112,114 A recent study
showed ESI-like ions can be produced when the analyte solution was pipetted near the
entrance aperture of a heated mass spectrometer inlet tube.197,253 MAIV was demonstrated
to produce ESI-like ions directly from a surface, e.g. mouse brain tissue sections, by
simply spotting a MAIV matrix on tissue and exposing it to vacuum without the
requirements of additional heat, voltage, or a laser.117,120
Here, we report the development of SAII and MAIV for rapid surface analysis of the
drug clozapine from brain tissue sections of drug-treated mice along with endogenous
lipids and other small molecules. Isotope dilution and standard addition were employed
for quantification.
8.2 Materials and Methods
Materials
All chemicals and mouse brain tissue sections were obtained as stated in Chapter 2.
Instrumentation
The LTQ Velos mass spectrometer (Thermo, Bremen, Germany) was used for SAII
and LC-ESI studies. For ESI, the voltage was 3 kV, sheath gas was 8, and inlet
temperature at 275 ºC.254 For SAII, the ESI source of the LTQ Velos instrument was
removed for direct access to the inlet as previously described.135 The temperature of the
inlet can be adjusted through the commercial temperature control of the inlet. In this
study the inlet tube was operated at 200 ºC to avoid peak broadening while ensuring
sufficient ion intensity. The sheath gas, auxiliary gas, sweep gas, and capillary voltage
were all set at 0. The mass spectra were acquired with automatic gain control on, with 5
microscans maximum injection time of 20. For tandem mass MS, collision energy of 35
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was applied for collision induced dissociation (CID) to fragment the isolated molecular
ion.
The SYNAPT G2 (Waters, Manchester, UK) mass spectrometer was used for MAIV
study. For MAIV on the MALDI source, the commercial intermediate pressure MALDI
was used with “LSIV” settings as previously reported.115 Briefly, the sample plate voltage
was set to 0, the laser power was 0 and was not initiated. An extraction voltage of 10 V
was applied. For MAIV operating at atmospheric pressure, the LockSpray ESI source
was removed and overridden.117 A modified skimmer cone was used as previously
introduced to provide better vacuum, with a notch to allow air flow.255
A nanoAcquity UPLC system (Waters, Milford, MA) equipped with a 1 mm x 50 mm
column packed with 1.7 µm C18 BEH particles was used for LC-ESI-MS/MS
quantification. A 3 min gradient using ACN/H2O/0.1% formic acid (organic composition
from 40% to 95%) was employed similar to a previous study using the same system.112
An optical microscope (Nikon, ECLIPSE, LV 100) was used to determine the
diameters of the surface areas analyzed. Luxol fast blue was doped into extracting solvent
and matrix solution to enhance the optical microscopic image by leaving the blue color
on the extraction area.
Sample Preparation
Sample Preparation and Clozapine Quantification using LC-ESI-MS/MS
Half of a tissue section was scraped from the glass slide holding the tissue and
dissolved in 50 µL MeOH. The mixture was vortexed for 1 min before being loaded in
centrifuge for 5 min. The supernatant was used for quantification. The other half was
reserved for surface analysis (Scheme 8.1.I and II.C).
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The calibration curve was obtained by LC-ESI-MS/MS using clozapine standard
solutions at concentration of 10, 25, 50, 100, and 200 fmol µL-1 plotted against peak area.
For sample work-up, 1 µL supernatant was diluted by 20-fold and 1 µL was injected onto
the UPLC column. For the comparison with surface SAII quantification, 1 µL MeOH was
used to extract material from the tissue section from drug-treated mouse. The 1 µL
solution was diluted by 147-fold before injected into UPLC system. All the LC-MS/MS
analyses were performed in triplicates.
Surface Sample Introduction Methods based on SAII
Surface SAII in discontinuous mode. Solution of 0.3 µL of MeOH hanging from a
pipet tip was touched to a control mouse brain tissue section to allow the droplet to
extract material from the surface (Scheme 8.1. II.A). The MeOH droplet was held still
touching the surface of the mouse brain tissue for about 3 seconds before it was drawn
back into the tip. The solvent-containing extracted material was subsequently directly
transferred into the heated inlet capillary of the LTQ Velos by placing the pipet tip near
the entrance aperture where the droplet was drawn immediately into the inlet by the
vacuum of the mass spectrometer, inducing ionization in the inlet tube.
Surface SAII in continuous mode. Two pieces of 20 cm long fused silica tube (75 µm
i.d., 360 µm o.d., Polymicro Technologies, Phoenix, AZ) were taped near the ends at
~90ºto keep a distance of about 1 mm between the two ends. Methanol was pumped
through one piece of fused silica tube by a syringe pump (Fusion 400, Chemyx Inc.,
Stafford, TX) at 5 µL min-1 flow from the non-taped end. The non-taped end of the other
piece of fused silica tube was inserted about 0.2 mm inside the mass spectrometer inlet. A
liquid junction bridge of the solvent was formed between the tips of the silica tubes with

108

the assistance of the vacuum in the mass spectrometer. A constant flow of MeOH was
created between the tips so that the formed liquid junction droplet touched against the
drug-treated mouse brain tissue section. Material from the surface was continuously
extracted by the liquid junction, and the solvent containing the extracted material was
transferred to the mass spectrometer through the second fused silica tube (Scheme 8.1.
II.B).
Quantification by SAII
Isotope dilution and standard addition were used to quantify clozapine from drugtreated mouse brain tissue. Stock solutions of clozapine and clozapine-d8 were prepared
in EtOH and acetone at 1 mg mL-1, respectively. The stock solution was diluted to 20
pmol µL-1 by water, and MeOH was used for further dilutions. Five standard solutions
were prepared. In each single solution, the concentration of clozapine-d8 was held
constant at 2 pmol µL-1 and the concentration of clozapine was varied. The final
clozapine:clozapine-d8 molar ratios were 0:1, 0.5:1, 1:1, 1.5:1, and 2:1.
For the quantification from solution, 0.5 µL of each solution was drawn into the 20
µL pipet tip (Fisher Scientific, Pittsburgh, PA) and directly introduced into the heated
inlet tube of the LTQ Velos. Eight repetitive measurements were performed from each
clozapine/clozapine-d8 standard and the ion intensities of the singly charged protonated
ions from clozapine (m/z 327) and clozapine-d8 (m/z 335) were recorded. The intensity
ratio at m/z 327:335 was calculated for each measurement and averaged. The average
intensity ratio at m/z 327:335 is plotted versus the concentration ratio of m/z 327:335, and
the standard deviation was used to represent the error bar.
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For the quantification from mouse brain tissue, 1 µL of each solution was drawn into
a long-tailed ultra micro gel tip (Genesee Scientific, San Diego, CA) and carefully
deposited on the sample surface. About 0.8 µL of the standard solution was picked up by
the same pipet tip after ~3 seconds and introduced into the heated inlet. The signals were
plotted the same way as using solution directly from the vial. The amount of clozapine
extracted from the surface is determined by extending the calibration curve to find the
intersection with the X-axis. Both the vehicle and drug-treated mouse brain tissue
sections were analyzed with the vehicle mice serving as the control.
Scheme 8.1. Schematic representation of the workflow of SAII and typical LCtandem MS methods. (I) Half of the brain tissue section from drug-treated mouse was
scraped off from the glass slide, the other half was preserved for surface analysis. (II)
From the preserved tissue section, surface SAII was performed in (A) discontinuous
mode – extracting materials by solvent-droplet hanging at the pipet tip, and (B)
continuous mode – extracting by liquid junction formed at the end of two pieces of
silica tube. MS and MS/MS were performed in continuous mode. (C) Typical sample
work-up was performed with the scraped tissue, the supernatant after vortex and
centrifugation was analyzed by either LC-ESI-MS/MS or SAII direct injection.
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Surface Analysis and Quantification by MAIV
MAIV operating from intermediate pressure vacuum: A series of standard mixtures of
clozapine:clozapine-d8 at different concentration ratios were used. The concentration
ratios were the same as in SAII (0:1, 0.5:1, 1:1, 1.5:1, 2:1), but at double the
concentration. The standard clozapine:clozapine-d8 mixture was pre-mixed with a 3NBN solution made by dissolving 5 mg in 100 µL ACN at 1:1 volume ratio. A solution
of 0.5 µL matrix/clozapine:clozapine-d8 mixtures was spotted on the tissue section. The
tissue section was loaded into the vacuum of the MALDI source after spotting each
standard, and data acquisition was started as soon as the sample plate was indexed in the
source. The mass spectrum was acquired for about 2 min. Brain tissue sections from both
control and drug-treated mice were analyzed the same way.
Scheme 8.2. Schematic representation of workflow of MAIV methods. (A) The solution
of 0.5 µL 3-NBN/clozapine:clozapine-d8 mixture was spotted on tissue surface and
loaded into the vacuum of an intermediate pressure MALDI source. (B) Four 1 µL 3NBN/clozapine:clozapine-d8 solutions were spotted on the tissue surface covering half of
the tissue section, and exposed to vacuum of a modified skimmer cone of the overridden
ESI source.
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MAIV operating from atmospheric pressure: The calibration curve was obtained
using control mouse brain tissue sections. A series of standard solutions of
clozapine:clozapine-d8 were prepared at the concentration ratio of 0:1, 1:1, 2:1, 3:1, with
the concentration of clozapine-d8 held at 4 pmol µL-1. The standard clozapine:clozapind8

solution

was

also

pre-mixed

with

the

3-NBN

solution.

Four

1

µL

matrix/clozapine:clozapine-d8 mixtures were spotted on the tissue surface. Half of the
tissue section was covered by this procedure. The tissue with half of it covered by the
matrix/clozapine:clozapine-d8 mixture was exposed to vacuum. This was accomplished
by holding the glass slide against the modified skimmer cone where it was held by the
vacuum for 10 minutes. For the quantification from the brain tissue section of drugtreated mouse, half of the tissue section was covered by the mixture of 3-NBN and 4
pmol µL-1 clozapine-d8 at 1:1 volume ratio. The signal intensity ratio at m/z 327:335 was
recorded and the amount of clozapine was quantified by standard addition method from
the calibration curve.
8.3 Results and Discussion
SAII has been reported to produce ESI-like ions by injecting analyte solution into a
heated inlet of a mass spectrometer.197,253 For analytes on a surface, such as tissue
sections, liquid extraction using proper solvents can be employed prior to SAII. The
material on the surface of a 20 µm-thick brain tissue section of a drug-treated mouse was
extracted by a MeOH droplet hanging from the pipet tip followed by transfer to the
heated inlet tube (Scheme 8.1.II.A). Data acquisition of the software was initiated before
surface extraction, therefore the total ion chronogram (TIC) reflects the entire duration of
sample analysis from exposure of solvent to surface to the ionization in inlet, which was
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only about 25 seconds as shown in Fig. 8.1A. The mass spectrum having good ion
abundances is dominated by phosphatidylcholines along with protonated clozapine and
alkali-adducted cholesterol (Fig. 8.1B). The lipid peaks were assigned according to
previously published data256 and no phosphocholine head group fragment (m/z 184) was
observed, unlike MALDI. 257 Tandem MS using CID was performed on the most
abundant lipid peak at m/z 798. MS2 on the parent ion produced mainly a loss of 59, and
MS3 on the major fragment ion at m/z 739 generated a fragment with a loss of 183
(Figure S8.1 in Appendix E). The loss of trimethylamine (Δm/z=59) and phosphocholine
head group (Δm/z=183) are characteristic for sodiated phosphatidylcholines.258 The inset
spectrum shows clozapine with its characteristic isotopic distribution. Brain tissue section
from a drug-treated mouse, which was from the same batch but had been stored frozen
for months at -80 °C, was analyzed in the same manner. The protonated clozapine ions
were observed at lower ion abundance, likely because the drug has degraded over time
(Figure S8.2 in Appendix E). One of the major clozapine metabolites, clozapine Noxide, 259 was also observed having the characteristic chlorine isotopic distribution.
Sodiated and potassiated cholesterol were assigned similar to an ambient infrared
MALDI surface study.260
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Figure 8.1. Fast surface assessment using a SAII method employing surface
extraction by 1 µL of MeOH in discontinuous mode as shown in Scheme 8.1. II.A.
(A) TIC of the entire duration of sample analysis including exposure of solvent to
surface to ionization in inlet. (B) Mass spectrum extracted from the TIC with the inset
showing the isotopic distribution of protonated clozapine ions. The blue number on
the top right corner denotes ion abundance.
The material was sampled directly from the tissue surface at ambient conditions, and the
mass analysis was obtained without the requirement of any voltage or extra connections
between surface sampling and sample introduction. The analysis was soft enough to
maintain the intact analyte structures with less chemical background. Neither cholesterol
fragment with the loss of water nor water clusters was detected as observed with
ionization methods employing matrix and/or a laser.240,260 This method is discontinuous
as solvent/lipid droplets are analyzed individually, yet it is a very simple sampling and
ionization approach.
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A continuous surface SAII sampling method was achieved by the configuration
shown in Scheme 8.1. II.B. A liquid junction is formed at the mouse brain tissue surface
by interfacing two pieces of fused silica tubing. Here, the glass plate containing the
mouse brain tissue section was hand held and manually moved over the surface to
analyze different areas. The TIC in Figure 8.2A shows the constant ion production for
about 1 min acquisition time. The mass spectrum from time point 0.37-0.86 min was
extracted from the TIC (Figure S8.3 in Appendix E) showing similar ions from lipids
and clozapine as discussed above, but at lower ion abundance. This may be due to the
shorter time the liquid remains on the surface, so that less material is extracted. Structural
characterization of clozapine present in the drug-treated mouse brain tissue was
confirmed by fragmenting the peak at m/z 327 (Figure 8.2B.1) using CID. The fragment
ions produced at m/z 270 and 296 were identical to those of a purchased standard (Figure
8.2B.2).23
The method development using direct pipetting SAII for quantification of drugs was
first established using standard clozapine:clozapine-d8 solutions from vials. The solution
of 0.5 µL clozapine and clozapine-d8 mixture at a certain concentration ratio was directly
introduced into the inlet of the mass spectrometer. As shown in Figure S8.4 in Appendix
E, at a concentration ratio of 0.5:1, the protonated peak height of clozapine (m/z 327)
versus clozapine-d8 (m/z 335) is approximately 0.54 (Figure S8.4A in Appendix E),
while a 1:1 concentration ratio results in the ion intensity ratio of approximately 1.08
(Figure S8.4B in Appendix E).
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Figure 8.2. Fast surface assessment using the SAII method employing surface
extraction by 1 µL of MeOH in continuous mode as shown in Scheme 8.1. II.B. (A)
TIC of the whole analysis for ~1.4 min. (B) SAII-CID-MS of the protonated
clozapine ions (1) directly extracted from tissue surface and (2) from synthesized
clozapine chemical solution. The blue numbers on the top right corner denote ion
abundances.
The average of the signal intensity ratio from 8 repetitive measurements of each standard
was plotted against the concentration ratio of clozapine:clozapine-d8 in Figure 8.3A. The
high regression coefficient (R2=0.9929) and small error bars demonstrate the
reproducibility of the SAII method for quantification. Using this calibration curve, an
unknown sample from a tissue section of a drug-treated mouse was analyzed. One µL
supernatant from half of the tissue section scraped off the glass slide was mixed with 1
µL of 4 pmol µL-1 clozapine-d8 solution producing a mixture containing 2 pmol µL-1
clozapine-d8. This solution was injected into the heated inlet. A signal intensity ratio of
0.694:1 at m/z 327:335 was obtained, reflecting the concentration of clozapine in the 1
µL extraction solution to be 1.27 pmol µL-1. In comparison, another 1 µL of the same
supernatant was further diluted by 20-fold and quantified by LC-MS/MS (Figure 8.3B).
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The concentration of the supernatant was determined to be 1.33 pmol µL-1. The total
analysis time spent on the SAII approach was only about 1 min for 5 replicates, where the
LC-MS/MS method took more than 30 min for triplicate analyses.
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Figure 8.3. Calibration curves of clozapine (A) using SAII by pipetting standard
clozapine:clozapine-d8 solutions at different concentration ratio with clozapine-d8 at
2 pmol µL-1, signal intensity ratio is plotted against concentration ratio; and (B) using
LC-ESI-MS/MS with standard clozapine solutions at different concentration, peak
area of the fragment ion at m/z 270 is plotted against concentration.
The other half of the 20 µm-thick tissue section was analyzed by surface analysis
methods. The same series of standard solutions of clozapine:clozapine-d8 were used to
extract material from the surface instead of pure MeOH solvent. As a control experiment,
the control tissue, for which the mouse was not treated with clozapine before sacrificing,
was analyzed first. When the solution of 1 µL clozapin:clozapine-d8 mixture at the
concentration ratio of 0.5:1 was used to extract material by contacting the surface for ~ 3
s and then transferred to the mass spectrometer inlet, the signal intensity ratio at m/z
327:335 obtained was 0.52:1 (Figure S8.5A in Appendix E), indicating no external
clozapine was detected after extraction. When the tissue section from drug-treated mouse
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was extracted by the same standard clozapine:clozapine-d8 mixture, the signal intensity
ratio increased to 2.20:1 (Figure S8.5B in Appendix E). The concentration ratio (X) was
plotted against the ion intensity ratio (Y) (Figure 8.4) with control tissue (red square) and
drug-treated tissue (blue triangle). The curve from drug-treated tissue has a significant
increase, indicating clozapine was extracted from the surface by the standard solutions.
Although only one measurement was taken from each standard solution, the linearity
(R2=0.9374) was confirmed by the high reducibility of this method (Figure 8.3A). The
amount of clozapine extracted by 1 µL solution was calculated by extending the
calibration curve to the x-axis. The intersection shows 2.68 pmol of clozapine was
extracted from the surface area of about 1.5 mm in diameter (Figure 8.4 inset) as
determined using optical microscopy. For a comparison with the LC-MS/MS method,
one µL pure MeOH was used to extract clozapine from the surface and analyzed by LCMS/MS after a 147-fold dilution. The amount of clozapine extracted by the 1 µL MeOH
was calculated as 2.58 pmol from the calibration curve.
The amount of clozapine quantified from surface extraction of the right half of the
tissue section is similar between SAII-MS and LC-MS/MS methods (2.68 pmol using
SAII vs. 2.58 pmol using LC-MS/MS from surface extraction), indicating the reliability
of the SAII method but at much faster analysis speed. However, the amount from 1 µL
solvent extraction on the right half is not reflective of the results obtained from the 1 µL
supernatant using traditional sample work-up and LC-MS/MS of the left half of the
section (2.68 pmol using SAII from surface extraction vs. 1.33 pmol using LC-MS/MS
from supernatant). We hypothesize that only the clozapine on the surface of the tissue
section was extracted by the surface extraction method. In contrast, when tissue section
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was scraped off, vortexed and centrifuged, the extracted clozapine is not limited to the
surface. To test our hypothesis, another set of tissue sections that were 10 µm-thick from
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a drug-treated mouse were analyzed in the same manner.
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Concentration ratio of clozapine:clozapine-d8

Figure 8.4. The right half of a 20 µm brain tissue section from drug-treated mouse
was quantified by SAII method in discontinuous mode as shown in Scheme 8.1. II.A.
Solution of 1 µL of each of the four standard clozapine:clozapine-d8 mixtures at
different concentration ratios was used for surface extraction and then pipetted into
the heated inlet of the mass spectrometer. Calibration curves were obtained by
plotting the signal intensity ratio against the concentration ratio. A brain tissue section
from a normal mouse was used as control. The inset shows an optical microscopy
image to illustrate the extracted area. For enhanced image, 1 µL MeOH was doped
with Luxol fast blue and the droplet was not removed from surface.
Table 8.1 shows the comparison of 10 µm and 20 µm-thick tissue sections, using both
the typical sample work-up and the novel surface SAII method. Thicker tissue results in
more clozapine extracted by vortex and centrifugation. The amount obtained from the 20
µm-thick tissue is approximately twice that of the 10 µm tissue as determined by LCMS/MS using the traditional tissue work-up. In contrast, the amount of clozapine
extracted from the surface was not significantly different (2.84 pmol for 10 µm and 2.68
pmol for 20 µm). This result indicates that the amount of clozapine determined by surface
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SAII is the amount per unit area that was extracted, and was not limited by tissue
thickness, at least for sections of 10 µm or greater.
Table 8.1. Amounts of clozapine quantified by typical LC-ESI-MS/MS (Scheme 8.1.
II.C) and surface SAII in discontinuous mode (Scheme 8.1. II.A). 10 µm and 20 µm
tissue sections were analyzed. For LC-ESI-MS/MS, the left half of the tissue section
was scraped off, dissolved in 50 µL MeOH, vortexed and centrifuged, results showed
the amount in pmol per µL supernatant. For surface SAII, results showed the amount
in pmol per µL solution used for surface extraction.
LC-ESI-MS/MS from
scraped tissue
Amount of clozapine in
1 µL supernatant

Amount of clozapine extracted
by 1 µL standard solution

10 µm

0.725 pmol

2.84 pmol

20 µm

1.33 pmol

2.68 pmol

Thickness

Surface SAII

SAII used in surface analysis and quantification is a simple and fast assessment but
limited to mass spectrometers equipped with a heated inlet tube. On instruments without
a commercially available heated inlet, MAIV has been demonstrated to produce ESI-like
ions directly from surfaces, including mouse brain tissue sections.117,120 The
quantification of clozapine using MAIV was first achieved on the intermediate pressure
vacuum MALDI source of a SYNAPT G2 instrument. The mixture of individual standard
clozapine:clozapine-d8 solutions mixed with 3-NBN matrix solution was spotted on the
control and drug-treated tissue sections and loaded into the vacuum using a MALDI plate
loader but without use of the laser. From each single matrix/clozapine:clozapine-d8 spot,
the mass spectrum was extracted over the sublimation period of time (ca. 2 min). An area
of about 1 mm2 covered by 3-NBN matrix was analyzed: matrix uncoated parts of the
tissue do not produce ions. The signal intensity ratio at m/z 327:355 was plotted against
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the concentration ratio of clozapine:clozapine-d8 from the standard solution (Figure 8.5).
The amount of clozapine from each spotted area was determined as 1.48 pmol from the
plots. Miniaturization of the tissue area covered by the matrix can be employed to
improve the spatial resolution of the analysis.117
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Figure 8.5. 20 µm brain tissue sections from drug-treated and control mice were
analyzed by MAIV operating at intermediate pressure. Solution of 0.5 µL 3NBN/clozapine:clozapine-d8 mixture was spotted on the tissue section and the
sample was loaded into the commercially available vacuum chamber (Scheme 8.2.A).
The matrix sublimed in approximately 2 min. The ion intensities of clozapine and
clozapine-d8 were averaged over the 2 min acquisition, and the intensity ratio was
plotted against concentration ratio. Insets show the microscopy images of the
matrix/clozapine:clozapine-d8 spotted on tissue section before and after MAIV
analysis.
MAIV on the vacuum source produced better linearity (R2=0.9797) than SAII,
because the average ion intensity summarized over a longer period of time provides
better reproducibility. However, the operation of MAIV on the commercial vacuum
MALDI source is time consuming and a significant amount of analyte is potentially
wasted in the 2 min loading time.117 Only one matrix/clozapine:clozapine-d8 mixture can
be spotted for each loading, otherwise all the spots would sublime simultaneously. To
achieve the goal of simpler assessment from the surface, the ESI source was overridden
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and employed for MAIV operating from atmospheric pressure as described previously.119
The source temperature was held at 80 ºC, and a sealed vacuum outer skimmer cone with
a notch115 to allow air flow was used for operation. Four 1 µL clozapine:clozapine-d8
solutions mixed with 3-NBN were spotted on a tissue section (control and drug-treated,
respectively) and covered half of the tissue section completely. The glass slide tissue
holder was sealed to the notched cone by the vacuum for a 10 min analysis. The total
analysis results of the 10 µm-thick brain tissue from drug-treated mouse are shown in
Figure S8.6 in Appendix E as an example. The matrix sublimed over this 10 min period
of time as shown in the TIC (Figure S8.6.I in Appendix E). Extracted clozapine, the
standard clozapine-d8, cholesterol, and lipids were observed from the total mass
spectrum and the two-dimensional plot of drift time vs. m/z (Figure S8.6.II in Appendix
E). Particularly, lipids were not directly observed from mouse brain tissue sections in
positive mode and the same heat-limited mass spectrometer.195 The nested dataset106
extracted from the two-dimensional plot (Figure S8.6.II.B insets in Appendix E) allows
the identification of clozapine and clozapin-d8 without additional time requirement. The
calibration curve was obtained using four standard clozapine:clozapine-d8 mixtures of
different concentration ratios on control tissue sections (Figure 8.6). The amount of
clozapine was determined by the standard addition method by spotting four 1 µL 3NBN/clozapine-d8 mixture on half of the tissue section. The quantification of this
method from 10 µm- and 20 µm-thick tissue sections did not show much difference (20.0
pmol for 10 µm and 19.4 pmol for 20 µm), indicating that the same amount of matrix
also extracts similar amount of clozapine only from the surface, regardless of the tissue
thickness.
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Figure 8.6. Calibration curve obtained by spotting 4 µL 3-NBN/clozapine:clozapined8 mixture on control mouse brain tissue sections. The glass slide holding the halfcovered tissue was then sealed to the vacuum on a modified skimmer cone and let
sublime for 10 min (Scheme 8.2.B). Ion intensity ratio was plotted against
concentration ratio. The red triangle and hollow square show the results obtained
from 10 µm and 20 µm tissue sections, respectively, from the drug-treated mouse
using standard addition method. The inset shows a picture of the modified skimmer
cone and a half-covered tissue section.
In comparison to SAII using liquid extraction, the amount of clozapine extracted by
MAIV is much higher. This is not only due to the fact that larger area was covered by
matrix, but also that more material was extracted for the same unit area when matrix was
employed. To further confirm our observation, the tissue, after surface extraction by SAII
and MAIV, was cut through the center breaking the glass slide, and the cross section was
examined under the microscope to determine the depth of droplet and matrix penetration
(Figure S8.7 in Appendix E). SAII on the 20 µm-thick tissue section, only ~3 µm had the
color from the doped Luxol fast blue dye indicating the wet area indicating the surface
extracted area in SAII (Figure S8.7.A in Appendix E). MAIV provides a result with
larger amount of clozapine than SAII, indicating that the matrix/clozapine:clozapine-d8
mixture went deeper into the tissue than solvent-extraction. Previous studies have shown
that MAIV can be destructive to tissue sections,117 and blue color in the microscopy
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image shows a deeper extraction for about 7 µm (Figure S8.7.B in Appendix E), more
than twice as deep compared to SAII liquid extraction.
8.4 Conclusion
Rapid and efficient surface assessment is achieved by surface SAII and MAIV
ionization methods. The surface quantification methods demonstrated in this work are
potentially useful where fast analysis is valued, e.g. disease diagnosis or drug screening;
one just needs to have the criterion of amounts of analyte per unit area of the surface
(instead of per unit weight tissue, or volume) from healthy and diseased/treated tissue. In
this case the thickness of the sample (>10 µm) has little impact on the analysis. With this
approach, the tissue need not be sectioned to a certain thickness for quantification.
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Chapter 9
CONCLUSION AND FUTURE PROSPECTUS
Novel ionization methods have been developed to produce ESI-like ions of biological
materials from AP and vacuum conditions for use in MS. The newly developed ionization
methods have been interfaced to a variety of commercially available mass spectrometers
from different vendors to utilize their features.
Inlet ionization methods operate from AP and are beneficial for the instruments
equipped with a heated inlet capillary. Ionization occurs in the heated inlet, with the
assistance of the pressure drop from AP to the first vacuum stage of the mass
spectrometer, regardless how the analyte is introduced into the inlet, with or without the
use of a laser, from the solid or solution state. The first example of total solvent-free
analysis by LSI-IMS-MS showed the production of multiply charged ions from solid state.
Insoluble compounds, e.g. membrane proteins from brain tissue, could benefit from the
solvent-free sample preparation.
For solution samples, the independence of any extra connection or voltage greatly
simplified the sample introduction method. Comparable sensitivity can be achieved by
nanoLC-SAII as by nanoESI, with much less labor force and expense. NanoLC-SAII
could potentially be employed for e.g. mammalian proteomics where the amount of
proteins that can be obtained is limited. The automated analysis by multiplexing SAII and
the mapping approach may potentially advance in any field that fast analyses are valued,
e.g. pharmaceutical or clinical analyses, for the merit of its simple of use, low
consumables cost, and little expertise required.
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Although a liquid sample introduction method, SAII also shows its application in fast
surface assessment by incorporating liquid-surface extraction. This ionization method is
not only fast but also softer than traditional ionization techniques. The typical isotope
dilution and external addition methods were well suited in this SAII approach to quantify
the drug from drug-treated tissue surface. Comparable results were obtained by SAII and
typical LC-ESI, but SAII takes much shorter time.
Vacuum ionization methods operating at AP or vacuum makes use of proper matrix
and the vacuum which any mass spectrometer has to produce ESI-like ions from solid
state. High performance mass spectrometer was used to obtain multiply charged ions
from solid state while maintaining the high mass resolving power. The mass resolution
achieved by FT-ICR is beneficial for e.g. proteomics by this hyphenated method with
MAIV, especially for those the solubility in sprayable solvent is restricted. The
instantaneous and continuous ion formation is favored by electron capture dissociation
that is currently available on FT-ICR instruments, too.
In summary, new ionization methods have shown advantages such as simple of use,
low cost, and ready to be coupled with other analytical techniques, etc. that provide the
potential for real world application. As listed in the “Holy Grail” in Scheme 1.1, for
example, sensitivity and dynamic range should be extended, so that some component in
low abundance from a complex environment, such as proteins from brain tissue, can be
detected besides the dominant lipids. The hyphenation of novel ionization methods with
other analytical techniques and high performance instrument is valuable for the analysis
of complex materials, e.g. interfacing UPLC with IMS-MS by MAIV could also free the
ionization from the restriction of spray conditions. Coupling the mentioned techniques
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with high mass resolution instrument and tandem MS could be greatly advantageous for
proteomics. Reproducibility should be improved for direct quantifications, ideally
without the need to add external standards. The spatial resolution of the surface analysis
approaches should be improved by employing a laser or miniaturizing solvent/matrix
deposition, so that the methods could be utilized for diagnoses of diseased tissue from the
healthy. The speed, simplicity, robustness, automation, low-cost will always be favorable
for e.g. pharmaceutical industry and drug discovery. With these being said, we have just
begun scratching the surface, there are a lot more needed to be studied.
Scheme 1.1 Technology development needed to expand the use of MS for
clinical applications [Adopted from Reference 18]. Points highlighted in blue
will need further investigation.
A.

B.
C.

Sensitivity and dynamic range: to observe all components (e.g.,
lipids and proteins, hydrophilic and hydrophobic, low and high
abundance) directly from native and complex environment (e.g., tissue,
plasma, serum, urine), improvements needed include:
1. Separation: to deal with complexity and isoforms (LC, mass
resolution, IMS)
2. Specificity: fragmentation (MS/MS: CID, ETD) for confirmation
and ID (bottom up, top down)
3. Reproducibility: for quantitation
4. Spatial resolution: for location (with and without a laser)
Speed: of data acquisition and interpretation
Robust, simple and cheap: automation, disposables
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APPENDIX A
TOTAL SOLVENT-FREE ANALYSIS SUPPLEMENTAL INFORMATION
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Figure S4.1. Solvent-based LSI-IMS-MS analysis of angiotensin I. (A) Total mass
spectrum and (B) 2-D plot of drift time versus m/z.
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Figure S4.2. (A) Solvent-based LSI-IMS-MS analysis and (B) ESI-IMS-MS of NAC. (1)
Total mass spectrum and (2) 2-D plots of drift time versus m/z.
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Figure S4.4. Total solvent-free analysis spectra of angiotensin I using 2,5-DHAP matrix
under different grinding time and frequency on SYNAPTTM G2 instrument.
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Figure S4.5. Total solvent-free analysis spectra of angiotensin I using (A) and (B) 2,5DHB matrix, (C) 2,5-DHAP under 25 Hz, different grinding times and capillary
temperature on LTQ-Velos instrument.
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A

B

Figure S4.6. Microscopy of liquid droplets produced by the ablation of (A) 2,5-DHB and
(B) 2,5-DHAP after the matrix had been ground for 10 minutes in TissueLyser II.

A

B

Figure S4.7. Microscopy of the ablation plume from 2,5-DHB after the matrix was
ground for 30 seconds in (A) TissueLyser II and (B) Vortexer.
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Figure S4.8. Solvent-free LSI-MS mass spectrum of angiotensin I acquired (A) with IMS
and (B) using TOF mode only (without IMS).
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Figure S4.9. Solvent-based LSI-IMS-MS analysis of a lipid (sphingomyelin, SM) and a
peptide (angiotensin I) mixture. (A) Total mass spectrum and (B) 2-D plots of drift time
versus m/z.
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Figure S4.10. Solvent-free LSI-IMS-MS analysis of (A) vegetable oil and (B) motor oil.
(1) Total mass spectrum and (2) 2-D plots of drift time versus m/z.
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Figure S4.11. LSI-IMS-MS of (A) crude petroleum oil using solvent-free sample
preparation with 2,5-DHAP matrix; (B) crude oil using solvent-based sample preparation
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with 2,5-DHAP matrix and (C) 2:1 toluene/methanol solvent with 2,5-DHAP matrix; left
panel (1) Total mass spectra and right panel (2) 2-D plots of drift time versus m/z.
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APPENDIX B
LC-SAII SUPPLEMENTAL INFORMATION
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Figure S5.1. Ion intensity changes with the distance between the silica tube tip and the
entrance of the inlet to the mass spectrometer.
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Figure S5.2. SAII-MS of ubiquitin. The liquid solvent/analyte droplet is placed with a
pipette tip (10 uL plastic tip) vertically just outside of the mass spectrometer inlet and
slowly pipetted off. The droplets formed are vacuum drawn into the inlet of the mass
spectrometer where inlet ionization of the analyte occurs. Solutions of 5 pmol ubiquitin
(10 µL) were used. Depending on the solution conditions and inlet temperature the
abundance of the highly charged ubiquitin ions varies; less volatile solvent conditions
require higher inlet temperatures: (A) ubiquitin in 100% water solution and (1) 300 °C
and (2) 450 °C and (B) ubiquitin in 50:50 ACN/H2O in 1% formic acid solution and (1)
50 °C and (2) 300 °C applied on the inlet of the mass spectrometer. In pure water, Na+
adducts are in high abundance lowering the overall intensity of any single peak. Addition
of formic acid as shown in B almost eliminates the Na+ adducts.
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Figure S5.3. Picture showing the setup for LC-nSAII:

Front view of Waters

NanoAcquity liquid chromatography, Thermo LTQ-Velos mass spectrometer and, here,
an automated x,y,z-stage for alignment of tip (Figure 1a) and the “picotip” extension
(Figure 1b) of the fused silica capillary tube of the LC column placed about 0.1 mm out
of the orifice inlet entrance of the mass spectrometer.
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Figure S5.4. LC-SAII-MS of 100 fmol µL-1 BSA tryptic digest acquired on the Thermo
LTQ Velos mass spectrometer. (A) The base peak chromatogram of 1 µL injection at 0.8
µL min-1 flow rate; (B) the base peak chromatogram of 1 µL injection at 1.2 µL min-1
flow rate. The m/z of the most intense peak from the mass spectra of each LC
chromatographic peak is labeled at the top of the peak. The mass range for MS data
acquisition is 555-1600.
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was the same as for the LC so that the inject time is included in the X-axis. The most
intense m/z obtained on the mass spectra for each chromatographic peak is labeled. (B)
Mass spectrum of the chromatographic peak at 17.8 min.
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150 ºC. (A) The base peak chromatogram of 1 µL injection at 800 nL min-1 flow rate; (B)
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APPENDIX C
HIGH THROUGHPUT MULTIPLEXING SAII SUPPLEMENTAL
INFORMATION

A. 1

B.

A. 2

C.

D.

E.
Scheme S6.1. Pictures of sample loading for SAII multiplexing using a 96-well plate. (A)
Vials (1) or wells (2) filled with analyte solutions or pure solvents in a 96-well plate
format. (B) Empty pipette tips mounted on another 96-vial plate (1). (C) Dip the tips into
the sample vials. (D) Tips filled with about 3 µL solutions by capillary action and are
ready to mount on the xy-stage.
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A.

Step 3. 100-fold dilution

Step 2. 100-fold dilution

Step 1. Tablet powder dip into these wells

B.

Contain tablet

Pure solvent

C.

Scheme S6.2. Pictures of sample loading for SAII multiplexing using a 384-well
microtiter plate. (A) The workflow of sample preparation of clarithromycin tablet in the
microtiter well plate. (B) 1 µL of each tablet solution and pure solvent was drawn into the
8-channel pipette. (C) The pipette is mounted on the xy-stage with the tips aligned with
the inlet orifice.
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Figure S6.1. A mixture of phosphorylated peptides (angiotensin II, cholecystokinin (1020), and calcitonin (15-29)) was pipetted into the inlet (Scheme 1A) which was heated to
250 °C. MS/MS spectra from the mixture of the doubly charged ions using CID are
shown in this figure. (A) phosphorylated angiotensin II at collision energy 30, data
acquired in the mass range of 155-2000; (B) phosphorylated cholecystokinin (10-20) at
collision energy 20, data acquired in the mass range of 180-2000; and (C) phosphorylated
calcitonin (15-29) at collision energy 20, data acquired in the m/z range of 245-2000;. 1
µL of 2.5 pmol µL-1 solution was used for each acquisition.
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Figure S6.2. SAII mass spectra of (A) 1 µL 2.5 pmol µL-1 myoglobin and (B) 1 µL 5
pmol µL-1 carbonic anhydrase obtained by pipetting the solution into the inlet (Scheme
1A) at an inlet temperature of 250 °C. The blue number in top right corner denotes the
ion intensity. Data were acquired in the m/z range of 600-2000.
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Figure S6.3. SAII mass spectra of (A) 5 pmol µL-1 angiotensin I in water at 150 °C, (B) 5
pmol µL-1 clozapine in chloroform at 250 °C with matching isotopic distribution, data
acquired in the mass range of 100-1000.and (C) 1 pmol µL-1 ubiquitin in 90:10
acetonitrile:water at 400 °C inlet temperatures. 1 µL solution of each solution was
pipetted into the inlet (Scheme 1A). Data were acquired in the m/z range of 150-2000.
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Figure S6.4. pH study of (I) 5 pmol µL-1 bovine insulin and (II) 10 pmol µL-1 lysozyme
using SAII-MS at an inlet temperature of 250 °C: pH: (A) 3 to 3.5, (B) ~4.5, (C) 6 to 6.8,
(D) 9 to 9.3. 2 µL solution was pipetted into the inlet (Scheme 1A). Data were acquired
in the m/z range of 150-2000.
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Figure S6.5. SAII mass spectra of (I) 5 pmol µL-1 bovine insulin in 50:50
methanol:water with 1% acetic acid and (II) 10 pmol µL-1 lysozyme in 50:50
acetonitrile:water with 0.1% formic acid at different inlet temperatures: (A) 150 °C, (B)
250 °C, (C) 350 °C, and (D) 450 °C. 2 µL solution was pipetted into the inlet (Scheme
1A). Data were acquired in the m/z range of 150-2000.
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Figure S6.6. SAII mass spectra of 10 pmol µL-1 lysozyme in water at different inlet
temperatures: (A) 150 °C, (B) 250 °C, (C) 350 °C, and (D) 450 °C. 2 µL solution was
pipetted into the inlet (Scheme 1A). Data were acquired in the m/z range of 150-2000.
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Figure S6.7. Multiplexing SAII-MS using the 8-channel pipette (Scheme 1B) at different
inlet temperatures: (I) 250 °C, (II) 350 °C, and (III) 450 °C in a total of ~15 seconds. (A)
The TIC and (B) mass spectra of the analysis of tips filled with (1) 2.5 pmol µL-1 leucine
enkephalin, (2) 1 pmol µL-1 galanin, and (3) 1 pmol µL-1 ubiquitin with solvent between
each two samples. 2 µL analyte/solvet was drawn into each pipet tip. The maximum
injection time was 100 ms. Data were acquired in the m/z range of 150-2000.
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Figure S6.8. SAII-MS using the 8-channel pipette (Scheme 1B) and an inlet temperature
of 150 °C. All three analytes were analyzed in a total of ~2 seconds. (I) The TIC of 5 tips
filled with angiotensin I, bovine insulin, and ubiquitin with pure solvent between each
two analytes. (II) Mass spectra extracted from (A) 0.26 min for 1 pmol µL-1 angiotensin
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I, (B) 0.28 min for 5 pmol µL-1 bovine insulin with some angiotensin I cross
contamination, and (C) 0.29 min for 1 pmol µL-1 ubiquitin. 2.5 µL analyte/solvent was
drawn into each pipet tip. The maximum injection time was 500 ms. Data were acquired
in the m/z range of 150-2000.
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Figure S6.9. Mapping using the 8-channel pipette (Scheme 1B). The solutions were
scanned from (I) low to high and (II) high to low concentrations. (A) Schematic
representation of content in each pipette tip. Red boxes indicate tips filled with 2 µL
clozapine solutions at 25 fmol µL-1, 50 fmol µL-1, and 100 fmol µL-1, respectively; grey
boxes represent pure solvent methanol. (B) The mapping of m/z 270 peak. Note that the
methanol solutions (grey boxes) furthest to the right in (I) and (II) are more intense than
the prior methanol solutions (second last) suggesting that carryover are neglectable in
both cases for the sample (samples solutions furthest to the right, red boxes). Data were
acquired in the m/z range of 90-345.
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Figure S6.10. SAII-MS/MS of clozapine using the 8-channel pipette (Scheme 1B). The
protonated ions were selected and fragmented by CID using normalized collision energy
of 30. The maximum injection time was 100 ms. (A) 1 µL of 1 fmol µL-1 clozapine and
(B) 3 µL of 0.5 fmol µL-1 clozapine was drawn into the pipette tip. The inlet temperature
was 250 °C. Data were acquired in the m/z range of 100-400.
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Figure S6.11. All six mass spectra (A to F) of 5 pmol µL-1 bovine insulin (in
methanol/water with acetic acid) extracted from the repetitive six cycles of SAII
multiplexing using a 96-vial plate (Scheme 1C) at the inlet temperature of 250 °C. The
numbers in blue in the top right corner indicate the ion intensity. Data were acquired in
the m/z range of 150-2000.
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Figure S6.12. SAII-MS using 84 tips mounted on a 96-vial plate (Scheme 1C) when the
inlet temperature was held at 250 °C in a total of ~ 10 min. (I) Total ion current. (II)
Mass spectra of (A) 1 pmol µL-1 clozapine (in methanol), (B) 2.5 pmol µL-1 leucine
enkephalin (in acetonitrile:water with formic acid), (C) 1 pmol µL-1 sphingomyelin (in
methanol with acetic acid), (D) 1 pmol µL-1 galanin (in acetonitrile:water with formic
acid), (E) 1 pmol µL-1 bovine insulin (in methanol:water with acetic acid), (F) 1 pmol µL1

ubiquitin (in acetonitrile:water with formic acid), and (G) 1 pmol µL-1 lysozyme (in

acetonitrile:water with formic acid). Data were acquired in the m/z range of 150-2000.
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Figure S6.13. Mapping using the 96-sample plate shown in Scheme 1C. (A) Schematic
representation of content in each pipet tip. Red boxes indicate tips filled with clozapine
solutions at 0.5, 5, 15, and 30 fmol µL-1, respectively; grey boxes represent pure solvent
methanol. (B) The mapping of m/z 270 peak obtained by selecting the m/z 327 ([M+H]+
ion) for CID fragmentation using normalized collision energy of 30. The maximum
injection time was 100 ms. Data were acquired in the m/z range of 90-345.
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APPENDIX D
MAIV ON FT-ICR SUPPLEMENTAL INFORMATION
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Figure S7.1. MAIV mass spectrum of a mixture of peptides and proteins including:
leucine enkephalin (Leu-enk), bombesin, allatostatin, and bovine insulin (BI). The inset
shows the +5 charge state of bovine insulin.
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Figure S7.2. MAIV mass spectra (I) and the +4 inset (II) of bovine insulin using
different plate voltages and data acquisition sizes. (A) 300 V plate voltage and 2 million
acquisition size; (B) 300 V plate voltage and 512 thousand acquisition size; and (C) 240
V plate voltage and 512 thousand acquisition size.
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Figure S7.3. MAIV mass spectra of angiotensin mixture using different plate voltages
and data acquisition sizes. (I) With 2 million acquisition size at (A) 0 V, (B) 200 V, (C)
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300V, (D) 400 V, and (E) 500V; (II) with 512 thousand acquisition size at (A) 210 V, (B)
230 V, (C) 240 V, (D) 250 V, and (E) 300 V.
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Figure S7.4. LSIV mass spectrum of 100 pmol ubiquitin using 2-NPG matrix
summarizing 20 scans. The laser power was 50%, the voltage applied on the target plate
is 400 V, and data acquisition size was 512 thousand.
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APPENDIX E
QUANTIFICATION SUPPLEMENTAL INFORMATION
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Figure S8.1. Characterization of phosphotidycholine (34:1) extracted from the brain
tissue section of a drug-treated mouse and pipetted into the heated inlet (Scheme 8.1.
II.A). (A) MS2 by fragmenting the most abundant peak from Figure 8.1. B ([PC 34:1 +
K]+) and CID was performed with CE=28. (B) MS3 by fragmenting the most abundant
product ion at m/z 739 using CID with CE=28. The blue numbers on the top right corner
denote ion intensities.
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Figure S8.2. Inset mass spectrum showing clozapine and one major metabolite, clozapine
N-oxide, obtained by surface extraction of an aged brain tissue section from drug-treated
mouse followed by SAII method in discontinuous mode (Scheme 8.1. II.A). The blue
number on the top right corner denotes ion intensities.
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Figure S8.3. Mass spectrum obtained by SAII in continuous surface extraction mode
(Scheme 8.1. II.B). A brain tissue section of drug-treated mouse was analyzed. The
mass spectrum was extracted from 0.37 to 0.86 min from the TIC shown in Figure 8.2A.
The blue number on the top right corner denotes ion intensity. The peaks were assigned
according to previous studies. No cholesterol fragment with the loss of water (at m/z 369)
or water cluster background was detected as observed in typical MALDI analysis.
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Figure S8.4. Mass spectra using SAII by pipetting 1 µL standard clozapine:clozapine-d8
solution from the vial into the heated mass spectrometer inlet. The concentration ratio of
clozapine:clozapine-d8 is (A) 0.5:1 and (B) 1:1 with the clozapine-d8 at 2 pmol µL-1. The
ion intensity ratio at m/z’s 327:335 is approximately (A) 0.54:1 and (B) 1.08:1. The blue
numbers on the top right corner denote ion intensities.
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Figure S8.5. Mass spectra using SAII in discontinuous mode (Scheme 8.1. II.A). The
material was extracted by using 1 µL standard solution (clozapine:clozapine-d8 at 0.5:1
with the clozapine-d8 at 2 pmol µL-1) from tissue section surfaces of (A) control and (B)
drug-treated mouse and pipette into the heated mass spectrometer inlet. The ion intensity
ratio at m/z’s 327:335 is approximately (A) 0.52:1 and (B) 2.20:1. The blue numbers on
the top right corner denote ion intensities.
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Figure S8.6. Half of a tissue section covered by four 1 µL matrix/clozapine:clozapine-d8
mixture and analyzed by MAIV operating at atmospheric pressure (Scheme 8.2.B). The
glass slide holding tissue section was sealed to the modified skimmer cone, and the
matrix sublimed over 10 min. (I) TIC showing continuous ion formation from a MAIV
analysis. (II): (A) Total mass spectrum, clozapine, clozapine-d8, cholesterol, and lipids
were observed; (B) two dimensional plots of drift time vs. m/z with insets showing
extracted (1) nested dataset and (2) mass spectrum from the blue-boxed area. The ion
intensity ratio at m/z’s 327:335 is approximately 3.02:1.
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Figure S8.7. Microscopy images of the glass slides holding 20 µm-thick tissue section
after

(A)

solvent-droplet

extraction

(Scheme

8.1.

II.A)

and

(B)

3-

NBN/clozapine:clozapine-d8 mixture sublimation for 10 min (Scheme 8.2.B). The tissue
section and the glass slide were cut through the center, and the images show the cross
section. The scale bar represents 50 µm, and a scale bar representing 20 µm is included to
indicate the thickness of the tissue section.

172

BIBLIOGRAPHY
1

Imami, K., Sugiyama, N., Kyono, Y., Tomita, M., & Ishihama, Y. (2008). Automated
phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS
using a calcined titania/C18 biphasic column.Analytical Sciences, 24(1), 161-166.

2

Mikesh, L. M., Ueberheide, B., Chi, A., Coon, J. J., Syka, J. E., Shabanowitz, J., &
Hunt, D. F. (2006). The utility of ETD mass spectrometry in proteomic
analysis. Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics,1764, 18111822.

3

Trimpin, S., Brizzard, B.L. (2009). Analysis of insoluble proteins. Biotechniques 46,
409-419.

4

Agranoff, B.W., Benjamins, J.A., Hajra, A.K. (1999) Basic Neurochemistry Molecular,
Cellular and Medical Aspects, 6th ed, Siegel, G. J., Agranoff, B. W., Albers, R. W.,
Fisher, S. K., Uhler, M. D. Eds., Lippincott Williams & Wilkins: Philadelphia, pp 4767.

5

McIlwain, H. and Bachelard, H.S. (1985) Biochemistry and the Central Nervous
System, Edinburgh: Churchill Livingstone.

6

Durcan, M., Rigdon, G.C., Norman, M.H., Morgan, P.F. (1995) Is clozapine selective
for the dopamine D4 receptor?. Life Sciences 57, PL275-283.

7

Farooqui, A. A., Horrocks, L. A., & Farooqui, T. (2000). Glycerophospholipids in
brain: their metabolism, incorporation into membranes, functions, and involvement in
neurological disorders. Chemistry and Physics of Lipids, 106, 1-29.

8

Fuchs, B., & Schiller, J. (2009). Application of MALDI‐TOF mass spectrometry
in lipidomics. European Journal of Lipid Science and Technology, 111, 83-98.

173

9

Dunn, W. B., Bailey, N. J., & Johnson, H. E. (2005). Measuring the metabolome:
current analytical technologies. Analyst, 130, 606-625.

10

Fiehn, O. (2002). Metabolomics–the link between genotypes and phenotypes. Plant
Molecular Biology, 48, 155-171.

11

Prakash, C., Shaffer, C. L., & Nedderman, A. (2007). Analytical strategies for
identifying drug metabolites. Mass Spectrometry Reviews, 26, 340-369.

12

Annesley, T. (2009). Mass spectrometry in the clinical laboratory: how have we done,
and where do we need to be?. Clinical Chemistry, 55, 1236-1239.

13

Saint-Marcoux, F., Sauvage, F. L., & Marquet, P. (2007). Current role of LC-MS in
therapeutic drug monitoring. Analytical and Bioanalytical Chemistry, 388, 1327-1349.

14

Diamandis, E. P. (2004). Mass spectrometry as a diagnostic and a cancer biomarker
discovery tool opportunities and potential limitations. Molecular & Cellular
Proteomics, 3(4), 367-378.

15

Rifai, N., Gillette, M. A., & Carr, S. A. (2006). Protein biomarker discovery and
validation: the long and uncertain path to clinical utility. Nature Biotechnology, 24,
971-983.

16

Engwegen, J. Y., Gast, M. C. W., Schellens, J. H., & Beijnen, J. H. (2006). Clinical
proteomics: searching for better tumour markers with SELDI-TOF mass
spectrometry. Trends in Pharmacological Sciences, 27, 251-259.

17

Meng, Q. H. (2013). Mass Spectrometry Applications in Clinical Diagnostics. Journal
of Clinic Experimental Pathology , S6, 2161-0681.

174

18

Trimpin, S., Wang, B., Lietz, C. B., Marshall, D. D., Richards, A. L., & Inutan, E. D.
(2013).

New

ionization

processes

and

applications

for

use

in

mass

spectrometry. Critical Reviews in Biochemistry and Molecular biology, 48, 409-429.
19

Strathmann, F. G., & Hoofnagle, A. N. (2011). Current and future applications of mass
spectrometry to the clinical laboratory. American Journal of Clinical Pathology, 136,
609-616.

20

Seeley, E. H., Oppenheimer, S. R., Mi, D., Chaurand, P., & Caprioli, R. M. (2008).
Enhancement of protein sensitivity for MALDI imaging mass spectrometry after
chemical treatment of tissue sections. Journal of the American Society for Mass
Spectrometry, 19, 1069-1077.

21

Goodwin, R. J. (2012). Sample preparation for mass spectrometry imaging: small
mistakes can lead to big consequences. Journal of Proteomics, 75, 4893-4911.

22

Mikesh, L. M., Ueberheide, B., Chi, A., Coon, J. J., Syka, J. E., Shabanowitz, J., &
Hunt, D. F. (2006). The utility of ETD mass spectrometry in proteomic
analysis. Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics,1764, 18111822.

23

Wiseman, J. M., Ifa, D. R., Zhu, Y., Kissinger, C. B., Manicke, N. E., Kissinger, P. T.,
& Cooks, R. G. (2008). Desorption electrospray ionization mass spectrometry:
Imaging drugs and metabolites in tissues. Proceedings of the National Academy of
Sciences, 105, 18120-18125.

24

El-Baba, T. J., Lutomski, C. A., Wang, B., Inutan, E. D., & Trimpin, S. (2014).
Toward high spatial resolution sampling and characterization of biological tissue
surfaces using mass spectrometry. Analytical and Bioanalytical Chemistry, 406, 1-9.

175

25

Coon, J. J., Syka, J. E., Shabanowitz, J., & Hunt, D. F. (2005). Tandem mass
spectrometry for peptide and protein sequence analysis. Biotechniques, 38, 519-523.

26

Coon, J. J. (2009). Collisions or electrons? Protein sequence analysis in the 21st
century. Analytical chemistry, 81, 3208-3215.

27

Mark, T. D. (1982). Fundamental aspects of electron impact ionization. International
Journal of Mass Spectrometry and Ion Physics, 45, 125-145.

28

Munson, M. S. B., & Field, F. H. (1966). Chemical ionization mass spectrometry. I.
General introduction. Journal of the American Chemical Society, 88, 2621-2630.

29

Barber, M., Bordoli, R.S., Sedgwick, R.D., Tyler, A.N. (1981). FAB of Solids as an
Ion Source in Mass Spectrometry. Nature 293, 270-275.

30

Honig, R.E. (1985). The Development of Secondary Ion-MS (SIMS): a Restrospective.
International Journal of Mass Spectrometry and Ion Processes. 66, 31-54.

31

Karas, M., Bachmann, D., Bahr, U., Hillenkamp, F. (1987). Matrix-Assisted
Ultraviolet-Laser Desorption of Nonvolatile Compounds. International Journal of
Mass Spectrometry and Ion Processes 78, 53-68.

32

Tanaka, K., Waki, H., Ido, Y., Akita, S., Yoshida, Y., Yoshida, T. (1988). Protein and
polymer analyses up to m/z 100 000 by laser ionization time-of-flight mass
spectrometry. Rapid Communications in Mass Spectrometry 2, 151-153.

33

Fenn, J. B., Mann, M., Meng, C. K., Wong, S. F., Whitehouse, C. M. (1989).
Electrospray ionization for mass spectrometry of large biomolecules. Science 246,
64–71.

176

34

Holle, A., Haase, A., Kayser, M., Höhndorf, J. (2006). Optimizing UV laser focus
profiles for improved MALDI performance. Journal of Mass Spectrometry 41, 705716.

35

Vestal, M. L., Juhasz, P., & Martin, S. A. (1995). Delayed extraction matrix‐assisted
laser desorption time‐of‐flight mass spectrometry. Rapid Communications in Mass
Spectrometry, 9, 1044-1050.

36

Trimpin, S., Rouhanipour, A., Az, R., Räder, H.J., Müllen, K. (2001). New aspects in
matrix-assisted laser desorption/ionization time-of-flight mass spectrometry: a
universal solvent-free sample preparation. Rapid Communications in Mass
Spectrometry 15, 1364-1373.

37

Trimpin, S., Deinzer, M.L. (2007). Solvent-free MALDI-MS for the analysis of a
membrane protein via the mini ball approach: Case study of bacteriorhodopsin.
Analytical Chemistry 79, 71-78.

38

Trimpin, S. Grimsdale, A.C., Räder, H.J., Müllen, K.(2002). Characterization of an
insoluble poly(9,9-diphenyl-2,7-ﬂuorene) by solvent-free sample preparation for
MALDI-TOF mass spectrometry. Analytical Chemistry 74, 3777-3782.

39

Trimpin, S. (2010). A perspective on MALDI alternatives – total solvent-free analysis
and electron transfer dissociation of highly charged ions by laserspray ionization.
Journal of Mass Spectrometry 45, 471-485.

40

Trimpin, S., Deinzer, M.L. (2005). Solvent-free MALDI-MS for the analysis of
biological samples via a mini-ball mill approach. Journal of the American Society for
Mass Spectrometry 16, 542-547.

177

41

Trimpin, S., & Deinzer, M. L. (2007). Solvent-free MALDI-MS for the analysis of βamyloid peptides via the mini-ball mill approach: Qualitative and quantitative
advances. Journal of the American Society for Mass Spectrometry, 18, 1533-1543.

42

Ehring, H., Karas, M., & Hillenkamp, F. (1992). Role of photoionization and
photochemistry in ionization processes of organic molecules and relevance for
matrix‐assisted laser desorption lonization mass spectrometry. Organic Mass
Spectrometry, 27, 472-480.

43

Karas, M., Glückmann, M., & Schäfer, J. (2000). Ionization in matrix‐assisted laser
desorption/ionization: singly charged molecular ions are the lucky survivors. Journal
of Mass Spectrometry, 35, 1-12.

44

Knochenmuss, R. (2006). Ion formation mechanisms in UV-MALDI. Analyst 131,
966-986.

45

Beavis, R. C., Chaudhary, T., & Chait, B. T. (1992). α‐Cyano‐4‐hydroxycinnamic acid
as a matrix for matrixassisted laser desorption mass spectromtry. Organic Mass
Spectrometry, 27, 156-158.

46

Karas, M., Bahr, U., Strupat, K., Hillenkamp, F., Tsarbopoulos, A., & Pramanik, B.
N. (1995). Matrix dependence of metastable fragmentation of glycoproteins in
MALDI TOF mass spectrometry. Analytical Chemistry, 67, 675-679.

47

Loboda, A.V. Krutchinsky, A.N., Bromirski, M. (2000). A tandem quadrupole/timeof-flight mass spectrometer with a matrix-assisted laser desorption/ionization source:
design and performance. Rapid Communications in Mass Spectrometry 14, 10471057.

178

48

Easterling, M.L., Mize, T.H., Amster, I.J. (1999). Routine part-per-million mass
accuracy for high-mass ions: Space-charge effects in MALDI FT-ICR Analytical
Chemistry 71, 624-632.

49

Li, L.J., Garden, R.W., Sweedler, J.V. (2000). Single-cell MALDI: a new tool for
direct peptide profiling. Trends in Biotechnology. 18, 151-160.

50

Chaurand, P., Luetzenkirchen, F., Spengler, B. (1999). Peptide and protein
identification by matrix-assisted laser desorption ionization (MALDI) and MALDIpost-source decay time-of-flight mass spectrometry. Journal of the American Society
for Mass Spectrometry 10, 91-103.

51

Schiller, J., Arnhold, J., Benard, S., Muller, M., Reichl, S., Arnold, K. (1999). Lipid
analysis by matrix-assisted laser desorption and ionization mass spectrometry: A
methodological approach. Analytical Biochemistry 267, 46-56.

52

Harvey, D.J. (1999). Matrix-assisted laser desorption/ionization mass spectrometry of
carbohydrates. Mass Spectrometry Reviews 18, 349-450.

53

Masuda, N., Ohnishi, T., Kawamoto, S. (1999). Analysis of chemical modification of
RNA from formalin-fixed samples and optimization of molecular biology
applications for such samples. Nucleic Acids Research 27, 4436-4443.

54

Claydon, M.A., Davey, S.N., EdwardsJones, V., Gordon, D.B. (1996). The rapid
identification

of

intact

microorganism

using

mass

spectrometry.

Nature

Biotechnology 14, 1584-1586.
55

McDonnell, L.A., Heeren, R.M.A. (2007). Imaging mass spectrometry. Mass
Spectrometry Reviews 26, 606-643.

179

56

Caprioli, R.M., Farmer, T.B., Gile, J. (1997). Molecular imaging of biological samples:
Localization of peptides and proteins using MALDI-TOF MS. Analytical Chemistry
69, 4751-4760.

57

Hankin, J.A., Barkley, R.M., Murphy, R.C. (2007). Sublimation as a method of matrix
application for mass spectrometric imaging. Journal of the American Society for Mass
Spectrometry. 18, 1646-1652.

58

Reyzer, M.L., Hsieh, Y.S., Ng, K., Korfmacher, W.A., Caprioli, R.M. (2003). Direct
analysis of drug candidates in tissue by matrix-assisted laser desorption/ionization
mass spectrometry. Journal of Mass Spectrometry 221, 1081-1092.

59

Schwartz, S.A., Reyzer, M.L., Caprioli, R.M. (2003). Direct tissue analysis using
matrix-assisted laser desorption/ionization mass spectrometry: practical spects of
sample preparation. Journal of Mass Spectrometry. 223, 699-708.

60

Kruse, R., Sweedler, J.V. Spatial proﬁling invertebrate ganglia using MALDI MS.
(2003). Journal of the American Society for Mass Spectrometry 14, 752-759.

61

Schober, Y., Guenther, S., Spengler B, Rompp, A. (2012). Single cell matrix-assisted
laser desorption/ionization mass spectrometry imaging. Analytical Chemistry 84,
6293-6297.

62

Jun, J.H., Song, Z., Liu, Z., Nikolau, B.J., Yeung, E.S., Lee, Y.J. (2012). High-spatial
and high-mass resolution imaging of surface metabolites of Arabidopsis thaliana by
laser desorption-ionizatin mass spectrometry using colloidal silver. Analytical
Chemistry 82, 3255-3265.

180

63

Pirman, D. A., Reich, R. F., Kiss, A., Heeren, R. M., & Yost, R. A. (2012).
Quantitative MALDI tandem mass spectrometric imaging of cocaine from brain
tissue with a deuterated internal standard. Analytical Chemistry, 85, 1081-1089.

64

Pirman, D. A., Kiss, A., Heeren, R. M., & Yost, R. A. (2012). Identifying tissuespecific signal variation in MALDI mass spectrometric imaging by use of an internal
standard. Analytical Chemistry 85, 1090-1096.

65

Laiko, V.V., Baldwin, M.A., Burlingame, A.L. (2000). Atmospheric pressure matrix
assisted laser desorption/ionization mass spectrometry. Analytical Chemistry 72, 652657.

66

Li, Y., Shrestha, B., Vertes, A. (2008). Atmospheric pressure infrared MALDI
imaging mass spectrometry for plant metabolomics. Analytical Chemistry 80, 407420.

67

Dorosheno, V.M., Laiko, V.V., Taranenko, N.I., Berkout, V.D., Lee, H.S. (2002).
Recent developments in atmospheric pressure MALDI mass spectrometry.
International Journal of Mass Spectrometry 221, 39-58.

68

Galicia M C, Vertes A, Callahan J H. (2002). Atmospheric pressure matrix-assisted
laser desorption/ionization in transmission geometry. Analytical chemistry, 74: 18911895.

69

Sheehan, E.W.; Willoughby, R. C. (June13, 2006) U. S. Patent 7,060,976.

70

Krutchinsky AN, Chait BT. (2002). On the nature of the chemical noise in MALDI
mass spectra. Journal of the American Society for Mass Spectrometry 13, 129-34.

71

Fenn, J.B. Electrospray wings for molecular elephants. (2003). Angewandte Chemie
International Edition 42, 3871-3894.

181

72

Konermann, L., Ahadi, E., Rodriguez, A.D., Vahidi, S. (2013). Unraveling the
Mechanism of Electrospray Ionization. Analytical Chemistry 85, 2-9.

73

Iribarne, J. V., Thomson, B. A. J. (1976). On the evaporation of small ions from
charged droplets. Journal of Chemical Physics 64, 2287-2294.

74

Dole, M., Mack, L.L., Hines, R.L. (1968). Molecular beams of macroions. Journal of
Chemical Physics. 49, 2240-2249.

75

Trimpin, S., Inutan, E.D., Herath, T.N., McEwen, C.N. (2010). Matrix-Assisted Laser
Desorption/Ionization Mass Spectrometry Method for Selectively Producing Either
Singly or Multiply Charged Molecular Ions. Analytical Chemistry 82, 11-15.

76

Pitt, J.J. Principles and Applications of Liquid Chromatography-Mass Spectrometry
in Clinical Biochemistry. (2009). Clinical Biochemist. Reviews 30, 19-34.

77

Elias, J. E., & Gygi, S. P. (2007). Target-decoy search strategy for increased
confidence in large-scale protein identifications by mass spectrometry. Nature
Methods, 4, 207-214.

78

Shen, Y.F., Zhao, R., Berger, S.J., Anderson, G.A., Rodriguez, N., Smith, R.D. (2002).
High-efficiency nanoscale liquid chromatography coupled on-line with mass
spectrometry using nanoelectrospray ionization for proteomics. Analytical Chemistry
74, 4235-4249.

79

Mann, W.M. (1996). Analytical properties of the nanoelectrospray ion source.
Analytical Chemistry 68, 1-8.

80

Smith, R.D. (2006). Future directions for electrospray ionization for biological
analysis using mass spectrometry. Biotechniques 41, 147-148.

182

81

Kebarle, P., & Verkerk, U. H. (2009). Electrospray: from ions in solution to ions in
the gas phase, what we know now. Mass Spectrometry Reviews, 28, 898-917.

82

Gibson, G.T.T., Mugo, S.M., Oleschuk, R.D. (2009). Nanoelectrospray emitters trends
and perspective. Mass Spectrometry Reviews 28, 918-936

83

Cody, R.B.; Laramee, J.A.; Durst, H.D. (2005). Versatile new ion source for the
analysis of materials in open air under ambient conditions. Analytical Chemistry 77,
2297-2302.

84

Venter, A.; Nefliu, M.; Cooks, R.G. (2008). Ambient desorption ionization mass
spectrometry. Trends in Analytical Chemistry 27, 284-290.

85

Takatz, Z.; Wiseman, J.M.; Gologan, B.; Cooks, R.G. (2004). Mass spectrometry
sampling under ambient conditions with desorption electrospray ionization. Science
3006, 471-473.

86

Ford, M.J.; Van Berkel, G.J. (2004). An improved thin-layer chromatography/mass
spectrometry coupling using a surface sampling probe electrospray ion trap system.
Rapid Communications in. Mass Spectrometry. 18, 1303-1309.

87

Haapala M.; Pol, J.; Saarela, V.; Arvola, V.; Kotiaho, T.; Ketola, R.A.; Franssila, S.;
Kauppila,

T.J.

Kostiainen,

R.

(2007).

Desorption

atmospheric

pressure

photoionization. Analytical Chemistry 79, 7867-7872.
88

McEwen C.N.; McKay R.G.; Larsen, B.S. (2005). Analysis of solids, liquids, and
biological tissues using solid probe introduction at atmospheric pressure on
commercial LC/MS instruments. Analytical Chemistry 77, 7826-7831.

183

89

Roach, P.J.; Laskin, J.; Laskin, A. (2010). Nanospray desorption electrospray
ionization: an ambient method for liquid-extraction surface sampling in mass
spectrometry. Analyst 135, 2233-2236.

90

Nemes, P.; Vertes, A. (2007). Laser ablation electrospray ionization for atmospheric
pressure, in vivo, and imaging mass spectrometry. Analytical Chemistry 79, 80988106.

91

Sampson, J.S.; Hawkridge, A.M.; Muddiman, D.C. (2005). Generation and detection
of multiply-charged peptides and proteins by matrix-assisted laser desorption
electrospray ionization (MALDESI) fourier transform ion cyclotron resonance mass
spectreomtry. Journal of the American Society for Mass Spectrometry 17, 1712-1716.

92

Shie,

J.;

Huang,

M.Z.;

Hsu,

H.J.

(2005).

Electrospray-assisted

laser

desorption/ionization mass spectrometry for direct ambient analysis of solids. Rapid
Communications in Mass Spectrometry 19, 3701-3704.
93

Ovchinnikova, O.S.; Kertesz, V.; Van Berkel, G.J. (2011). Combining transmission
geometry laser ablation and a non-contact continuous flow surface sampling
probe/electrospray emitter for mass spectrometry based chemical imaging. Rapid
Communications in Mass Spectrometry 25, 3735-3740.

94

Chernushevich, I. V., Loboda, A. V., & Thomson, B. A. (2001). An introduction to
quadrupole–time‐of‐flight mass spectrometry. Journal of Mass Spectrometry,36, 849865.

95

Fuerstenau, S. D., Benner, W. H., Thomas, J. J., Brugidou, C., Bothner, B., & Siuzdak,
G. (2001). Mass spectrometry of an intact virus. Angewandte Chemie International
Edition, 40, 541-544.

184

96

Satoh, T., Sato, T., & Tamura, J. (2007). Development of a high-performance
MALDI-TOF mass spectrometer utilizing a spiral ion trajectory. Journal of the
American Society for Mass Spectrometry, 18, 1318-1323.

97

Hopfgartner, G., Varesio, E., Tschäppät, V., Grivet, C., Bourgogne, E., & Leuthold, L.
A. (2004). Triple quadrupole linear ion trap mass spectrometer for the analysis of
small molecules and macromolecules. Journal of Mass Spectrometry, 39, 845-855.

98

Lange, V., Picotti, P., Domon, B., & Aebersold, R. (2008). Selected reaction
monitoring for quantitative proteomics: a tutorial. Molecular Systems Biology,4, 1-14.

99

Pekar Second, T., Blethrow, J. D., Schwartz, J. C., Merrihew, G. E., MacCoss, M. J.,
Swaney, D. L., Jason D. Russell, Joshua J. Coon, & Zabrouskov, V. (2009). Dualpressure linear ion trap mass spectrometer improving the analysis of complex protein
mixtures.Analytical Chemistry, 81, 7757-7765.

100

Hager, J. W. (2002). A new linear ion trap mass spectrometer. Rapid Communications
in Mass Spectrometry, 16, 512-526.

101

Marshall,

A.

G.,

&

Hendrickson,

C.

L.

(2008).

High-resolution

mass

spectrometers. Annual Reviews of Analytical Chemistry 1, 579-599.
102

Steen, H., Küster, B., & Mann, M. (2001). Quadrupole time‐of‐flight versus
triple‐quadrupole mass spectrometry for the determination of phosphopeptides
by precursor ion scanning. Journal of Mass Spectrometry, 36, 782-790.

103

Clemmer, D. E., & Jarrold, M. F. (1997). Ion mobility measurements and their
applications to clusters and biomolecules. Journal of Mass Spectrometry,32, 577-592.

185

104

Wyttenbach, T., & Bowers, M. T. (2003). Gas-phase conformations: The ion
mobility/ion chromatography method. Modern Mass Spectrometry (pp. 207-232).
Springer Berlin Heidelberg.

105

Liu, X., Valentine, S. J., Plasencia, M. D., Trimpin, S., Naylor, S., & Clemmer, D. E.
(2007). Mapping the human plasma proteome by SCX-LC-IMS-MS. Journal of the
American Society for Mass Spectrometry, 18, 1249-1264.

106

Trimpin, S., Tan, B., Bohrer, B. C., O’Dell, D. K., Merenbloom, S. I., Pazos, M. X.,
Clemmer, D.E., & Walker, J. M. (2009). Profiling of phospholipids and related lipid
structures

using

multidimensional

ion

mobility

spectrometry-mass

spectrometry. International Journal of Mass Spectrometry, 287, 58-69.
107

Trimpin, S., Inutan, E. D., Herath, T. N., McEwen, C. N.,(2010). Laserspray
ionization, a new atmospheric pressure MALDI method for producing highly charged
gas-phase ions of peptides and proteins directly from solid solutions. Molecular &
Cellular Proteomics, 9, 362-367.

108

McEwen, C. N.,

Larsen, B. S., Trimpin, S. (2010). Laserspray ionization on a

commercial atmospheric pressure-MALDI mass spectrometer ion source: selecting
singly or multiply charged ions. Analytical Chemistry, 82, 4998-5001.
109

McEwen, C. N., Pagnotti, V. S., Inutan, E. D., Trimpin, S. (2010). New paradigm in
ionization: multiply charged ion formation from a solid matrix without a laser or
voltage. Analytical Chemistry, 82, 9164-9168.

110

Li, J., Inutan, E. D., Wang, B., Lietz, C. B., Green, D. R., Manly, C. D., Richards, A.
L., Marshall, D. D., Lingenfelter, S., Ren, Y., Trimpin, S. (2012). Matrix assisted
ionization: new aromatic and nonaromatic matrix compounds producing multiply

186

charged lipid, peptide, and protein ions in the positive and negative mode observed
directly from surfaces. Journal of the American Society for Mass Spectrometry, 23,
1625-1643.
111

Pagnotti, V. S., Chubatyi, N. D., McEwen, C. N. (2011). Solvent assisted inlet
ionization: an ultrasensitive new liquid introduction ionization method for mass
spectrometry[J]. Analytical Chemistry, 83, 3981-3985.

112

Pagnotti, V. S., Inutan, E. D., Marshall, D. D., Trimpin, S., McEwen, C. N. (2011).
Inlet ionization: a new highly sensitive approach for liquid chromatography/mass
spectrometry of small and large molecules. Analytical Chemistry, 83, 7591-7594.

113

Pagnotti, V. S., Chakrabarty, S., Harron, A. F., McEwen, C. N. (2012). Increasing the
sensitivity of liquid introduction mass spectrometry by combining electrospray
ionization and solvent assisted inlet ionization. Analytical Chemistry, 84, 6828-6832.

114

Pagnotti, V. S., Chakrabarty, S., McEwen, C. N. (2013). Carbonation and other super
saturated gases as solution modifiers for improved sensitivity in solvent assisted
ionization inlet (SAII) and ESI. Journal of the American Society for Mass
Spectrometry, 24, 186-192.

115

Inutan, E. D., Wang, B., Trimpin, S. (2010). Commercial intermediate pressure
MALDI ion mobility spectrometry mass spectrometer capable of producing highly
charged laserspray ionization ions. Analytical Chemistry, 83, 678-684.

116

Trimpin, S., Ren, Y., Wang, B., Lietz, C. B., Richards, A. L., Marshall, D. D., Inutan,
E. D. (2011). Extending the laserspray ionization concept to produce highly charged
ions at high vacuum on a time-of-flight mass analyzer. Analytical Chemistry, 83,
5469-5475.

187

117

Inutan, E. D., Trimpin S. (2013). Matrix assisted ionization vacuum (MAIV), a new
ionization method for biological materials analysis using mass spectrometry.
Molecular & Cellular Proteomics, 12, 792-796.

118

Trimpin, S., Inutan, E. D. (2013). Matrix assisted ionization in vacuum, a sensitive
and widely applicable ionization method for mass spectrometry. Journal of The
American Society for Mass Spectrometry, 24, 722-732.

119

Trimpin, S., Inutan, E. D. (2013) New ionization method for analysis on atmospheric
pressure ionization mass spectrometers requiring only vacuum and matrix assistance.
Analytical Chemistry, 85, 2005-2009.

120

Inutan, E.D., Wager-Miller, J., Narayan, S.B., Mackie, K., Trimpin, S. (2013). The
potential for clinical applications using a new ionization method combined with ion
mobility spectrometry-mass spectrometry. International Journal for Ion Mobility
Spectrometry 16, 145-159.

121

Inutan, E., & Trimpin, S. (2010). Laserspray ionization (LSI) ion mobility
spectrometry (IMS) mass spectrometry. Journal of the American Society for Mass
Spectrometry, 21, 1260-1264.

122

Trimpin, S.; Wang, B.; Inutan, E.D.; Li, J.; Lietz, C.B.; Harron, A.; Pagnotti, V.S.;
Sardelis, D.; McEwen, C.N. (2013). A Mechanism for Ionization of Nonvolatile
Compounds in Mass Spectrometry: Considerations from MALDI and Inlet Ionization.
Journal of the American Society for Mass Spectrometry 23, 1644-1660.

123

Bhattacharyya, I.; Maze, J.T.; Ewing, G.E.; Jarrold, M.F. (2011). Charge Separation
from the Bursting of Bubbles on Water. Journal of Physical Chemistry A 115, 57235728.

188

124

Vestal, M.L. (1983). Ionization Techniques for Non-Volatile Molecules. Mass
Spectrometry Reviews 2, 447-480.

125

Trimpin, S.; Wang, B. (2015). Inlet and Vacuum Ionization from Ambient Conditions, in:
Ambient Ionization Mass Spectrometry, Royal Society of Chemistry, by Eds. Marek Domin
and Robert Cody, 423-444.

126

Chakrabarty, S.; Pagnotti, V.; Wang, B.; Trimpin, S.; McEwen, C.N. (2014).
Ionization from Ice in Mass Spectrometry and a Possible Connection to
Thunderstorms, Analytical Chemistry 86, 7343-7350.

127

Trimpin, S.; Lutomski, C. A.; El-Baba, T. J.; Woodall, D. W.; Foley, C. D.; Manly, C.
D.; Wang, B.; Liu, C.; Harless, B. M.; Kumar, R.; Imperial, L. F.; Inutan, E. D. (2014)
Magic matrices for ionization in mass spectrometry. International Journal of Mass
Spectrometry, doi: 10.1016/j.ijms.2014.07.033.

128

Van Berkel, G. J., Pasilis, S. P., & Ovchinnikova, O. (2008). Established and
emerging atmospheric pressure surface sampling/ionization techniques for mass
spectrometry. Journal of Mass Spectrometry, 43, 1161-1180.

129

Trimpin, S., Herath, T. N., Inutan, E. D., Cernat, S. A., Miller, J. B., Mackie, K., &
Walker, J. M. (2009). Field‐free transmission geometry atmospheric pressure
matrix‐assisted laser desorption/ionization for rapid analysis of unadulterated tissue
samples. Rapid Communications in Mass Spectrometry,23, 3023-3027.

130

Zydel, F., Trimpin, S., & McEwen, C. N. (2010). Laserspray ionization using an
atmospheric solids analysis probe for sample introduction. Journal of the American
Society for Mass Spectrometry, 21, 1889-1892.

189

131

McEwen, C. N., & Trimpin, S. (2011). An alternative ionization paradigm for
atmospheric pressure mass spectrometry: flying elephants from Trojan horses.
International Journal of Mass Spectrometry, 300, 167-172.

132

Inutan, E. D., & Trimpin, S. (2010). Laserspray Ionization-Ion Mobility
Spectrometry− Mass Spectrometry: Baseline Separation of Isomeric Amyloids
without the Use of Solvents Desorbed and Ionized Directly from a Surface.Journal of
proteome research, 9, 6077-6081.

133

Richards, A. L., Marshall, D. D., Inutan, E. D., McEwen, C. N., & Trimpin, S. (2011).
High‐throughput analysis of peptides and proteins by laserspray ionization mass
spectrometry. Rapid Communications in Mass Spectrometry,25, 247-250.

134

Inutan, E. D., Richards, A. L., Wager-Miller, J., Mackie, K., McEwen, C. N., &
Trimpin, S. (2011). Laserspray ionization, a new method for protein analysis directly
from tissue at atmospheric pressure with ultrahigh mass resolution and electron
transfer dissociation. Molecular & Cellular Proteomics, 10, M110-000760.

135

Richards, A. L., Lietz, C. B., Wager‐Miller, J. B., Mackie, K., & Trimpin, S. (2011).
Imaging mass spectrometry in transmission geometry. Rapid Communications in
Mass Spectrometry, 25, 815-820.

136

Trimpin, S., Herath, T. N., Inutan, E. D., Wager-Miller, J., Kowalski, P., Claude, E.,
Walker, J. M., & Mackie, K. (2009). Automated solvent-free matrix deposition for
tissue imaging by mass spectrometry. Analytical Chemistry, 82, 359-367.

137

Schilling, B.; Miller, A; Miller, J. P.; Gaman, E. A.; Ellerby, L. M.; Gibson, B. W.;
Hughes, R. E. Proceedings of the 55th ASMS Conference on Mass Spectrometry and
Allied Topics, 2007, Indianapolis, IN, ThPZ7.

190

138

Hanton, S. D., & Parees, D. M. (2005). Extending the solvent-free MALDI sample
preparation method. Journal of the American Society for Mass Spectrometry, 16, 9093.

139

Trimpin, S., Wijerathne, K., & McEwen, C. N. (2009). Rapid methods of polymer and
polymer additives identification: multi-sample solvent-free MALDI, pyrolysis at
atmospheric

pressure,

and

atmospheric

solids

analysis

probe

mass

spectrometry. Analytica Chimica Acta, 654, 20-25.
140

Trimpin, S., & McEwen, C. N. (2007). Multisample preparation methods for the
solvent-free MALDI-MS analysis of synthetic polymers. Journal of the American
Society for Mass Spectrometry, 18, 377-381.

141

Pomerantz, A.E., Ventura, G.T., McKenna, A.M., Cañas, J.A., Auman, J., Koerner, K.,
Curry, D., Nelson, R.K., Reddy, C.M., Rodgers, R.P., Marshall, A.G., Peters, K.E.,
& Mullins, O.C. (2010). The geochemical origin of a viscosity gradient in a
petroleum reservoir. Organic Geochemistry 41, 812-821.

142

Pringle, S. D., Giles, K., Wildgoose, J. L., Williams, J. P., Slade, S. E., Thalassinos,
K., Bateman, R. H., Bwers, M. T., & Scrivens, J. H. (2007). An investigation of the
mobility separation of some peptide and protein ions using a new hybrid
quadrupole/travelling wave IMS/oa-ToF instrument. International Journal of Mass
Spectrometry, 261, 1-12.

143

Trimpin, S., Clemmer, D. E., & McEwen, C. N. (2007). Charge-remote fragmentation
of lithiated fatty acids on a TOF-TOF instrument using matrix-ionization. Journal of
the American Society for Mass Spectrometry, 18, 1967-1972.

191

144

McLean, J. A., Ruotolo, B. T., Gillig, K. J., & Russell, D. H. (2005). Ion mobility–
mass spectrometry: a new paradigm for proteomics. International Journal of Mass
Spectrometry, 240, 301-315.

145

Rodgers, R. P., Schaub, T. M., & Marshall, A. G. (2005). Petroleomics: MS Returns
to Its Roots. Analytical Chemistry, 77, 20-27A.

146

Fernandez-Lima, F. A., Becker, C., McKenna, A. M., Rodgers, R. P., Marshall, A. G.,
& Russell, D. H. (2009). Petroleum crude oil characterization by IMS-MS and FTICR
MS. Analytical Chemistry, 81, 9941-9947.

147

Ahmed, A., Cho, Y. J., No, M. H., Koh, J., Tomczyk, N., Giles, K., Yoo, J. S., & Kim,
S. (2010). Application of the Mason− Schamp equation and ion mobility mass
spectrometry to identify structurally related compounds in crude oil. Analytical
Chemistry, 83, 77-83.

148

Purcell, J. M., Hendrickson, C. L., Rodgers, R. P., & Marshall, A. G. (2006).
Atmospheric pressure photoionization Fourier transform ion cyclotron resonance
mass spectrometry for complex mixture analysis. Analytical Chemistry, 78, 59065912.

149

Yoshimura, K., Przybilla, L., Ito, S., Brand, J. D., Wehmeir, M., Räder, H. J., &
Müllen, K. (2001). Characterization of large synthetic polycyclic aromatic
hydrocarbons

by MALDI‐and

LD‐TOF mass

spectrometry. Macromolecular

Chemistry and Physics, 202, 215-222.
150

Przybilla, L., Brand, J. D., Yoshimura, K., Räder, H. J., & Müllen, K. (2000).
MALDI-TOF mass spectrometry of insoluble giant polycyclic aromatic hydrocarbons
by a new method of sample preparation. Analytical Chemistry,72, 4591-4597.

192

151

Cristadoro, A., Kulkarni, S. U., Burgess, W. A., Cervo, E. G., Räder, H. J., Müllen, K.,
Bruce, D. A., & Thies, M. C. (2009). Structural characterization of the oligomeric
constituents of petroleum pitches. Carbon, 47, 2358-2370.

152

Cristadoro, A., Räder, H. J., & Müllen, K. (2008). Quantitative analyses of fullerene
and polycyclic aromatic hydrocarbon mixtures via solvent‐free matrix‐assisted laser
desorption/ionization

mass

spectrometry. Rapid

Communications

in

Mass

Spectrometry, 22, 2463-2470.
153

Pinkston, D. S., Duan, P., Gallardo, V. A., Habicht, S. C., Tan, X., Qian, K., Gray, M.,
& Kenttamaa, H. I. (2009). Analysis of asphaltenes and asphaltene model compounds
by laser-induced acoustic desorption/Fourier transform ion cyclotron resonance mass
spectrometry. Energy & Fuels, 23, 5564-5570.

154

Trimpin, S., Keune, S., Räder, H. J., & Müllen, K. (2006). Solvent-free MALDI-MS:
developmental improvements in the reliability and the potential of MALDI in the
analysis of synthetic polymers and giant organic molecules. Journal of the American
Society for Mass Spectrometry, 17, 661-671.

155

Trimpin, S., & Clemmer, D. E. (2008). Ion mobility spectrometry/mass spectrometry
snapshots for assessing the molecular compositions of complex polymeric
systems. Analytical Chemistry, 80, 9073-9083.

156

Yamashita, M., & Fenn, J. B. (1984). Negative ion production with the electrospray
ion source. The Journal of Physical Chemistry, 88, 4671-4675.

157

Zhigilei, L. V., & Garrison, B. J. (2000). Microscopic mechanisms of laser ablation of
organic solids in the thermal and stress confinement irradiation regimes. Journal of
Applied Physics, 88, 1281-1298.

193

158

Zhigilei, L. V., Kodali, P., & Garrison, B. J. (1997). On the threshold behavior in laser
ablation of organic solids. Chemical Physics Letters, 276, 269-273.

159

Trimpin, S., Räder, H. J., & Müllen, K. (2006). Investigations of theoretical principles
for

MALDI-MS

derived

from

solvent-free

sample

preparation:

Part

I.

Preorganization. International Journal of Mass Spectrometry, 253, 13-21.
160

Hanton, S. D., & Stets, J. R. (2009). Determining the time needed for the vortex
method for preparing solvent-free MALDI samples of low molecular mass
polymers. Journal of the American Society for Mass Spectrometry, 20, 1115-1118.

161

Hanton, S. D., McEvoy, T. M., & Stets, J. R. (2008). Imaging the morphology of
solvent-free prepared MALDI samples. Journal of the American Society for Mass
Spectrometry, 19, 874-881.

162

Pizzala, H., Barrère, C., Mazarin, M., Ziarelli, F., & Charles, L. (2009). Solid state
nuclear

magnetic

resonance

as

a

tool

to

explore

solvent-free

MALDI

samples. Journal of the American Society for Mass Spectrometry, 20, 1906-1911.
163

Sroka-Bartnicka, A., Ciesielski, W., Libiszowski, J., Duda, A., Sochacki, M., &
Potrzebowski, M. J. (2009). Complementarity of solvent-free MALDI TOF and solidstate NMR spectroscopy in spectral analysis of polylactides. Analytical Chemistry, 82,
323-328.

164

Kononikhin, A. S., Nikolaev, E. N., Frankevich, V., & Zenobi, R. (2005). Letter:
Multiply charged ions in matrix-assisted laser desorption/ionization generated from
electrosprayed sample layers. European Journal of Mass Spectrometry,11, 257-260.

165

Glückmann, M., Pfenninger, A., Krüger, R., Thierolf, M., Karasa, M., Horneffer, V.,
Hillenkamp, F., & Strupat, K. (2001). Mechanisms in MALDI analysis: surface

194

interaction

or

incorporation

of

analytes?. International

Journal

of

Mass

Spectrometry, 210, 121-132.
166

Knochenmuss, R. (2003). A quantitative model of ultraviolet matrix-assisted laser
desorption/ionization including analyte ion generation. Analytical Chemistry, 75,
2199-2207.

167

Wachs, T., Conboy, J. C., Garcia, F., & Henion, J. D. (1991). Liquid chromatographymass

spectrometry

and

related

techniques

via

atmospheric

pressure

ionization. Journal of Chromatographic Science, 29, 357-366.
168

Niessen, W. M. A., & Tinke, A. P. (1995). Liquid chromatography-mass spectrometry
general principles and instrumentation. Journal of Chromatography A, 703, 37-57.

169

Mehlis, B., & Kertscher, U. (1997). Liquid chromatography/mass spectrometry of
peptides of biological samples. Analytica Chimica Acta, 352, 71-83.

170

Srinivas, P., Krishna, P., Sadanandam, M. (2010). Nano liquid chromatography in
pharmaceutical analysis – a review. International Journal of Pharmaceutical Science,
2, 728-737.

171

Shen, Y., Tolic, N., Masselon, C., Paša-Tolic, L., Camp, D. G., Hixson, K. K., Zhao,
R., Anderson, G. A., & Smith, R. D. (2004). Ultrasensitive proteomics using highefficiency

on-line

micro-SPE-nanoLC-nanoESI

MS

and

MS/MS. Analytical

chemistry 76, 144-154.
172

Smith, R. D., Shen, Y., & Tang, K. (2004). Ultrasensitive and quantitative analyses
from combined separations-mass spectrometry for the characterization of
proteomes. Accounts of Chemical Research, 37, 269-278.

195

173

Wilm, M., & Mann, M. (1996). Analytical properties of the nanoelectrospray ion
source. Analytical Chemistry, 68, 1-8.

174

Tang, K., Page, J. S., Marginean, I., Kelly, R. T., & Smith, R. D. (2011). Improving
liquid chromatography-mass spectrometry sensitivity using a subambient pressure
ionization with nanoelectrospray (SPIN) interface. Journal of the American Society
for Mass Spectrometry, 22, 1318-1325.

175

Page, J. S., Tang, K., Kelly, R. T., & Smith, R. D. (2008). Subambient pressure
ionization with nanoelectrospray source and interface for improved sensitivity in
mass spectrometry. Analytical Chemistry, 80, 1800-1805.

176

. Hirabayashi, A., Sakairi, M., Koizumi, H. (1994) Sonic Spray Ionization method for
atmospheric-pressure ionization mass-spectrometry. Analytical Chemistry 66, 45574559.

177

. Hirabayashi, A., Hirabayashi, Y., Sakairi, M, Koizumi, H. (1996) Multiply-charged
ion formation by sonic spray, Rapid Communications in Mass Spectrometry 10, 17031705

178

Koehn, F. E., & Carter, G. T. (2005). The evolving role of natural products in drug
discovery. Nature Reviews Drug Discovery, 4, 206-220.

179

Leszczyniecka, M., Roberts, T., Dent, P., Grant, S., & Fisher, P. B. (2001).
Differentiation

therapy

of

human

cancer:

basic

science

and

clinical

applications. Pharmacology & Therapeutics, 90, 105-156.
180

Brown, D., & Superti-Furga, G. (2003). Rediscovering the sweet spot in drug
discovery. Drug Discovery Today, 8, 1067-1077.

196

181

Hertzberg, R. P., & Pope, A. J. (2000). High-throughput screening: new technology
for the 21st century. Current Opinion in Chemical Biology, 4, 445-451.

182

Lapos, J. A., Manica, D. P., & Ewing, A. G. (2002). Dual fluorescence and
electrochemical detection on an electrophoresis microchip. Analytical Chemistry, 74,
3348-3353.

183

Wang, M., Roman, G. T., Perry, M. L., & Kennedy, R. T. (2009). Microfluidic chip
for high efficiency electrophoretic analysis of segmented flow from a microdialysis
probe and in vivo chemical monitoring. Analytical Chemistry, 81, 9072-9078.

184

Trim, P. J., Djidja, M. C., Atkinson, S. J., Oakes, K., Cole, L. M., Anderson, D. M.,
Hart, P. J., Francese, S., & Clench, M. R. (2010). Introduction of a 20 kHz Nd: YVO4
laser into a hybrid quadrupole time-of-flight mass spectrometer for MALDI-MS
imaging.Analytical and Bioanalytical Chemistry, 397, 3409-3419.

185

Kim, T., Udseth, H. R., & Smith, R. D. (2000). Improved ion transmission from
atmospheric pressure to high vacuum using a multicapillary inlet and electrodynamic
ion funnel interface. Analytical Chemistry, 72, 5014-5019.

186

Moini, M., Jiang, L., & Bootwala, S. (2011). High‐throughput analysis using gated
multi‐inlet mass spectrometry. Rapid Communications in Mass Spectrometry, 25,
789-794.

187

Li, J. Y., Chen, Y., Deninno, M. P., O'Connell, T. N., & Hop, C. E. (2005).
Identification of a novel glutathione adduct of diclofenac, 4′-hydroxy-2′-glutathiondeschloro-diclofenac, upon incubation with human liver microsomes. Drug
Metabolism and Disposition 33, 484-488.

197

188

Kim, S., Rodgers, R. P., Blakney, G. T., Hendrickson, C. L., & Marshall, A. G. (2009).
Automated electrospray ionization FT-ICR mass spectrometry for petroleum
analysis. Journal of the American Society for Mass Spectrometry, 20, 263-268.

189

Kertesz, V., & Van Berkel, G. J. (2010). Fully automated liquid extraction‐based
surface sampling and ionization using a chip‐based robotic nanoelectrospray
platform. Journal of Mass Spectrometry, 45, 252-260.

190

Edwards, R. L., Creese, A. J., Baumert, M., Griffiths, P., Bunch, J., & Cooper, H. J.
(2011). Hemoglobin variant analysis via direct surface sampling of dried blood spots
coupled with high-resolution mass spectrometry. Analytical Chemistry, 83, 22652270.

191

van der Hooft, J. J., Vervoort, J., Bino, R. J., & de Vos, R. C. (2012). Spectral trees as
a robust annotation tool in LC–MS based metabolomics. Metabolomics, 8, 691-703.

192

Pei, J., Li, Q., Lee, M. S., Valaskovic, G. A., & Kennedy, R. T. (2009). Analysis of
samples stored as individual plugs in a capillary by electrospray ionization mass
spectrometry. Analytical Chemistry, 81, 6558-6561.

193

Sun, S., Slaney, T. R., & Kennedy, R. T. (2012). Label free screening of enzyme
inhibitors at femtomole scale using segmented flow electrospray ionization mass
spectrometry. Analytical Chemistry, 84, 5794-5800.

194

Sterling, H. J., Cassou, C. A., Susa, A. C., & Williams, E. R. (2012). Electrothermal
supercharging of proteins in native electrospray ionization. Analytical Chemistry, 84,
3795-3801.

198

195

Richards, A. L., Lietz, C. B., Wager-Miller, J., Mackie, K., & Trimpin, S. (2012).
Localization and imaging of gangliosides in mouse brain tissue sections by laserspray
ionization inlet. Journal of Lipid Research, 53, 1390-1398.

196

Chubatyi, N. D., Pagnotti, V. S., Bentzley, C. M., & McEwen, C. N. (2012). High
sensitivity steroid analysis using liquid chromatography/solvent‐assisted inlet
ionization mass spectrometry. Rapid Communications in Mass Spectrometry, 26, 887892.

197

Wang, B., Inutan, E. D., & Trimpin, S. (2012). A new approach to high sensitivity
liquid chromatography-mass spectrometry of peptides using nanoflow solvent
assisted inlet ionization. Journal of the American Society for Mass Spectrometry, 23,
442-445.

198

Pagnotti, V.S., Inutan, E.D., Marshall, D.D., McEwen, C.N., Trimpin, S. (2011). Inlet
ionization: a new highly sensitive approach for liquid chromatography/mass
spectrometry of small and large molecules. Analytical Chemistry 83, 7591-7594.

199

Rohner, T. C., Staab, D., & Stoeckli, M. (2005). MALDI mass spectrometric imaging
of biological tissue sections. Mechanisms of Ageing and Development,126, 177-185.

200

Bushee, J. L., & Argikar, U. A. (2011). An experimental approach to enhance
precursor ion fragmentation for metabolite identification studies: application of dual
collision cells in an orbital trap. Rapid Communications in Mass Spectrometry, 25,
1356-1362.

201

Oswald, S., Peters, J., Venner, M., & Siegmund, W. (2011). LC–MS/MS method for
the simultaneous determination of clarithromycin, rifampicin and their main

199

metabolites in horse plasma, epithelial lining fluid and broncho-alveolar
cells. Journal of Pharmaceutical and Biomedical Analysis, 55, 194-201.
202

Qin, J., & Chait, B. T. (1996). Matrix-assisted laser desorption ion trap mass
spectrometry: efficient trapping and ejection of ions. Analytical Chemistry, 68, 21022107.

203

Ding, L., Sudakov, M., Brancia, F. L., Giles, R., & Kumashiro, S. (2004). A digital
ion trap mass spectrometer coupled with atmospheric pressure ion sources. Journal of
Mass Spectrometry, 39, 471-484.

204

Chi, L., Wolff, J. J., Laremore, T. N., Restaino, O. F., Xie, J., Schiraldi, C., Toida, T.,
Amster, I. J., & Linhardt, R. J. (2008). Structural analysis of bikunin
glycosaminoglycan.Journal of the American Chemical Society, 130, 2617-2625.

205

Laremore, T. N., Leach III, F. E., Solakyildirim, K., Amster, I. J., & Linhardt, R. J.
(2010).

Chapter

Three-Glycosaminoglycan

Characterization

by

Electrospray

Ionization Mass Spectrometry Including Fourier Transform Mass Spectrometry.
Methods in Enzymology, 478, 79-108.
206

Valentine, S. J., Plasencia, M. D., Liu, X., Krishnan, M., Naylor, S., Udseth, H. R.,
Smith, R. D., & Clemmer, D. E. (2006). Toward plasma proteome profiling with ion
mobility-mass spectrometry. Journal of Proteome Research, 5, 2977-2984.

207

Dwivedi, P., & Schultz, A. J. (2010). Metabolic profiling of human blood by highresolution ion mobility mass spectrometry (IM-MS). International Journal of Mass
Spectrometry, 298, 78-90.

208

Devenport, N. A., Reynolds, J. C., Weston, D. J., Wilson, I. D., & Creaser, C. S.
(2012). Direct extraction of urinary analytes from undeveloped reversed-phase thin

200

layer chromatography plates using a solvent gradient combined with on-line
electrospray ionisation ion mobility-mass spectrometry. Analyst, 137, 3510-3513.
209

Wuhrer, M., Stam, J. C., van de Geijn, F. E., Koeleman, C. A., Verrips, C. T., Dolhain,
R. J., Hokke, C. H. & Deelder, A. M. (2007). Glycosylation profiling of
immunoglobulin G (IgG) subclasses from human serum. Proteomics, 7, 4070-4081.

210

Swaney, D. L., Wenger, C. D., Thomson, J. A., & Coon, J. J. (2009). Human
embryonic stem cell phosphoproteome revealed by electron transfer dissociation
tandem mass spectrometry. Proceedings of the National Academy of Sciences, 106,
995-1000.

211

Garcia, B. A., Busby, S. A., Barber, C. M., Shabanowitz, J., Allis, C. D., & Hunt, D. F.
(2004). Characterization of phosphorylation sites on histone H1 isoforms by tandem
mass spectrometry. Journal of Proteome Research, 3, 1219-1227.

212

Udeshi, N. D., Compton, P. D., Shabanowitz, J., Hunt, D. F., & Rose, K. L. (2008).
Methods for analyzing peptides and proteins on a chromatographic timescale by
electron-transfer dissociation mass spectrometry. Nature Protocols, 3, 1709-1717.

213

Motoyama, A., & Yates III, J. R. (2008). Multidimensional LC separations in shotgun
proteomics. Analytical Chemistry, 80, 7187-7193.

214

Delahunty, C., & Yates Iii, J. R. (2005). Protein identification using 2d-lcms/ms. Methods, 35, 248-255.

215

Nyadong, L., Inutan, E. D., Wang, X., Hendrickson, C. L., Trimpin, S., & Marshall, A.
G. (2013). Laserspray and matrix-assisted ionization inlet coupled to high-field FTICR mass spectrometry for peptide and protein analysis. Journal of the American
Society for Mass Spectrometry, 24, 320-328.

201

216

Marshall, A. G., Hendrickson, C. L., & Jackson, G. S. (1998). Fourier transform ion
cyclotron resonance mass spectrometry: a primer. Mass Spectrometry Reviews, 17, 135.

217

Zenobi, R., & Knochenmuss, R. (1998). Ion formation in MALDI mass
spectrometry. Mass Spectrometry Reviews, 17, 337-366.

218

Kinsel, G. R., Gimon‐Kinsel, M. E., Gillig, K. J., & Russell, D. H. (1999).
Investigation of the dynamics of matrix‐assisted laser desorption/ionization ion
formation using an electrostatic analyzer/time‐of‐flight mass spectrometer. Journal of
Mass Spectrometry, 34, 684-690.

219

Fournier, I., Brunot, A., Tabet, J. C., & Bolbach, G. (2002). Delayed extraction
experiments using a repulsive potential before ion extraction: evidence of clusters as
ion precursors in UV-MALDI. Part I: dynamical effects with the matrix 2, 5dihydroxybenzoic acid. International Journal of Mass Spectrometry,213, 203-215.

220

Vestal, M. L. (2009). Modern MALDI time‐of‐flight mass spectrometry. Journal of
Mass Spectrometry, 44, 303-317.

221

Stavenhagen, K., Hinneburg, H., Thaysen‐Andersen, M., Hartmann, L., Silva, D. V.,
Fuchser, J., Kaspar, S., Rapp, E., Seeberger, P. H., & Kolarich, D. (2013).
Quantitative mapping of glycoprotein micro‐heterogeneity and macro‐heterogeneity:
an evaluation of mass spectrometry signal strengths using synthetic peptides and
glycopeptides. Journal of Mass Spectrometry, 48, 627-639.

222

Chakrabarty, S., Pagnotti, V. S., Inutan, E. D., Trimpin, S., & McEwen, C. N. (2013).
A new matrix assisted ionization method for the analysis of volatile and nonvolatile

202

compounds by atmospheric probe mass spectrometry. Journal of The American
Society for Mass Spectrometry, 24, 1102-1107.
223

Mitchell, J.

Jr., Deveraux, H. D. (1978) Determination of traces of organic-

compounds in atmosphere – role of detectors in gas-chromatography. Analytica
Chimica Acta 100, 45-52.
224

Sweeting, L. M., Cashel, M. L., & Rosenblatt, M. M. (1992). Triboluminescence
spectra of organic crystals are sensitive to conditions of acquisition. Journal of
Luminescence, 52, 281-291.

225

Sweeting, L. M. (2001). Triboluminescence with and without air. Chemistry of
Materials, 13, 854-870.

226

Batoy, S. M. A., Borgmann, S., Flick, K., Griffith, J., Jones, J. J., Saraswathi, V.,
Hasty, A. H., Kaiser, P., & Wilkins, C. L. (2009). Lipid and phospholipid profiling of
biological samples using MALDI Fourier transform mass spectrometry. Lipids, 44,
367-371.

227

Catherman, A. D., Li, M., Tran, J. C., Durbin, K. R., Compton, P. D., Early, B. P.,
Thomas, P. M., & Kelleher, N. L. (2013). Top down proteomics of human membrane
proteins from enriched mitochondrial fractions. Analytical Chemistry, 85, 1880-1888.

228

Cooper, H. J., Håkansson, K., & Marshall, A. G. (2005). The role of electron capture
dissociation in biomolecular analysis. Mass Spectrometry Reviews, 24, 201-222.

229

Zubarev, R. A., Kelleher, N. L., & McLafferty, F. W. (1998). Electron capture
dissociation of multiply charged protein cations. A nonergodic process. Journal of the
American Chemical Society, 120, 3265-3266.

203

230

Chi, A., Huttenhower, C., Geer, L. Y., Coon, J. J., Syka, J. E., Bai, D. L., ... & Hunt, D.
F. (2007). Analysis of phosphorylation sites on proteins from Saccharomyces
cerevisiae by electron transfer dissociation (ETD) mass spectrometry. Proceedings of
the National Academy of Sciences, 104, 2193-2198.

231

Lee, M. S., & Kerns, E. H. (1999). LC/MS applications in drug development.Mass
Spectrometry Reviews, 18, 187-279.

232

Fenselau, C., & Demirev, P. A. (2001). Characterization of intact microorganisms by
MALDI mass spectrometry. Mass Spectrometry Reviews,20, 157-171.

233

Vismeh, R., Waldon, D. J., Teffera, Y., & Zhao, Z. (2012). Localization and
quantification of drugs in animal tissues by use of desorption electrospray ionization
mass spectrometry imaging. Analytical Chemistry, 84, 5439-5445.

234

Gygi, S. P., Rist, B., Gerber, S. A., Turecek, F., Gelb, M. H., & Aebersold, R. (1999).
Quantitative analysis of complex protein mixtures using isotope-coded affinity
tags. Nature Biotechnology, 17, 994-999.

235

Li, X., Fang, X., Yu, Z., Sheng, G., Wu, M., Fu, J., & Chen, H. (2012). Direct
quantification of creatinine in human urine by using isotope dilution extractive
electrospray ionization tandem mass spectrometry. Analytica Chimica Acta, 748, 5357.

236

Vanderford, B. J., & Snyder, S. A. (2006). Analysis of pharmaceuticals in water by
isotope dilution liquid chromatography/tandem mass spectrometry. Environmental
Science & Technology, 40, 7312-7320.

237

Keshishian, H., Addona, T., Burgess, M., Kuhn, E., & Carr, S. A. (2007).
Quantitative, multiplexed assays for low abundance proteins in plasma by targeted

204

mass spectrometry and stable isotope dilution. Molecular & Cellular Proteomics, 6,
2212-2229.
238

Dams, R., Huestis, M. A., Lambert, W. E., & Murphy, C. M. (2003). Matrix effect in
bio-analysis of illicit drugs with LC-MS/MS: influence of ionization type, sample
preparation, and biofluid. Journal of the American Society for Mass Spectrometry, 14,
1290-1294.

239

Benijts, T., Dams, R., Lambert, W., & De Leenheer, A. (2004). Countering matrix
effects in environmental liquid chromatography–electrospray ionization tandem mass
spectrometry water analysis for endocrine disrupting chemicals. Journal of
Chromatography A, 1029, 153-159.

240

Jackson, S. N., Wang, H. Y. J., & Woods, A. S. (2005). Direct profiling of lipid
distribution in brain tissue using MALDI-TOFMS. Analytical Chemistry, 77, 45234527.

241

Stoeckli, M., Staab, D., & Schweitzer, A. (2007). Compound and metabolite
distribution measured by MALDI mass spectrometric imaging in whole-body tissue
sections. International Journal of Mass Spectrometry, 260, 195-202.

242

Cornett, D. S., Reyzer, M. L., Chaurand, P., & Caprioli, R. M. (2007). MALDI
imaging mass spectrometry: molecular snapshots of biochemical systems. Nature
methods, 4, 828-833.

243

Stoeckli, M., Chaurand, P., Hallahan, D. E., & Caprioli, R. M. (2001). Imaging mass
spectrometry: a new technology for the analysis of protein expression in mammalian
tissues. Nature medicine, 7, 493-496.

205

244

Krutchinsky, A. N., & Chait, B. T. (2002). On the nature of the chemical noise in
MALDI mass spectra. Journal of the American Society for Mass Spectrometry, 13,
129-134.

245

Puolitaival, S. M., Burnum, K. E., Cornett, D. S., & Caprioli, R. M. (2008). Solventfree matrix dry-coating for MALDI imaging of phospholipids. Journal of the
American Society for Mass Spectrometry, 19, 882-886.

246

Wiseman, J. M., Evans, C. A., Bowen, C. L., & Kennedy, J. H. (2010). Direct analysis
of dried blood spots utilizing desorption electrospray ionization (DESI) mass
spectrometry. Analyst, 135, 720-725.

247

Eberlin, L. S., Ferreira, C. R., Dill, A. L., Ifa, D. R., & Cooks, R. G. (2011).
Desorption electrospray ionization mass spectrometry for lipid characterization and
biological tissue imaging. Biochimica et Biophysica Acta (BBA)-Molecular and Cell
Biology of Lipids, 1811, 946-960.

248

Cooks, R. G., Manicke, N. E., Dill, A. L., Ifa, D. R., Eberlin, L. S., Costa, A. B., ... &
Ouyang, Z. (2011). New ionization methods and miniature mass spectrometers for
biomedicine: DESI imaging for cancer diagnostics and paper spray ionization for
therapeutic drug monitoring. Faraday Discussions, 149, 247-267.

249

Ifa, D. R., Wu, C., Ouyang, Z., & Cooks, R. G. (2010). Desorption electrospray
ionization and other ambient ionization methods: current progress and preview.
Analyst, 135, 669-681.

250

Norris, J. L., & Caprioli, R. M. (2013). Analysis of tissue specimens by matrixassisted laser desorption/ionization imaging mass spectrometry in biological and
clinical research. Chemical Reviews, 113, 2309-2342.

206

251

Chaurand, P., Schriver, K. E., & Caprioli, R. M. (2007). Instrument design and
characterization for high resolution MALDI‐MS imaging of tissue sections. Journal
of Mass Spectrometry, 42, 476-489.

252

Schäfer, K. C., Dénes, J., Albrecht, K., Szaniszló, T., Balog, J., Skoumal, R., ... &
Takáts, Z. (2009). In vivo, in situ tissue analysis using rapid evaporative ionization
mass spectrometry. Angewandte Chemie International Edition, 48, 8240-8242.

253

Wang, B., & Trimpin, S. (2013). High-throughput solvent assisted ionization inlet for
use in mass spectrometry. Analytical chemistry, 86, 1000-1006.

254

Webb, K. J., Xu, T., Park, S. K., & Yates III, J. R. (2013). Modified MuDPIT
separation identified 4488 proteins in a system-wide analysis of quiescence in
yeast. Journal of Proteome Research, 12, 2177-2184.

255

Lutomski, C. A., El-Baba, T. J., Inutan, E. D. V., Manly, C. D., Wager-Miller, J.,
Mackie, K., & Trimpin, S. (2014). Transmission Geometry Laserspray Ionization
Vacuum Using an Atmospheric Pressure Inlet. Analytical Chemistry.

256

Laskin, J., Heath, B. S., Roach, P. J., Cazares, L., & Semmes, O. J. (2011). Tissue
imaging

using

nanospray

desorption

electrospray

ionization

mass

spectrometry. Analytical chemistry, 84, 141-148.
257

Harvey, D. J. (1995). Matrix‐assisted laser desorption/ionization mass spectrometry of
phospholipids. Journal of Mass Spectrometry, 30, 1333-1346.

258

Jackson, S. N., Wang, H. Y. J., & Woods, A. S. (2005). In situ structural
characterization

of

phosphatidylcholines

in

brain

tissue

using

MALDI-

MS/MS.Journal of the American Society for Mass Spectrometry, 16, 2052-2056.

207

259

Baldessarini, R. J., Centorrino, F., Flood, J. G., Volpicelli, S. A., Huston-Lyons, D., &
Cohen, B. M. (1993). Tissue concentrations of clozapine and its metabolites in the
rat. Neuropsychopharmacology, 9, 117-124.

260

Shrestha, B., Nemes, P., Nazarian, J., Hathout, Y., Hoffman, E. P., & Vertes, A.
(2010). Direct analysis of lipids and small metabolites in mouse brain tissue by AP
IR-MALDI and reactive LAESI mass spectrometry. Analyst, 135, 751-758.

208

ABSTRACT
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Inlet ionization and vacuum ionization are novel ionization methods to produce
electrospray ionization (ESI)–like ions from the solid or liquid states, operating from
atmospheric pressure (AP) or vacuum, without the use of voltage or the necessity of high
energy input such as a laser or particle beam. The fundamental aspects were probed for
better understanding of the novel ionization processes. Initial applications were attempted
to utilize the novel ionization methods for fast, robust, and quantitative analyses.
For inlet ionizations (laserspray ionization inlet, LSII; matrix assisted ionization inlet,
MAII; and solvent assisted ionization inlet, SAII), small (e.g. drugs) to large (e.g.
proteins) non-volatile molecules are ionized with the assistance of heat and pressure drop,
and are operated from AP. The ease of operation, rapidness of data acquisition, and
simplicity of coupling with other techniques achieved by SAII, have enabled the inlet
ionization for high throughput multiplexing analyses, hyphenation with liquid
chromatography (especially at low flow rates), and fast surface assessment and drug

209

quantifications. LSII has been utilized together with solvent-free sample preparation and
solvent-free gas-phase separation for total solvent-free analysis.
The production of multiply charged ions from solid states by vacuum ionization was
utilized

to

encompass

the

advantages

from

ESI

and

matrix-assisted

laser

desorption/ionization (MALDI), for better characterization from surfaces and extending
the mass range of high performance mass spectrometers. Operating from AP provides the
potential for vacuum ionization to be applied in high throughput analysis. The continuous
ion formation also benefits matrix assisted ionization vacuum (MAIV) for drug
quantification with better reproducibility.
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